{
  "meta": {
    "id": "test9",
    "title": "Pulmonary Medicine & Critical Care",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A patient with a history of fever for the past 4 days and new onset of breathlessness was admitted to ICU as he was deteriorating. He was unresponsive to the incremental flow rate of oxygen and his oxygen saturation was progressively decreasing. He was intubated and a Chest X-ray was ordered, and the findings are shown in the image below. His PaO2/FiO2 was 204 mmHg. What is the most likely diagnosis? (FMGE JUNE 2021)",
      "options": [
        {
          "label": "A",
          "text": "ARDS",
          "correct": true
        },
        {
          "label": "B",
          "text": "Atelectasis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Heart Failure",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pulmonary Fibrosis",
          "correct": false
        }
      ],
      "correct_answer": "A. ARDS",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/28/screenshot-2024-09-28-175412.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) ARDS</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 ARDS is diagnosed based on acute onset, bilateral infiltrates on chest imaging, non-cardiogenic pulmonary edema, and a PaO2/FiO2 ratio indicative of the severity of hypoxemia. Recognizing these criteria is crucial for timely and appropriate management.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3ea1ba0c",
      "audio": ""
    },
    {
      "text": "According to the berlin definition, moderate ARDS is characterized by all, except: (NEET PG 2018)",
      "options": [
        {
          "label": "A",
          "text": "PaO2/FiO2 ratio 200-300 mm/Hg",
          "correct": true
        },
        {
          "label": "B",
          "text": "Bilateral interstitial infiltrates",
          "correct": false
        },
        {
          "label": "C",
          "text": "Symptom onset within a week",
          "correct": false
        },
        {
          "label": "D",
          "text": "No cardiac failure on echocardiography",
          "correct": false
        }
      ],
      "correct_answer": "A. PaO2/FiO2 ratio 200-300 mm/Hg",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. PaO2/FiO2 ratio 200-300 mm/Hg</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Bilateral interstitial infiltrates: This is correct and consistent with all classifications of ARDS, which require bilateral opacities on imaging, either from chest radiographs or CT, indicative of pulmonary edema not fully explained by cardiac failure or fluid overload.</li><li>\u2022 Option B. Bilateral interstitial infiltrates:</li><li>\u2022 Option C. Symptom onset within a week: True for the Berlin definition, which stipulates that ARDS must occur within 7 days of a known clinical insult or new or worsening respiratory symptoms.</li><li>\u2022 Option C. Symptom onset within a week:</li><li>\u2022 Option D. No cardiac failure on echocardiography: Also true according to the Berlin definition, as the pulmonary edema should not be fully explained by cardiac failure or fluid overload, thus necessitating the exclusion of cardiac failure through echocardiography.</li><li>\u2022 Option D. No cardiac failure on echocardiography:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 2012 Berlin Definition:</li><li>\u27a4 2012 Berlin Definition:</li><li>\u27a4 Onset within 7 days after a known clinical insult or new or worsening respiratory symptoms B/L opacities (Alveolar/Interstitial that are \"consistent with pulmonary edema\" on chest radiographs or chest CT) Minimum PEEP setting or CPAP, 5 cm of water.</li><li>\u27a4 Onset within 7 days after a known clinical insult or new or worsening respiratory symptoms</li><li>\u27a4 Onset within 7 days</li><li>\u27a4 B/L opacities (Alveolar/Interstitial that are \"consistent with pulmonary edema\" on chest radiographs or chest CT)</li><li>\u27a4 \"consistent with pulmonary edema\"</li><li>\u27a4 Minimum PEEP setting or CPAP, 5 cm of water.</li><li>\u27a4 PaO 2 : FiO 2 assessed on invasive mechanical ventilation (CPAP criterion used for the diagnosis of mild ARDS).</li><li>\u27a4 Categorization of ARDS severity (on the basis of FiO 2 ):</li><li>\u27a4 Categorization of ARDS severity (on the basis of FiO 2 ):</li><li>\u27a4 Mild: 200-300 Moderate: 100-200 Severe: <100</li><li>\u27a4 Mild: 200-300</li><li>\u27a4 Moderate: 100-200</li><li>\u27a4 Severe: <100</li><li>\u27a4 In resource limited settings Kigali Modifications was proposed (2016):</li><li>\u27a4 Kigali Modifications</li><li>\u27a4 Bilateral opacities could be documented by either ultrasonography or chest radiograph . Oxygenation criteria: pulse oximetry oxygen saturation (SpO 2 )/FiO 2 ratio \u2264 315 without the requirement for PEEP.</li><li>\u27a4 Bilateral opacities could be documented by either ultrasonography or chest radiograph .</li><li>\u27a4 Oxygenation criteria: pulse oximetry oxygen saturation (SpO 2 )/FiO 2 ratio \u2264 315 without the requirement for PEEP.</li><li>\u27a4 (SpO 2 )/FiO 2 ratio \u2264 315 without the requirement for PEEP.</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference - Harrison/Respiratory Failure/Chap 301</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "845a94d4",
      "audio": ""
    },
    {
      "text": "A 60-year-old man presents to the emergency department with severe shortness of breath and confusion. On examination, he is febrile, has a turbid urine and tachypneic with diffuse crackles heard on lung auscultation. His arterial blood gas (ABG) shows pH 7.50, PaCO2 30 mmHg, and PaO2 45 mmHg despite being on 100% oxygen. What is the most likely cause of his hypoxemia ?",
      "options": [
        {
          "label": "A",
          "text": "Pulmonary embolism",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pneumonia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypoventilation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acute Respiratory Distress Syndrome (ARDS)",
          "correct": true
        }
      ],
      "correct_answer": "D. Acute Respiratory Distress Syndrome (ARDS)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Acute Respiratory Distress Syndrome (ARDS)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Pulmonary embolism: Typically causes an increased V/Q ratio and can result in hypoxemia, but it often responds to 100% oxygen.</li><li>\u2022 Option A. Pulmonary embolism:</li><li>\u2022 Option B. Pneumonia : Causes hypoxemia due to V/Q mismatch or shunting, but some improvement is usually seen with 100% oxygen.</li><li>\u2022 Option B. Pneumonia</li><li>\u2022 Option C. Hypoventilation : Leads to hypercapnia and hypoxemia but usually presents with a normal A-a gradient and improves with supplemental oxygen.</li><li>\u2022 Option C. Hypoventilation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 ARDS causes severe V/Q mismatch and shunting due to widespread inflammation and damage to the alveolar-capillary membrane, leading to refractory hypoxemia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a56d2fd7",
      "audio": ""
    },
    {
      "text": "A 55-year-old woman presents to the emergency department with sudden onset of shortness of breath and pleuritic chest pain. Her arterial blood gas (ABG) shows pH 7.45, PaCO2 35 mmHg, and PaO2 60 mmHg on room air. Which condition is associated with an increased V/Q ratio and results in increased dead space ?",
      "options": [
        {
          "label": "A",
          "text": "Pulmonary embolism",
          "correct": true
        },
        {
          "label": "B",
          "text": "Severe pneumonia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Atelectasis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pulmonary arteriovenous malformation",
          "correct": false
        }
      ],
      "correct_answer": "A. Pulmonary embolism",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Pulmonary embolism</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Severe pneumonia : Typically causes a decreased V/Q ratio due to alveolar filling with inflammatory exudate, leading to a shunt-like effect.</li><li>\u2022 Option B.</li><li>\u2022 Severe pneumonia</li><li>\u2022 Option C. Atelectasis : Causes a decreased V/Q ratio due to collapse of alveoli, leading to areas of the lung being under-ventilated.</li><li>\u2022 Option C.</li><li>\u2022 Atelectasis</li><li>\u2022 Option D. Pulmonary arteriovenous malformation : Typically causes a right-to-left shunt, leading to a decreased V/Q ratio and hypoxemiaTop of Form</li><li>\u2022 Option D.</li><li>\u2022 Pulmonary arteriovenous malformation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Pulmonary embolism increases the V/Q ratio and dead space by obstructing blood flow, causing areas of the lung to be ventilated but not perfused, leading to hypoxemia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1b877533",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman with a history of COPD exacerbation is brought to the emergency department with worsening shortness of breath and wheezing. Her arterial blood gas (ABG) shows a PaO2 of 55 mmHg on room air. The intervening physician decides to deliver oxygen precisely at 24-28% FiO2. Which oxygen delivery system would be most appropriate for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Simple nasal cannula (SNC)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Non-rebreather mask (NRBM)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Venturi mask",
          "correct": true
        },
        {
          "label": "D",
          "text": "Partial rebreather mask (PRBM)",
          "correct": false
        }
      ],
      "correct_answer": "C. Venturi mask",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)Venturi mask</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Simple nasal cannula (SNC): Provides variable FiO2 (24-44%) depending on the flow rate and the patient's breathing pattern, which does not ensure consistent oxygen delivery.</li><li>\u2022 Option A. Simple nasal cannula (SNC):</li><li>\u2022 Option B. Non-rebreather mask (NRBM): Delivers a high FiO2 (60-90%) but does so variably and is generally used for short-term situations due to the risk of oxygen toxicity.</li><li>\u2022 Option B. Non-rebreather mask (NRBM):</li><li>\u2022 Option D. Partial rebreather mask (PRBM): Provides a variable FiO2 (40-70%) and is less precise in delivering a controlled and consistent oxygen concentration, which is not ideal for patients with COPD who need stable oxygen levels.</li><li>\u2022 Option D. Partial rebreather mask (PRBM):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The Venturi mask provides a controlled FiO2, ideal for patients needing consistent oxygen levels, such as those with COPD exacerbation, ensuring precise delivery of the desired oxygen concentration.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8e0dd25a",
      "audio": ""
    },
    {
      "text": "A 65-year-old patient in the ICU has just been extubated after mechanical ventilation. The medical team wants to prevent reintubation by providing adequate respiratory support. Which oxygen delivery system should be considered?",
      "options": [
        {
          "label": "A",
          "text": "Simple nasal cannula (SNC)",
          "correct": false
        },
        {
          "label": "B",
          "text": "High flow nasal oxygen (HFNO)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Simple face mask (SFM)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Non-rebreather mask (NRBM)",
          "correct": false
        }
      ],
      "correct_answer": "B. High flow nasal oxygen (HFNO)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) \u00a0High flow nasal oxygen (HFNO)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Simple nasal cannula (SNC): Provides variable and lower flow rates (1-6 L/min) with FiO2 ranging from 24-44%, which may not be sufficient for post-extubation support.</li><li>\u2022 Option A. Simple nasal cannula (SNC):</li><li>\u2022 Option C. Simple face mask (SFM): Delivers variable FiO2 (35-60%) with flow rates of 5-10 L/min, but does not provide the high flow and CPAP-like effects needed for post-extubation support.</li><li>\u2022 Option C. Simple face mask (SFM):</li><li>\u2022 Option D. Non-rebreather mask (NRBM): Provides high FiO2 (60-90%) and is suitable for short-term use in severe hypoxemia, but does not offer the same level of support and comfort as HFNO for preventing reintubation in post-extubation patients.</li><li>\u2022 Option D. Non-rebreather mask (NRBM):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 High flow nasal oxygen (HFNO) provides effective respiratory support and reduces the risk of reintubation in post-extubation patients by delivering high oxygen flow rates, CPAP-like effects, and reducing inspiratory effort.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a1fcdd57",
      "audio": ""
    },
    {
      "text": "Match the Oxygen delivery systems:",
      "options": [
        {
          "label": "A",
          "text": "A \u2013 iv, B-i, C-iv, D-iii",
          "correct": false
        },
        {
          "label": "B",
          "text": "A-iii, B-iv, C-i, D-ii",
          "correct": false
        },
        {
          "label": "C",
          "text": "A-iii, B-i, C-iv, D-ii",
          "correct": true
        },
        {
          "label": "D",
          "text": "A-i, B-ii, C-iii, D-iv",
          "correct": false
        }
      ],
      "correct_answer": "C. A-iii, B-i, C-iv, D-ii",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-120216.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) A-iii, B-i, C-iv, D-ii</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Understand and correctly identify the various oxygen delivery systems and their corresponding features to ensure appropriate usage in clinical settings.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "540db519",
      "audio": ""
    },
    {
      "text": "A 68-year-old woman with a history of congestive heart failure (CHF) and chronic obstructive pulmonary disease (COPD) presents to the emergency department with severe shortness of breath, a respiratory rate of 28 breaths per minute, and signs of increased work of breathing. The medical team considers initiating non-invasive ventilation (NIV). All of the following are contraindications except:",
      "options": [
        {
          "label": "A",
          "text": "Claustrophobia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Severe upper gastrointestinal bleeding (UGIB)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Poor mask fit",
          "correct": false
        },
        {
          "label": "D",
          "text": "Severe dyspnea with increased work of breathing",
          "correct": true
        }
      ],
      "correct_answer": "D. Severe dyspnea with increased work of breathing",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Severe dyspnea with increased work of breathing</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Claustrophobia: Patients with claustrophobia may not tolerate the mask required for NIV, making it a contraindication.</li><li>\u2022 Option A. Claustrophobia:</li><li>\u2022 Option B. Severe upper gastrointestinal bleeding (UGIB): UGIB poses a risk for aspiration, which can be exacerbated by positive pressure ventilation, making NIV unsafe.</li><li>\u2022 Option B. Severe upper gastrointestinal bleeding (UGIB):</li><li>\u2022 Option C. Poor mask fit: An effective seal is crucial for NIV to work properly. Poor mask fit can lead to air leaks, reducing the efficacy of the treatment and increasing the risk of failure.</li><li>\u2022 Option C. Poor mask fit:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b6f9a3a7",
      "audio": ""
    },
    {
      "text": "A 72-year-old man with a history of congestive heart failure (CHF) is in the ICU after being successfully extubated following mechanical ventilation. During a spontaneous breathing trial (SBT), his PaCO2 is measured at 48 mmHg. What is the most appropriate management to reduce this risk?",
      "options": [
        {
          "label": "A",
          "text": "Initiate NIPPV for 24 hours post-extubation",
          "correct": true
        },
        {
          "label": "B",
          "text": "Place the patient on a simple nasal cannula",
          "correct": false
        },
        {
          "label": "C",
          "text": "Observe without additional support",
          "correct": false
        },
        {
          "label": "D",
          "text": "Reintubate immediately",
          "correct": false
        }
      ],
      "correct_answer": "A. Initiate NIPPV for 24 hours post-extubation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Initiate NIPPV for 24 hours post-extubation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Place the patient on a simple nasal cannula: This provides supplemental oxygen but does not offer the same level of respiratory support as NIPPV, which is crucial for preventing reintubation in high-risk patients.</li><li>\u2022 Option B. Place the patient on a simple nasal cannula:</li><li>\u2022 Option C. Observe without additional support: Observation alone does not address the underlying risk of respiratory failure and reintubation in a high-risk patient.</li><li>\u2022 Option C. Observe without additional support:</li><li>\u2022 Option D. Reintubate immediately: Immediate reintubation is not necessary if the patient is currently stable and NIPPV can provide sufficient support to prevent respiratory failure.</li><li>\u2022 Option D. Reintubate immediately:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 NIPPV should be initiated for 24 hours post-extubation in high-risk patients to reduce the risk of reintubation and associated mortality.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "85936b77",
      "audio": ""
    },
    {
      "text": "Identify A and B:",
      "options": [
        {
          "label": "A",
          "text": "A-EPAP, B-IPAP",
          "correct": true
        },
        {
          "label": "B",
          "text": "A-IPAP, B-EPAP",
          "correct": false
        },
        {
          "label": "C",
          "text": "A-CPAP, B-IPAP",
          "correct": false
        },
        {
          "label": "D",
          "text": "A-IPAP, B-CPAP",
          "correct": false
        }
      ],
      "correct_answer": "A. A-EPAP, B-IPAP",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-104756.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) A-EPAP, B-IPAP</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. A-IPAP, B-EPAP: This is incorrect because A represents the lower pressure during exhalation (EPAP), and B represents the higher pressure during inhalation (IPAP), not the other way around.</li><li>\u2022 Option B. A-IPAP, B-EPAP:</li><li>\u2022 Option C. A-CPAP, B-IPAP: This is incorrect because CPAP provides a constant level of pressure throughout the breathing cycle, not the variable pressures shown in the image. The image illustrates the variable pressures of BPAP, not CPAP.</li><li>\u2022 Option C. A-CPAP, B-IPAP:</li><li>\u2022 Option D. A-IPAP, B-CPAP: This is incorrect because CPAP provides a single, continuous pressure and does not have variable pressures like those shown for IPAP and EPAP in the image. The image illustrates BPAP, with A as EPAP and B as IPAP.</li><li>\u2022 Option D. A-IPAP, B-CPAP:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 In bilevel positive airway pressure (BPAP) therapy, EPAP (Expiratory Positive Airway Pressure) keeps airways open during exhalation, while IPAP (Inspiratory Positive Airway Pressure) provides support during inhalation to improve ventilation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bcfb77c1",
      "audio": ""
    },
    {
      "text": "All are features of the MOANS criteria except:",
      "options": [
        {
          "label": "A",
          "text": "Mask seal",
          "correct": false
        },
        {
          "label": "B",
          "text": "Obesity",
          "correct": false
        },
        {
          "label": "C",
          "text": "Age",
          "correct": false
        },
        {
          "label": "D",
          "text": "Neck mobility",
          "correct": true
        }
      ],
      "correct_answer": "D. Neck mobility",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Neck mobility</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Mask seal: Difficulty in achieving a proper mask seal due to facial hair, facial injuries, etc., is a feature of MOANS.</li><li>\u2022 Option A. Mask seal:</li><li>\u2022 Option B. Obesity: Obesity is a factor in the MOANS criteria that can complicate bag-mask ventilation due to increased airway obstruction and difficulty in ventilation.</li><li>\u2022 Option B. Obesity:</li><li>\u2022 Option C. Age: Age over 55 can affect airway anatomy and lung compliance, making ventilation more challenging.</li><li>\u2022 Option C. Age:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Neck mobility is part of the LEMON criteria for assessing difficult intubation, not the MOANS criteria for predicting difficult bag-mask ventilation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1c6a308d",
      "audio": ""
    },
    {
      "text": "All are features of the LEMON criteria except:",
      "options": [
        {
          "label": "A",
          "text": "Look externally",
          "correct": false
        },
        {
          "label": "B",
          "text": "Evaluate 3-3-2 rule",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mallampati score",
          "correct": false
        },
        {
          "label": "D",
          "text": "No teeth",
          "correct": true
        }
      ],
      "correct_answer": "D. No teeth",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) No teeth</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Look externally: This involves a visual assessment of external features that might predict difficulty with intubation.</li><li>\u2022 Option A. Look externally:</li><li>\u2022 Option B. Evaluate 3-3-2 rule: This assesses mouth opening, mandible space, and neck distance to predict intubation difficulty.</li><li>\u2022 Option B. Evaluate 3-3-2 rule:</li><li>\u2022 Option C. Mallampati score: This evaluates the visibility of oropharyngeal structures to predict intubation difficulty.</li><li>\u2022 Option C. Mallampati score:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 \"No teeth\" is part of the MOANS criteria for assessing difficult bag-mask ventilation, not the LEMON criteria for predicting difficult intubation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5e6b2f11",
      "audio": ""
    },
    {
      "text": "A 54-year-old man is being assessed for intubation. The clinician uses the Mallampati score to evaluate the visibility of the oropharyngeal structures. Which of the following best describes a Mallampati Grade III?",
      "options": [
        {
          "label": "A",
          "text": "Entire soft palate, uvula, and tonsillar pillars are visible",
          "correct": false
        },
        {
          "label": "B",
          "text": "Soft palate, base of uvula, and part of the tonsillar pillars are visible",
          "correct": false
        },
        {
          "label": "C",
          "text": "Soft palate and base of uvula are visible, but the tonsillar pillars are not visible",
          "correct": true
        },
        {
          "label": "D",
          "text": "Only the hard palate is visible",
          "correct": false
        }
      ],
      "correct_answer": "C. Soft palate and base of uvula are visible, but the tonsillar pillars are not visible",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-093638.png"
      ],
      "explanation": "<p><strong>Ans. C) Soft palate and base of uvula are visible, but the tonsillar pillars are not visible</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Entire soft palate, uvula, and tonsillar pillars are visible: This describes a Mallampati Grade I, indicating an easy intubation.</li><li>\u2022 Option A. Entire soft palate, uvula, and tonsillar pillars are visible:</li><li>\u2022 Option B. Soft palate, base of uvula, and part of the tonsillar pillars are visible: This describes a Mallampati Grade II, suggesting a slightly more difficult intubation than Grade I.</li><li>\u2022 Option B. Soft palate, base of uvula, and part of the tonsillar pillars are visible:</li><li>\u2022 Option D. Only the hard palate is visible: This describes a Mallampati Grade IV, indicating a very difficult intubation.</li><li>\u2022 Option D. Only the hard palate is visible:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A Mallampati Grade III indicates that the soft palate and base of the uvula are visible, but the tonsillar pillars are not visible, predicting a moderately difficult intubation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e83b54e9",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman is undergoing intubation, and the clinician uses the Cormack-Lehane classification to describe the view of the glottis during laryngoscopy. Which of the following best describes a Cormack-Lehane Grade III view?",
      "options": [
        {
          "label": "A",
          "text": "Full view of the glottis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Partial view of the glottis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Only the epiglottis is visible, no part of the glottis can be seen",
          "correct": true
        },
        {
          "label": "D",
          "text": "Neither the glottis nor the epiglottis is visible",
          "correct": false
        }
      ],
      "correct_answer": "C. Only the epiglottis is visible, no part of the glottis can be seen",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Only the epiglottis is visible, no part of the glottis can be seen</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Full view of the glottis: This describes a Cormack-Lehane Grade I, indicating an easy intubation.</li><li>\u2022 Option A. Full view of the glottis:</li><li>\u2022 Option B. Partial view of the glottis: This describes a Cormack-Lehane Grade II, suggesting a moderately difficult intubation.</li><li>\u2022 Option B. Partial view of the glottis:</li><li>\u2022 Option D. Neither the glottis nor the epiglottis is visible: This describes a Cormack-Lehane Grade IV, indicating a very difficult intubation.</li><li>\u2022 Option D. Neither the glottis nor the epiglottis is visible:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A Cormack-Lehane Grade III view indicates that only the epiglottis is visible, with no view of the glottis, predicting a difficult intubation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "aef14c81",
      "audio": ""
    },
    {
      "text": "A 55-year-old obese patient with a history of obstructive sleep apnea presents with breathlessness. Rapid Sequence Intubation is initiated, and the emergency physician decides to use a modified position for intubation. What is the ideal position ?",
      "options": [
        {
          "label": "A",
          "text": "Simple head extension",
          "correct": false
        },
        {
          "label": "B",
          "text": "Simple head flexion",
          "correct": false
        },
        {
          "label": "C",
          "text": "HEAD/RAMP",
          "correct": true
        },
        {
          "label": "D",
          "text": "Recovery position",
          "correct": false
        }
      ],
      "correct_answer": "C. HEAD/RAMP",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-094119_Lcv5tQt.png"
      ],
      "explanation": "<p><strong>Ans. C) HEAD/RAMP</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Simple head extension: This position may not provide the optimal alignment needed for intubation in obese patients or those with obstructive sleep apnea.</li><li>\u2022 Option A. Simple head extension:</li><li>\u2022 Option B. Simple head flexion: This position is not suitable for intubation as it can obstruct the airway and worsen the glottic view.</li><li>\u2022 Option B. Simple head flexion:</li><li>\u2022 Option D. Recovery position: This position is used for unconscious but breathing patients to maintain an open airway, not for intubation.</li><li>\u2022 Option D. Recovery position:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The HEAD/RAMP (Head-Elevated Laryngoscopy Position/Rapid Airway Management Position) is ideal for intubating obese patients or those with obstructive sleep apnea, aligning the external auditory meatus with the sternal notch to improve glottic view during laryngoscopy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b4de1ad1",
      "audio": ""
    },
    {
      "text": "A 30-year-old man is found unconscious but breathing with a stable pulse at a park. To ensure his airway remains open and to prevent aspiration, the first responder decides to place him in the recovery position. What is the correct description of the recovery position ?",
      "options": [
        {
          "label": "A",
          "text": "Lying flat on his back with head extension",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lying flat on his back with head flexion",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lying on his side with his lower arm extended and upper leg bent",
          "correct": true
        },
        {
          "label": "D",
          "text": "Sitting up with head tilted forward",
          "correct": false
        }
      ],
      "correct_answer": "C. Lying on his side with his lower arm extended and upper leg bent",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/25/screenshot-2024-06-25-171344.png"
      ],
      "explanation": "<p><strong>Ans. C) Lying on his side with his lower arm extended and upper leg bent</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Lying flat on his back with head extension: This position does not protect the airway from aspiration and may not keep it open in an unconscious patient.</li><li>\u2022 Option A. Lying flat on his back with head extension:</li><li>\u2022 Option B. Lying flat on his back with head flexion: This position can obstruct the airway and increase the risk of aspiration.</li><li>\u2022 Option B. Lying flat on his back with head flexion:</li><li>\u2022 Option D. Sitting up with head tilted forward: While this can help maintain an airway, it is not a stable position for an unconscious person and does not prevent aspiration as effectively as the recovery position.</li><li>\u2022 Option D. Sitting up with head tilted forward:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The recovery position involves placing an unconscious but breathing patient on their side with the lower arm extended and the upper leg bent to maintain an open airway and prevent aspiration.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "696d6c29",
      "audio": ""
    },
    {
      "text": "A 45-year-old patient in septic shock requires intubation and sedation. The intensivist gives a bolus of hydrocortisone after intubation. What sedative is given ?",
      "options": [
        {
          "label": "A",
          "text": "Ketamine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Etomidate",
          "correct": true
        },
        {
          "label": "C",
          "text": "Midazolam",
          "correct": false
        },
        {
          "label": "D",
          "text": "Propofol",
          "correct": false
        }
      ],
      "correct_answer": "B. Etomidate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Etomidate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Ketamine: Ketamine does not suppress adrenal function and is known for its bronchodilatory properties and catecholamine release.</li><li>\u2022 Option A. Ketamine:</li><li>\u2022 Option C. Midazolam: Midazolam is an amnestic and antiepileptic but does not have significant effects on adrenal function.</li><li>\u2022 Option C. Midazolam:</li><li>\u2022 Option D. Propofol: Propofol does not suppress adrenal function but can cause hypotension, which is undesirable in septic shock.</li><li>\u2022 Option D. Propofol:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Etomidate is often used for sedation in septic shock due to its excellent sedation profile and minimal hypotensive effects, but it requires administration of hydrocortisone to counteract its adrenal suppression.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2686ba1d",
      "audio": ""
    },
    {
      "text": "A patient presented with refractory status epilepticus and propofol infusion was started. Which of the following is false regarding propofol infusion syndrome (PRIS) ?",
      "options": [
        {
          "label": "A",
          "text": "PRIS is associated with use of high doses of propofol (> 5 mg/kg/h)",
          "correct": false
        },
        {
          "label": "B",
          "text": "PRIS can present with metabolic acidosis and rhabdomyolysis",
          "correct": false
        },
        {
          "label": "C",
          "text": "PRIS is characterized by hyperglycemia",
          "correct": true
        },
        {
          "label": "D",
          "text": "PRIS can lead to cardiac and renal failure",
          "correct": false
        }
      ],
      "correct_answer": "C. PRIS is characterized by hyperglycemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) PRIS is characterized by hyperglycemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. PRIS is associated with high doses of propofol (> 5 mg/kg/h): This is true. High doses and prolonged infusions of propofol are risk factors for developing PRIS.</li><li>\u2022 Option A. PRIS is associated with high doses of propofol (> 5 mg/kg/h):</li><li>\u2022 Option B. PRIS can present with metabolic acidosis and rhabdomyolysis: This is true. Metabolic acidosis and rhabdomyolysis are key features of PRIS.</li><li>\u2022 Option B. PRIS can present with metabolic acidosis and rhabdomyolysis:</li><li>\u2022 Option D. PRIS can lead to cardiac and renal failure: This is true. PRIS can result in severe complications, including cardiac and renal failure.</li><li>\u2022 Option D. PRIS can lead to cardiac and renal failure:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Propofol infusion syndrome (PRIS) is associated with metabolic acidosis, rhabdomyolysis, hyperkalemia, and can lead to cardiac and renal failure, but it is not typically characterized by hyperglycemia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "986cf0e8",
      "audio": ""
    },
    {
      "text": "A patient with a history of asthma presents with status asthmaticus and requires sedation for intubation. Which sedative from the table is the most appropriate choice due to its bronchodilatory properties ?",
      "options": [
        {
          "label": "A",
          "text": "Etomidate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ketamine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Midazolam",
          "correct": false
        },
        {
          "label": "D",
          "text": "Thiopental sodium",
          "correct": false
        }
      ],
      "correct_answer": "B. Ketamine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Ketamine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Etomidate: While Etomidate provides excellent sedation without causing hypotension, it does not have bronchodilatory properties.</li><li>\u2022 Option A. Etomidate:</li><li>\u2022 Option C. Midazolam: Midazolam is an amnestic and antiepileptic but does not have bronchodilatory effects.</li><li>\u2022 Option C. Midazolam:</li><li>\u2022 Option D. Thiopental sodium: Thiopental sodium is a potent sedative and myocardial depressant but is relatively contraindicated in patients with reactive airway disease (RAD) and does not have bronchodilatory properties.</li><li>\u2022 Option D. Thiopental sodium:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ketamine is the preferred sedative for intubation in patients with status asthmaticus due to its bronchodilatory properties, which help manage severe asthma exacerbations.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1dc5636",
      "audio": ""
    },
    {
      "text": "A 40-year-old man with a history of muscular dystrophy presents to the emergency department with severe respiratory distress. The team decides to perform rapid sequence intubation (RSI). Which of the following conditions is NOT a contraindication for the use of succinylcholine in this patient ?",
      "options": [
        {
          "label": "A",
          "text": "Hypokalemia",
          "correct": true
        },
        {
          "label": "B",
          "text": "Malignant hyperthermia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypertension",
          "correct": false
        },
        {
          "label": "D",
          "text": "Muscular dystrophy",
          "correct": false
        }
      ],
      "correct_answer": "A. Hypokalemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Hypokalemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Malignant hyperthermia: Succinylcholine can trigger malignant hyperthermia, a potentially life-threatening condition, making it a contraindication.</li><li>\u2022 Option B. Malignant hyperthermia:</li><li>\u2022 Option C. Hypertension: Hypertension itself is not a contraindication for succinylcholine, but it is important to monitor blood pressure as succinylcholine can have cardiovascular effects.</li><li>\u2022 Option C. Hypertension:</li><li>\u2022 Option D. Muscular dystrophy: Succinylcholine is contraindicated in patients with muscular dystrophy because it can cause severe hyperkalemia and rhabdomyolysis, leading to potentially fatal complications.</li><li>\u2022 Option D. Muscular dystrophy:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hypokalemia is not a contraindication for the use of succinylcholine; however, conditions like malignant hyperthermia and muscular dystrophy are contraindications due to the risk of severe hyperkalemia and other complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9a352fbd",
      "audio": ""
    },
    {
      "text": "A 5-year-old child requires rapid sequence intubation (RSI) due to severe trauma after falling from a height. What is a potential side effect of succinylcholine in this patient ?",
      "options": [
        {
          "label": "A",
          "text": "Hypertension",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bradycardia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Hyperglycemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypothermia",
          "correct": false
        }
      ],
      "correct_answer": "B. Bradycardia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Bradycardia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hypertension: While succinylcholine can cause transient increases in blood pressure, it is not as significant a concern as bradycardia, especially in pediatric patients.</li><li>\u2022 Option A. Hypertension:</li><li>\u2022 Option C. Hyperglycemia: Hyperglycemia is not a known side effect of succinylcholine.</li><li>\u2022 Option C. Hyperglycemia:</li><li>\u2022 Option D. Hypothermia: Succinylcholine is associated with malignant hyperthermia, which is a hypermetabolic state, not hypothermia.</li><li>\u2022 Option D. Hypothermia:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Succinylcholine can cause bradycardia, particularly in pediatric patients, often requiring treatment with atropine.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ae7ab50a",
      "audio": ""
    },
    {
      "text": "A 60-year-old chronic alcoholic with cirrhosis and portal hypertension requires intubation and continuous neuromuscular blockade in the ICU. Which agent is the most appropriate ?",
      "options": [
        {
          "label": "A",
          "text": "Succinylcholine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rocuronium",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vecuronium",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cisatracurium",
          "correct": true
        }
      ],
      "correct_answer": "D. Cisatracurium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Cisatracurium</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Succinylcholine: Succinylcholine is used for rapid sequence intubation due to its fast onset and short duration, but it is not suitable for continuous neuromuscular blockade due to its short duration and potential side effects such as hyperkalemia and malignant hyperthermia.</li><li>\u2022 Option A. Succinylcholine:</li><li>\u2022 Option B. Rocuronium: Rocuronium is primarily metabolized by the liver, making it less suitable for continuous use in patients with significant liver impairment like cirrhosis, due to the risk of prolonged effects.</li><li>\u2022 Option B. Rocuronium:</li><li>\u2022 Option C. Vecuronium: Vecuronium also relies significantly on hepatic metabolism and renal elimination, which can lead to prolonged neuromuscular blockade in patients with liver failure, making it less ideal for continuous use in such patients.</li><li>\u2022 Option C. Vecuronium:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cisatracurium is the preferred agent for continuous neuromuscular blockade in patients with liver dysfunction, such as cirrhosis and portal hypertension, due to its metabolism via Hofmann elimination and ester hydrolysis, which are independent of liver function.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7d8b9fb7",
      "audio": ""
    },
    {
      "text": "A 67-year-old man with sick sinus syndrome requires intubation. Which neuromuscular blocker could be beneficial in him?",
      "options": [
        {
          "label": "A",
          "text": "Succinylcholine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rocuronium",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vecuronium",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pancuronium",
          "correct": true
        }
      ],
      "correct_answer": "D. Pancuronium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Pancuronium</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Succinylcholine: Succinylcholine is not ideal for patients with sick sinus syndrome as it can cause bradycardia and is primarily used for rapid sequence intubation rather than continuous blockade.</li><li>\u2022 Option A. Succinylcholine:</li><li>\u2022 Option B. Rocuronium: Rocuronium does not have vagal blocking properties and would not provide the same benefit in preventing bradycardia.</li><li>\u2022 Option B. Rocuronium:</li><li>\u2022 Option C. Vecuronium: Vecuronium also lacks vagal blocking properties and would not be as beneficial in managing bradycardia associated with sick sinus syndrome.</li><li>\u2022 Option C. Vecuronium:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pancuronium is beneficial for patients with sick sinus syndrome requiring intubation due to its vagal blocking properties, which help mitigate bradycardia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d1b374e1",
      "audio": ""
    },
    {
      "text": "A 22 year old lady patient presents with an anaphylactic shock after consuming a peanut. Which of the following drugs should be avoided?",
      "options": [
        {
          "label": "A",
          "text": "Mivacurium",
          "correct": true
        },
        {
          "label": "B",
          "text": "Etomidate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ketamine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Succinylcholine",
          "correct": false
        }
      ],
      "correct_answer": "A. Mivacurium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Mivacurium</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Etomidate: Etomidate is not known to cause histamine release and is generally considered safe in anaphylactic shock.</li><li>\u2022 Option B. Etomidate:</li><li>\u2022 Option C. Ketamine: Ketamine is also safe in anaphylactic reactions and can be beneficial due to its bronchodilatory properties.</li><li>\u2022 Option C. Ketamine:</li><li>\u2022 Option D. Succinylcholine: While succinylcholine has other side effects, it does not typically cause significant histamine release that would exacerbate anaphylactic shock.</li><li>\u2022 Option D. Succinylcholine:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mivacurium should be avoided in patients experiencing anaphylactic shock as it can cause histamine release, potentially worsening the anaphylactic reaction.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1840ea6c",
      "audio": ""
    },
    {
      "text": "During rapid sequence intubation (RSI), the Sellick maneuver is performed to prevent aspiration. What is a potential complication associated with improper application of this maneuver?",
      "options": [
        {
          "label": "A",
          "text": "Increased gastric reflux",
          "correct": false
        },
        {
          "label": "B",
          "text": "Esophageal rupture",
          "correct": false
        },
        {
          "label": "C",
          "text": "Decreased ventilation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Bronchospasm",
          "correct": false
        }
      ],
      "correct_answer": "C. Decreased ventilation",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-100044.png"
      ],
      "explanation": "<p><strong>Ans. C) Decreased ventilation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Increased gastric reflux: The maneuver is intended to prevent this by occluding the esophagus.</li><li>\u2022 Option A. Increased gastric reflux:</li><li>\u2022 Option B. Esophageal rupture: While theoretically possible, this is extremely rare and not a common complication.</li><li>\u2022 Option B. Esophageal rupture:</li><li>\u2022 Option D. Bronchospasm: This is not typically associated with the Sellick maneuver; it is more related to airway irritants or asthma.</li><li>\u2022 Option D. Bronchospasm:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Improper application of the Sellick maneuver (cricoid pressure) during rapid sequence intubation can lead to decreased ventilation by compressing the trachea or obstructing the airway.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9017caa6",
      "audio": ""
    },
    {
      "text": "A patient is undergoing rapid sequence intubation (RSI), and the initial attempt to visualize the vocal cords is unsuccessful. The clinician applies the BURP maneuver. What is the primary purpose of this maneuver ?",
      "options": [
        {
          "label": "A",
          "text": "To increase the diameter of the trachea",
          "correct": false
        },
        {
          "label": "B",
          "text": "To improve visualization of the vocal cords",
          "correct": true
        },
        {
          "label": "C",
          "text": "To prevent aspiration",
          "correct": false
        },
        {
          "label": "D",
          "text": "To stabilize the patient's neck",
          "correct": false
        }
      ],
      "correct_answer": "B. To improve visualization of the vocal cords",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) To improve visualization of the vocal cords</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. To increase the diameter of the trachea: The maneuver does not affect the tracheal diameter.</li><li>\u2022 Option A. To increase the diameter of the trachea:</li><li>\u2022 Option C. To prevent aspiration: This is not the primary goal of the BURP maneuver; cricoid pressure is used for preventing aspiration.</li><li>\u2022 Option C. To prevent aspiration:</li><li>\u2022 Option D. To stabilize the patient's neck: While it may help to some extent, stabilization is not the primary goal of the BURP maneuver.</li><li>\u2022 Option D. To stabilize the patient's neck:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The primary purpose of the BURP maneuver (Backward Upward Rightward Pressure) is to improve visualization of the vocal cords during intubation by optimizing the position of the larynx.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a11e1111",
      "audio": ""
    },
    {
      "text": "Identify the technique \u2013",
      "options": [
        {
          "label": "A",
          "text": "C-E technique",
          "correct": true
        },
        {
          "label": "B",
          "text": "V-E technique",
          "correct": false
        },
        {
          "label": "C",
          "text": "BURP technique",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sellick technique",
          "correct": false
        }
      ],
      "correct_answer": "A. C-E technique",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-100504.png"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-100609_q8LfTRt.png",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-100826.png",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-100857.png"
      ],
      "explanation": "<p><strong>Ans. A) C-E technique</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. V-E technique: With this technique, the thumbs and thenar eminence are placed over each side of the mask while the second through fifth digits pull the jaw upward</li><li>\u2022 Option B. V-E technique:</li><li>\u2022 Option C. BURP technique: The BURP technique involves applying backward, upward, and rightward pressure on the thyroid cartilage to improve glottic visualization, not related to mask sealing.</li><li>\u2022 Option C. BURP technique:</li><li>\u2022 Option D. Sellick technique: The Sellick technique involves applying pressure to the cricoid cartilage to prevent aspiration, not related to the mask sealing technique shown.</li><li>\u2022 Option D. Sellick technique:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The C-E technique for bag-valve-mask ventilation involves using the thumb and index finger to form a \"C\" shape around the mask to create a seal, while the other three fingers form an \"E\" shape to lift the mandible and open the airway.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "de69c6fd",
      "audio": ""
    },
    {
      "text": "Which reversal agent is used for quick reversal of rocuronium ?",
      "options": [
        {
          "label": "A",
          "text": "Neostigmine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sugammadex",
          "correct": true
        },
        {
          "label": "C",
          "text": "Atropine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Edrophonium",
          "correct": false
        }
      ],
      "correct_answer": "B. Sugammadex",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Sugammadex</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Neostigmine: Neostigmine is a cholinesterase inhibitor used to reverse non-depolarizing neuromuscular blockers, but it is not as rapid or specific as sugammadex for rocuronium.</li><li>\u2022 Option A. Neostigmine:</li><li>\u2022 Option C. Atropine: Atropine is an anticholinergic agent used to treat bradycardia and to reduce secretions, not for reversing neuromuscular blockade.</li><li>\u2022 Option C. Atropine:</li><li>\u2022 Option D. Edrophonium: Edrophonium is a cholinesterase inhibitor used for diagnosing myasthenia gravis and reversing neuromuscular blockade, but it is not as effective or specific as sugammadex for rocuronium.</li><li>\u2022 Option D. Edrophonium:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Sugammadex is the specific and rapid reversal agent for rocuronium, encapsulating the neuromuscular blocking agent to quickly reverse its effects.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a2c0d420",
      "audio": ""
    },
    {
      "text": "A 44-year-old patient presented with severe pneumonia and was intubated. His condition improved and he was planned to extubate. On TOF stimulation, he has a TOF ratio of 0.9. What does this suggest?",
      "options": [
        {
          "label": "A",
          "text": "Safe to extubate",
          "correct": true
        },
        {
          "label": "B",
          "text": "Unsafe to extubate",
          "correct": false
        },
        {
          "label": "C",
          "text": "He is at risk of reintubation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Incomplete recovery from neuromuscular blockade",
          "correct": false
        }
      ],
      "correct_answer": "A. Safe to extubate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Safe to extubate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Unsafe to extubate: A TOFR of 0.9 indicates adequate recovery, so it is not unsafe to extubate.</li><li>\u2022 Option B. Unsafe to extubate:</li><li>\u2022 Option C. He is at risk of reintubation: While all extubated patients should be monitored, a TOFR of 0.9 suggests that the patient has sufficiently recovered from neuromuscular blockade, making the risk of reintubation due to neuromuscular weakness low.</li><li>\u2022 Option C. He is at risk of reintubation:</li><li>\u2022 Option D. Incomplete recovery from neuromuscular blockade: Incomplete recovery is suggested by a TOFR below 0.9; a TOFR of 0.9 indicates complete recovery.</li><li>\u2022 Option D. Incomplete recovery from neuromuscular blockade:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A TOF ratio (TOFR) of 0.9 or higher indicates adequate recovery from neuromuscular blockade, suggesting that it is safe to proceed with extubation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "893d89c5",
      "audio": ""
    },
    {
      "text": "The image shows an end-tidal CO2 (ETCO2) waveform. What does the pattern in the ETCO2 waveform suggest ?",
      "options": [
        {
          "label": "A",
          "text": "Hypoventilation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bronchospasm",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rebreathing",
          "correct": false
        },
        {
          "label": "D",
          "text": "Esophageal intubation",
          "correct": true
        }
      ],
      "correct_answer": "D. Esophageal intubation",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-101651.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Esophageal intubation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hypoventilation: Hypoventilation would show a gradual rise in the ETCO2 levels, not a flat line.</li><li>\u2022 Option A. Hypoventilation:</li><li>\u2022 Option B. Bronchospasm: Bronchospasm typically produces a shark-fin appearance in the ETCO2 waveform due to prolonged expiration.</li><li>\u2022 Option B. Bronchospasm:</li><li>\u2022 Option C. Rebreathing: Rebreathing results in a gradually rising baseline of the ETCO2 waveform, not a flat line.</li><li>\u2022 Option C. Rebreathing:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A flat ETCO2 waveform suggests esophageal intubation, indicating that the endotracheal tube is incorrectly placed in the esophagus rather than the trachea, preventing proper ventilation and resulting in minimal or absent CO2 detection.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1251deea",
      "audio": ""
    },
    {
      "text": "A 60-year-old male patient is undergoing surgery and is intubated with mechanical ventilation. The ETCO2 waveform shown in the image is observed. What does this indicate ?",
      "options": [
        {
          "label": "A",
          "text": "Hypoventilation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Spontaneous diaphragmatic movements",
          "correct": true
        },
        {
          "label": "C",
          "text": "Rebreathing of exhaled gases",
          "correct": false
        },
        {
          "label": "D",
          "text": "Esophageal intubation",
          "correct": false
        }
      ],
      "correct_answer": "B. Spontaneous diaphragmatic movements",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-101933.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Spontaneous diaphragmatic movements</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hypoventilation: Hypoventilation would show elevated ETCO2 levels with longer intervals between the peaks but would not have the characteristic cleft.</li><li>\u2022 Option A. Hypoventilation:</li><li>\u2022 Option C. Rebreathing of exhaled gases: Rebreathing results in a gradually rising baseline of the ETCO2 waveform due to the accumulation of CO2.</li><li>\u2022 Option C. Rebreathing of exhaled gases:</li><li>\u2022 Option D. Esophageal intubation: Esophageal intubation would result in a flat or very low ETCO2 waveform, indicating minimal CO2 detection.</li><li>\u2022 Option D. Esophageal intubation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The \"curare cleft\" in the ETCO2 waveform indicates spontaneous diaphragmatic movements or breaths in a patient who is partially recovering from neuromuscular blockade. This occurs when the effects of muscle relaxants are wearing off, and the patient begins to take spontaneous breaths.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6e941c3a",
      "audio": ""
    },
    {
      "text": "A 55-year-old man presents with sudden onset of chest pain and shortness of breath shortly after the insertion of a subclavian catheter. The chest X-ray shown in the image was taken following the procedure. What is the most likely diagnosis based on the X-ray findings ?",
      "options": [
        {
          "label": "A",
          "text": "Right Hemothorax",
          "correct": false
        },
        {
          "label": "B",
          "text": "Right upper lobe collapse",
          "correct": false
        },
        {
          "label": "C",
          "text": "Right Pneumothorax",
          "correct": true
        },
        {
          "label": "D",
          "text": "Aspiration Pneumonia (R) lower lobe",
          "correct": false
        }
      ],
      "correct_answer": "C. Right Pneumothorax",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-102105.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Right Pneumothorax</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Right Hemothorax: Hemothorax would present with fluid accumulation in the pleural space, appearing as a homogenous opacity on the affected side, not the absence of lung markings seen in pneumothorax.</li><li>\u2022 Option A. Right Hemothorax:</li><li>\u2022 Option B. Right upper lobe collapse: Upper lobe collapse would show signs of volume loss such as elevation of the horizontal fissure, not the absence of lung markings characteristic of pneumothorax.</li><li>\u2022 Option B. Right upper lobe collapse:</li><li>\u2022 Option D. Aspiration Pneumonia (R) lower lobe: Aspiration pneumonia would present with infiltrates or consolidation in the lower lobe, not the absence of lung markings seen in pneumothorax.Top of Form</li><li>\u2022 Option D. Aspiration Pneumonia (R) lower lobe:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The chest X-ray shows a right pneumothorax, indicated by the presence of a visible pleural line with the absence of lung markings beyond this line on the right side, a common complication following subclavian catheter insertion.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "39387a53",
      "audio": ""
    },
    {
      "text": "A 70-year-old female patient requires the insertion of a nasogastric (NG) tube for feeding. What describes the best method to ensure adequate length of the tube ?",
      "options": [
        {
          "label": "A",
          "text": "Measuring from the nose to the xiphoid process",
          "correct": false
        },
        {
          "label": "B",
          "text": "Measuring from the nose to the earlobe to the xiphoid process",
          "correct": true
        },
        {
          "label": "C",
          "text": "Measuring from the nose to the earlobe to the umbilicus",
          "correct": false
        },
        {
          "label": "D",
          "text": "Measuring from the nose to the sternum to the umbilicus",
          "correct": false
        }
      ],
      "correct_answer": "B. Measuring from the nose to the earlobe to the xiphoid process",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Measuring from the nose to the earlobe to the xiphoid process</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Measuring from the nose to the xiphoid process: This method does not account for the curvature of the nasopharynx and esophagus.</li><li>\u2022 Option A. Measuring from the nose to the xiphoid process:</li><li>\u2022 Option C. Measuring from the nose to the earlobe to the umbilicus: This method would result in an excessively long tube length.</li><li>\u2022 Option C. Measuring from the nose to the earlobe to the umbilicus:</li><li>\u2022 Option D. Measuring from the nose to the sternum to the umbilicus: This method is not a recognized technique for NG tube placement and would result in an incorrect tube length.</li><li>\u2022 Option D. Measuring from the nose to the sternum to the umbilicus:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The NEX method for measuring the adequate length of a nasogastric (NG) tube involves measuring from the nose (N) to the earlobe (E) to the xiphoid process (X) to ensure the tube reaches the stomach without coiling in the esophagus or stopping short.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "88d77938",
      "audio": ""
    },
    {
      "text": "A 28-year-old male patient presents to the emergency department after a motor vehicle accident. He is experiencing severe shortness of breath and chest pain on the left side. The chest X-ray shown in the image was taken upon arrival. What is the most likely diagnosis based on the X-ray findings ?",
      "options": [
        {
          "label": "A",
          "text": "Right Hemothorax",
          "correct": false
        },
        {
          "label": "B",
          "text": "Right Pneumothorax",
          "correct": false
        },
        {
          "label": "C",
          "text": "Right endobronchial intubation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Left Tension Pneumothorax",
          "correct": false
        }
      ],
      "correct_answer": "C. Right endobronchial intubation",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-102454.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Right endobronchial intubation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Right Hemothorax: A hemothorax would present with fluid accumulation, appearing as a homogenous opacity on the affected side rather than hyperinflation of one lung and collapse of the other.</li><li>\u2022 Option A. Right Hemothorax:</li><li>\u2022 Option B. Right Pneumothorax: A pneumothorax would show absence of lung markings on the affected side and potentially tracheal deviation, not hyperinflation and collapse.</li><li>\u2022 Option B. Right Pneumothorax:</li><li>\u2022 Option D. Left Tension Pneumothorax: A tension pneumothorax would show absence of lung markings on the affected side and tracheal deviation away from the affected side, which is not seen here.</li><li>\u2022 Option D. Left Tension Pneumothorax:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The chest X-ray shows hyperinflation of the right lung and collapse of the left lung, indicating right endobronchial intubation, where the endotracheal tube is inserted too far and enters the right mainstem bronchus, leading to overventilation of the right lung and collapse of the left lung.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "20aa7439",
      "audio": ""
    },
    {
      "text": "A 55-year-old female patient is on mechanical ventilation and is being weaned off. Which mode of ventilation is best in this situation ?",
      "options": [
        {
          "label": "A",
          "text": "IMV",
          "correct": false
        },
        {
          "label": "B",
          "text": "SIMV",
          "correct": false
        },
        {
          "label": "C",
          "text": "AC",
          "correct": false
        },
        {
          "label": "D",
          "text": "PSV",
          "correct": true
        }
      ],
      "correct_answer": "D. PSV",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) PSV</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. IMV: Intermittent Mandatory Ventilation provides a set number of mandatory breaths per minute with no support to patient-initiated breaths, which is not ideal for weaning.</li><li>\u2022 Option A. IMV:</li><li>\u2022 Option B. SIMV: Synchronized Intermittent Mandatory Ventilation provides a set number of mandatory breaths per minute with synchronized support to patient-initiated breaths, but it may still provide more support than necessary for a weaning patient.</li><li>\u2022 Option B. SIMV:</li><li>\u2022 Option C. AC: Assist Control Ventilation provides a set number of mandatory breaths per minute with full support to any additional breaths initiated by the patient, which is ideal to support respiratory failure but not during weaning.</li><li>\u2022 Option C. AC:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pressure Support Ventilation (PSV) is the most suitable mode for weaning a patient off mechanical ventilation as it provides partial support to patient-initiated breaths, facilitating gradual assumption of breathing effort by the patient.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bfd44e15",
      "audio": ""
    },
    {
      "text": "A 65-year-old male with acute respiratory distress syndrome (ARDS) is admitted to the ICU and placed on mechanical ventilation. The physician needs to set the ventilator to ensure the patient receives a fixed number of mandatory breaths per minute with full support to patient-initiated breaths. Which mode of ventilation should be used ?",
      "options": [
        {
          "label": "A",
          "text": "Assist Control (AC)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Intermittent Mandatory Ventilation (IMV)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Synchronized Intermittent Mandatory Ventilation (SIMV)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pressure Support Ventilation (PSV)",
          "correct": false
        }
      ],
      "correct_answer": "A. Assist Control (AC)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Assist Control (AC)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Intermittent Mandatory Ventilation (IMV): IMV delivers a set number of mandatory breaths per minute but does not provide support for patient-initiated breaths, making it less suitable for a patient requiring full support.</li><li>\u2022 Option B. Intermittent Mandatory Ventilation (IMV):</li><li>\u2022 Option C. Synchronized Intermittent Mandatory Ventilation (SIMV): SIMV delivers a set number of mandatory breaths per minute and synchronizes support with patient-initiated breaths but does not provide full support to each breath, which may not be sufficient for severe ARDS.</li><li>\u2022 Option C. Synchronized Intermittent Mandatory Ventilation (SIMV):</li><li>\u2022 Option D. Pressure Support Ventilation (PSV): PSV does not deliver mandatory breaths and only provides support to spontaneous breaths, which is not adequate for a patient with severe ARDS who requires consistent mandatory ventilation support.</li><li>\u2022 Option D. Pressure Support Ventilation (PSV):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Assist Control (AC) ventilation is suitable for patients with ARDS as it provides a set number of mandatory breaths per minute with full support to any patient-initiated breaths, ensuring consistent ventilatory support.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ff0b252d",
      "audio": ""
    },
    {
      "text": "A 68-year-old male patient with ARDS is on mechanical ventilation. What is the target peak Plateau pressure (P-PLATEAU) to ensure lung protection?",
      "options": [
        {
          "label": "A",
          "text": "\u2264 20 cm H2O",
          "correct": false
        },
        {
          "label": "B",
          "text": "\u2264 25 cm H2O",
          "correct": false
        },
        {
          "label": "C",
          "text": "\u2264 30 cm H2O",
          "correct": true
        },
        {
          "label": "D",
          "text": "\u2264 40 cm H2O",
          "correct": false
        }
      ],
      "correct_answer": "C. \u2264 30 cm H2O",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) \u2264 30 cm H2O</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. \u2264 20 cm H2O: While a plateau pressure this low would certainly minimize the risk of VILI, it is often not practical or achievable in patients with ARDS who require higher pressures to maintain adequate oxygenation and ventilation.</li><li>\u2022 Option A. \u2264 20 cm H2O:</li><li>\u2022 Option B. \u2264 25 cm H2O: Incorrect since the target plateau pressure is \u2264 30 cm H2O</li><li>\u2022 Option B. \u2264 25 cm H2O:</li><li>\u2022 Option D. \u2264 40 cm H2O: This is the target PIP (Peak Inspiratory Pressure) and not plateau pressure.</li><li>\u2022 Option D. \u2264 40 cm H2O:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For patients with ARDS on mechanical ventilation, the target plateau pressure (P-PLATEAU) should be \u2264 30 cm H2O to minimize the risk of ventilator-induced lung injury.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "859d4bb5",
      "audio": ""
    },
    {
      "text": "For a ventilated patient, the tidal volume (VT) is 350 mL, PEEP is 5 cm H2O and Plateau pressure is 40 cm H2O. What is the inference?",
      "options": [
        {
          "label": "A",
          "text": "C = 10, Poor compliance",
          "correct": true
        },
        {
          "label": "B",
          "text": "C = 60, good compliance",
          "correct": false
        },
        {
          "label": "C",
          "text": "C = 10, good compliance",
          "correct": false
        },
        {
          "label": "D",
          "text": "C = 60, poor compliance",
          "correct": false
        }
      ],
      "correct_answer": "A. C = 10, Poor compliance",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) C = 10, Poor compliance</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. C = 60, good compliance: Incorrect calculation and interpretation. Compliance is not 60 and poor compliance is inferred.</li><li>\u2022 Option B. C = 60, good compliance:</li><li>\u2022 Option C. C = 10, good compliance: The calculation is correct, but compliance of 10 is poor, not good.</li><li>\u2022 Option C. C = 10, good compliance:</li><li>\u2022 Option D. C = 60, poor compliance: Incorrect calculation. Compliance of 60 mL/cm H2O would indicate good compliance, not poor.</li><li>\u2022 Option D. C = 60, poor compliance:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For ventilated patients, a compliance value significantly lower than 60 mL/cm H2O indicates poor lung compliance, reflecting increased lung stiffness or decreased distensibility.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3648285c",
      "audio": ""
    },
    {
      "text": "A 56-year-old woman with history of SLE presents to the emergency department with sudden onset of severe shortness of breath. She is rapidly intubated due to respiratory failure. During mechanical ventilation, both the peak inspiratory pressure (PIP) and plateau pressure (P-PLATEAU) are observed to be within normal limits. What is the most likely cause of her symptoms ?",
      "options": [
        {
          "label": "A",
          "text": "Bronchospasm",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pulmonary embolism",
          "correct": true
        },
        {
          "label": "C",
          "text": "Acute Respiratory Distress Syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pneumonia",
          "correct": false
        }
      ],
      "correct_answer": "B. Pulmonary embolism",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Pulmonary embolism</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Bronchospasm: This condition usually increases airway resistance, leading to elevated PIP with a normal P-PLATEAU.</li><li>\u2022 Option A. Bronchospasm:</li><li>\u2022 Option C. Acute Respiratory Distress Syndrome: ARDS typically results in decreased lung compliance, causing increased PIP and P-PLATEAU.</li><li>\u2022 Option C. Acute Respiratory Distress Syndrome:</li><li>\u2022 Option D. Pneumonia: Pneumonia can cause increased airway pressures due to reduced compliance or increased secretions, typically resulting in elevated PIP and sometimes P-PLATEAU depending on the severity and extent of the infection.</li><li>\u2022 Option D. Pneumonia:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Normal PIP and P-PLATEAU in mechanically ventilated patients with severe respiratory symptoms suggest an extra-thoracic cause such as pulmonary embolism.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5bbf8f85",
      "audio": ""
    },
    {
      "text": "A 45-year-old male with a history of chronic obstructive pulmonary disease (COPD) is admitted to the ICU with severe respiratory distress. He is placed on mechanical ventilation. During his course, you observe an increase in plateau pressure (P-PLATEAU). Which condition is most likely causing the increase P-PLATEAU?",
      "options": [
        {
          "label": "A",
          "text": "Pulmonary embolism",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bronchospasm",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pneumothorax",
          "correct": true
        },
        {
          "label": "D",
          "text": "Aspiration of mucus",
          "correct": false
        }
      ],
      "correct_answer": "C. Pneumothorax",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Pneumothorax</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Pulmonary embolism: Presents with normal pressures</li><li>\u2022 Option A. Pulmonary embolism:</li><li>\u2022 Option B. Bronchospasm: Bronchospasm increases airway resistance, which would elevate PIP but not P-PLATEAU because the issue lies within the airways rather than lung compliance.</li><li>\u2022 Option B. Bronchospasm:</li><li>\u2022 Option D. Aspiration of mucus: Aspiration of mucus primarily increases airway resistance, leading to an elevated PIP but P-PLATEAU will be normal as lung compliance is relatively normal</li><li>\u2022 Option D. Aspiration of mucus:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 An increase in plateau pressure (P-PLATEAU) in a mechanically ventilated patient suggests a decrease in lung compliance, which is commonly seen in conditions such as pneumothorax.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "483b1c7e",
      "audio": ""
    },
    {
      "text": "A 58-year-old male patient has been on mechanical ventilation for several days. Currently he is being weaned. Which of the following conditions excludes performing a spontaneous breathing trial (SBT)?",
      "options": [
        {
          "label": "A",
          "text": "TOFR 0.9 & off paralysis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hb of 10g/dL",
          "correct": false
        },
        {
          "label": "C",
          "text": "pH of 7.26",
          "correct": false
        },
        {
          "label": "D",
          "text": "RR of 32/min",
          "correct": true
        }
      ],
      "correct_answer": "D. RR of 32/min",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) RR of 32/min</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. TOFR 0.9 & off paralysis: This is a required condition for performing an SBT.</li><li>\u2022 Option A. TOFR 0.9 & off paralysis:</li><li>\u2022 Option B. Hb of 10g/dL: This is an additional criterion but does not exclude performing an SBT.</li><li>\u2022 Option B. Hb of 10g/dL:</li><li>\u2022 Option C. pH of 7.26: This meets the required condition of pH > 7.25 and does not exclude performing an SBT.</li><li>\u2022 Option C. pH of 7.26:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A respiratory rate (RR) of 32/min is higher than the required threshold for a spontaneous breathing trial (SBT), indicating the patient is not ready for an SBT.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "72a50eae",
      "audio": ""
    },
    {
      "text": "A 58-year-old male patient has been on mechanical ventilation for several days. The medical team is assessing his readiness for a spontaneous breathing trial (SBT). Which of the following is appropriate for conducting a spontaneous breathing trial (SBT)?",
      "options": [
        {
          "label": "A",
          "text": "T piece ventilation",
          "correct": true
        },
        {
          "label": "B",
          "text": "NIPPV (Non-Invasive Positive Pressure Ventilation)",
          "correct": false
        },
        {
          "label": "C",
          "text": "NRBM (Non-Rebreather Mask) at 10-15L per minute",
          "correct": false
        },
        {
          "label": "D",
          "text": "Simple Face Mask at 8L per minute",
          "correct": false
        }
      ],
      "correct_answer": "A. T piece ventilation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) T piece ventilation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. NIPPV (Non-Invasive Positive Pressure Ventilation): Used post intubation to reduce the rates of re-intubation in a high risk patient. Since SBTs are performed prior to extubation NIPPV makes no sense.</li><li>\u2022 Option B. NIPPV (Non-Invasive Positive Pressure Ventilation):</li><li>\u2022 Option C. NRBM (Non-Rebreather Mask) at 10-15L per minute: This is used to deliver high concentrations of oxygen but does not support SBTs.</li><li>\u2022 Option C. NRBM (Non-Rebreather Mask) at 10-15L per minute:</li><li>\u2022 Option D. Simple Face Mask at 8L per minute: Unsuitable for SBTs. Can be used post-extubation if patients are NOT at high risk, to provide O2 support.</li><li>\u2022 Option D. Simple Face Mask at 8L per minute:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 T piece ventilation is commonly used for spontaneous breathing trials (SBT) as it allows the patient to breathe spontaneously without any assistance, closely simulating the conditions post-extubation</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c3e90698",
      "audio": ""
    },
    {
      "text": "A 64-year-old female patient with a history of COPD is admitted to the ICU and requires mechanical ventilation due to a severe exacerbation. On the 10th day of mechanical ventilation, she develops a fever and worsening oxygenation. CXR revealed new infiltrates. The patient has a recent history of hospitalization for a UTI. Which of the following antibiotic regimens is most appropriate ?",
      "options": [
        {
          "label": "A",
          "text": "Piperacillin + tazobactam + Amikacin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cefepime + Doxycycline + Linezolid",
          "correct": false
        },
        {
          "label": "C",
          "text": "Levofloxacin + Vancomycin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Meropenem + levofloxacin + Linezolid",
          "correct": true
        }
      ],
      "correct_answer": "D. Meropenem + levofloxacin + Linezolid",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Meropenem + Levofloxacin + Linezolid</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Piperacillin + tazobactam + Amikacin: This combination MRSA coverage.</li><li>\u2022 Option A. Piperacillin + tazobactam + Amikacin:</li><li>\u2022 Option B. Cefepime + Doxycycline + Linezolid: Second drug must be an aminoglycoside or a respiratory quinolone or a polypeptide drug (colistin/polymyxin B). Doxycycline is not recommended in VAP.</li><li>\u2022 Option B. Cefepime + Doxycycline + Linezolid:</li><li>\u2022 Option C. Levofloxacin + Vancomycin: Beta lactams are a must in VAP, hence this regime is inadequate.</li><li>\u2022 Option C. Levofloxacin + Vancomycin:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Broad-spectrum antibiotic regimens, such as Meropenem + Levofloxacin + Linezolid, are necessary to cover multidrug-resistant gram-negative bacteria and MRSA in ventilator-associated pneumonia (VAP).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7b2ce209",
      "audio": ""
    },
    {
      "text": "A 70-year-old male patient has been diagnosed with ventilator-associated pneumonia (VAP) and is receiving appropriate antibiotic therapy. What is the recommended duration of antibiotic treatment for VAP to ensure optimal clinical outcomes ?",
      "options": [
        {
          "label": "A",
          "text": "3-5 days",
          "correct": false
        },
        {
          "label": "B",
          "text": "7 days",
          "correct": true
        },
        {
          "label": "C",
          "text": "10-14 days",
          "correct": false
        },
        {
          "label": "D",
          "text": "21 days",
          "correct": false
        }
      ],
      "correct_answer": "B. 7 days",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) 7 days</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. 3-5 days: This duration is generally considered too short for treating VAP and may not be sufficient to ensure complete eradication of the infection.</li><li>\u2022 Option A. 3-5 days:</li><li>\u2022 Option C. 10-14 days: Although previously recommended, this longer duration is not typically necessary for most cases of VAP and can increase the risk of antibiotic resistance and adverse effects.</li><li>\u2022 Option C. 10-14 days:</li><li>\u2022 Option D. 21 days: Such an extended duration is rarely necessary and would likely contribute to the development of antibiotic resistance and other negative consequences.</li><li>\u2022 Option D. 21 days:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The recommended duration of antibiotic treatment for ventilator-associated pneumonia (VAP) is 7 days to ensure optimal clinical outcomes and minimize the risk of antibiotic resistance.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "914333e0",
      "audio": ""
    },
    {
      "text": "A 65-year-old male patient is intubated and on mechanical ventilation in the ICU. Which of the following strategies is least likely to reduce the risk of VAP ?",
      "options": [
        {
          "label": "A",
          "text": "Hand hygiene practices",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevation of the head of the bed",
          "correct": false
        },
        {
          "label": "C",
          "text": "Routine suctioning of subglottic secretions",
          "correct": false
        },
        {
          "label": "D",
          "text": "Avoiding unnecessary antibiotic use",
          "correct": true
        }
      ],
      "correct_answer": "D. Avoiding unnecessary antibiotic use",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Avoiding unnecessary antibiotic use</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hand hygiene practices: Effective hand hygiene practices are fundamental in preventing hospital-acquired infections, including VAP, by reducing the transmission of pathogens.</li><li>\u2022 Option A. Hand hygiene practices:</li><li>\u2022 Option B. Elevation of the head of the bed: Elevating the head of the bed to 30-45 degrees helps prevent aspiration, a significant risk factor for VAP.</li><li>\u2022 Option B. Elevation of the head of the bed:</li><li>\u2022 Option C. Routine suctioning of subglottic secretions: This practice helps remove secretions that accumulate above the cuff of the endotracheal tube, which can reduce the risk of aspiration and subsequent pneumonia.</li><li>\u2022 Option C. Routine suctioning of subglottic secretions:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Avoiding unnecessary antibiotic use is essential for preventing antibiotic resistance but does not directly reduce the risk of ventilator-associated pneumonia (VAP).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fa16b62f",
      "audio": ""
    },
    {
      "text": "A 65-year-old male with COPD is admitted due to worsening fever, fatigue, and shortness of breath. Chest X-ray shows left lower lobe consolidation. Despite treatment and resolution of pneumonia, the patient develops dyspnea and elevated pCO2 during attempts to wean from mechanical ventilation. Which test is used to identify the cause of weaning failure ?",
      "options": [
        {
          "label": "A",
          "text": "Muscle biopsy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Electroneuromyography (ENMG)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Hypoxic response test",
          "correct": false
        },
        {
          "label": "D",
          "text": "End-tidal CO2 (EtCO2) measurements",
          "correct": false
        }
      ],
      "correct_answer": "B. Electroneuromyography (ENMG)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Electroneuromyography (ENMG)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Muscle biopsy: While a muscle biopsy can provide detailed information about muscle pathology, it is invasive and not typically the first-line diagnostic test for weaning failure.</li><li>\u2022 Option A. Muscle biopsy:</li><li>\u2022 Option C. Hypoxic response test: This test is not relevant for diagnosing the cause of weaning failure and is more commonly used to assess chemoreceptor function.</li><li>\u2022 Option C. Hypoxic response test:</li><li>\u2022 Option D. End-tidal CO2 (EtCO2) measurements: While EtCO2 can monitor ventilation and detect issues like hypoventilation, it does not diagnose neuromuscular causes of weaning failure.</li><li>\u2022 Option D. End-tidal CO2 (EtCO2) measurements:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Electroneuromyography (ENMG) is used to assess neuromuscular function and can help identify causes of weaning failure related to critical illness polyneuropathy or myopathy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9c974303",
      "audio": ""
    },
    {
      "text": "A 55-year-old female patient who has been on mechanical ventilation for 10 days is found to have stridor upon an attempted extubation. What is the most appropriate management in this patient ?",
      "options": [
        {
          "label": "A",
          "text": "Administer Methylprednisolone",
          "correct": true
        },
        {
          "label": "B",
          "text": "Perform an immediate tracheostomy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase the inspiratory pressure",
          "correct": false
        },
        {
          "label": "D",
          "text": "Administer Salbutamol",
          "correct": false
        }
      ],
      "correct_answer": "A. Administer Methylprednisolone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Administer Methylprednisolone</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Perform an immediate tracheostomy: This is not the first-line treatment for stridor due to laryngeal edema. It is considered if less invasive measures fail and if the airway obstruction is severe.</li><li>\u2022 Option B. Perform an immediate tracheostomy:</li><li>\u2022 Option C. Increase the inspiratory pressure: This approach does not address the underlying issue of laryngeal edema and can lead to further complications by increasing airway pressures unnecessarily.</li><li>\u2022 Option C. Increase the inspiratory pressure:</li><li>\u2022 Option D. Administer Salbutamol: While useful for bronchospasm and lower airway obstruction, Salbutamol does not reduce inflammation or edema in the upper airway, such as the larynx.</li><li>\u2022 Option D. Administer Salbutamol:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Administering methylprednisolone is the standard management for stridor caused by laryngeal edema in ventilated patients, as it helps reduce inflammation and edema.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "eb8e12fa",
      "audio": ""
    },
    {
      "text": "A 40 year old man developed severe respiratory distress after a viral pneumonia. Which of the following is incorrect regarding ARDS ?",
      "options": [
        {
          "label": "A",
          "text": "ARDS is a diagnosis of exclusion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bilateral infiltrates on lung USG",
          "correct": false
        },
        {
          "label": "C",
          "text": "PaO2/FiO2 ratio of 250 on HFNO 20L per minute",
          "correct": true
        },
        {
          "label": "D",
          "text": "SpO2 of 95% and SpO2/FiO2 ratio of 295",
          "correct": false
        }
      ],
      "correct_answer": "C. PaO2/FiO2 ratio of 250 on HFNO 20L per minute",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/picture1_ORDcJzP.jpg"
      ],
      "explanation": "<p><strong>Ans. C) PaO2/FiO2 ratio of 250 on HFNO 20L per minute</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. To diagnose ARDS , other causes has to be ruled out, hence it is a true statement.</li><li>\u2022 Option A. To diagnose ARDS</li><li>\u2022 Option B. Bilateral infiltrates on lung USG (or Chest X ray or CT scan) is a requirement for ARDS diagnosis, hence it is a true statement.</li><li>\u2022 Option B. Bilateral infiltrates on lung USG</li><li>\u2022 Option D. SpO2/FiO2 \u2264 315 with SpO2 \u2264 97% is a new addition and can be used as an alternative to the traditional PaO2/FiO2 ratio in resource poor settings. Hence it is a true statement</li><li>\u2022 Option D. SpO2/FiO2 \u2264 315 with SpO2 \u2264 97%</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 PaO2/FiO2 ratio for ARDS diagnosis can now be measured with NIV/CPAP or HFNC with O2 flow > 30 L/min. SpO2/FiO2 ratio should be \u2264 315 with SpO2 \u2264 97%.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "161729e3",
      "audio": ""
    },
    {
      "text": "A 33 year old man developed sepsis and ARDS following a penetrating injury to the abdomen. Which of the following is the earliest pathology in ARDS ?",
      "options": [
        {
          "label": "A",
          "text": "Endothelial injury",
          "correct": true
        },
        {
          "label": "B",
          "text": "Exudative damage",
          "correct": false
        },
        {
          "label": "C",
          "text": "Diffuse Alveolar Damage",
          "correct": false
        },
        {
          "label": "D",
          "text": "Type 2 Pneumocyte hyperplasia",
          "correct": false
        }
      ],
      "correct_answer": "A. Endothelial injury",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Endothelial injury</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Exudative damage : This phase follows endothelial injury and is characterized by the accumulation of protein-rich fluid in the alveoli, formation of hyaline membranes, and the presence of inflammatory cells.</li><li>\u2022 Option B. Exudative damage</li><li>\u2022 Option C. Diffuse Alveolar Damage : This is a histopathological term often used to describe the changes seen in the exudative and proliferative phases of ARDS, but it is not the earliest event.</li><li>\u2022 Option C. Diffuse Alveolar Damage</li><li>\u2022 Option D. Type 2 Pneumocyte hyperplasia : This occurs later in the course of ARDS as part of the reparative process during the proliferative or fibrotic phases.</li><li>\u2022 Option D. Type 2 Pneumocyte hyperplasia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The earliest pathology in ARDS involves injury to the pulmonary endothelium, which leads to increased permeability and edema.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e0235337",
      "audio": ""
    },
    {
      "text": "What is the most common cause of ARDS?",
      "options": [
        {
          "label": "A",
          "text": "Aspiration",
          "correct": false
        },
        {
          "label": "B",
          "text": "Trauma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pneumonia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sepsis",
          "correct": true
        }
      ],
      "correct_answer": "D. Sepsis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Sepsis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Aspiration: While aspiration can cause ARDS, it is less common than sepsis. The patient's clinical context and history of sepsis make this less likely.</li><li>\u2022 Option A. Aspiration:</li><li>\u2022 Option B. Trauma: Trauma is another cause of ARDS but is not relevant in this patient\u2019s history, which centers on sepsis from a urinary tract infection.</li><li>\u2022 Option B. Trauma:</li><li>\u2022 Option C. Pneumonia: Pneumonia can lead to ARDS, but in this case, the primary underlying cause is sepsis secondary to a urinary tract infection, as indicated by the patient\u2019s clinical presentation and progression.</li><li>\u2022 Option C. Pneumonia:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Sepsis is the most common cause of ARDS due to the systemic inflammatory response leading to widespread endothelial injury and increased vascular permeability.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e184757b",
      "audio": ""
    },
    {
      "text": "A 60kg female with a history of diabetes and hypertension is admitted to the ICU with acute respiratory distress syndrome (ARDS) secondary to severe pneumonia. She is intubated and placed on mechanical ventilation. What is the most appropriate tidal volume setting for this patient to minimize ventilator-induced lung injury ?",
      "options": [
        {
          "label": "A",
          "text": "360 mL",
          "correct": true
        },
        {
          "label": "B",
          "text": "480 mL",
          "correct": false
        },
        {
          "label": "C",
          "text": "600 mL",
          "correct": false
        },
        {
          "label": "D",
          "text": "720 mL",
          "correct": false
        }
      ],
      "correct_answer": "A. 360 mL",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) 360 mL</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. 480 mL: This tidal volume (8 mL/kg) exceeds the recommended range and could increase the risk of lung injury.</li><li>\u2022 Option B. 480 mL:</li><li>\u2022 Option C. 600 mL: This tidal volume (10 mL/kg) is too high and significantly increases the risk of barotrauma and volutrauma in ARDS patients.</li><li>\u2022 Option C. 600 mL:</li><li>\u2022 Option D. 720 mL: This tidal volume (12 mL/kg) is excessively high and would likely cause severe ventilator-induced lung injury.</li><li>\u2022 Option D. 720 mL:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The recommended tidal volume for ARDS management is 4-6 mL/kg of predicted body weight to minimize the risk of ventilator-induced lung injury.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a33e8885",
      "audio": ""
    },
    {
      "text": "A 62-year-old male) is admitted to the ICU with severe ARDS secondary to COVID-19 pneumonia. Despite optimal ventilator settings, the patient remains severely hypoxemic with a PaO2/FiO2 ratio of 80.Which of the following interventions is most appropriate to improve oxygenation in this patient ?",
      "options": [
        {
          "label": "A",
          "text": "Increase tidal volume to 8 mL/kg",
          "correct": false
        },
        {
          "label": "B",
          "text": "Administer diuretics",
          "correct": false
        },
        {
          "label": "C",
          "text": "Prone positioning",
          "correct": true
        },
        {
          "label": "D",
          "text": "Increase FiO2 to 100%",
          "correct": false
        }
      ],
      "correct_answer": "C. Prone positioning",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Prone positioning</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Increase tidal volume to 8 mL/kg: Increasing the tidal volume to 8 mL/kg is not recommended in ARDS as it can lead to ventilator-induced lung injury due to overdistention of the alveoli. The recommended tidal volume for ARDS is 4-6 mL/kg of predicted body weight.</li><li>\u2022 Option A. Increase tidal volume to 8 mL/kg:</li><li>\u2022 Option B. Administer diuretics: While diuretics can be useful in managing fluid overload, they are not a primary intervention for improving oxygenation in severe ARDS.</li><li>\u2022 Option B. Administer diuretics:</li><li>\u2022 Option D. Increase FiO2 to 100%: Increasing FiO2 to 100% may temporarily improve oxygenation but can lead to oxygen toxicity if used for prolonged periods. It does not address the underlying issue of poor oxygenation due to lung mechanics and is not a sustainable long-term solution.</li><li>\u2022 Option D. Increase FiO2 to 100%:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Prone positioning is an evidence-based intervention that can significantly improve oxygenation in patients with severe ARDS by redistributing lung perfusion, improving ventilation-perfusion matching, and enhancing alveolar recruitment.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "66baf408",
      "audio": ""
    },
    {
      "text": "A 50 kg female is admitted to the ICU with severe ARDS. he is intubated and on mechanical ventilation. Her ventilator settings are as follows: Tidal volume 300 mL, FiO2 80% and PEEP 8 cm H2O. Her ABG reports show a PaO2/FiO2 ratio of 100 and her SpO2 is 94%. Which of the following interventions should be the next step ?",
      "options": [
        {
          "label": "A",
          "text": "Increase tidal volume to 400 mL",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increase FiO2 to 100%",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase PEEP to 12 cm H2O",
          "correct": true
        },
        {
          "label": "D",
          "text": "Increase respiratory rate",
          "correct": false
        }
      ],
      "correct_answer": "C. Increase PEEP to 12 cm H2O",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Increase PEEP to 12 cm H2O</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Increase tidal volume to 400 mL: Increasing the tidal volume is not recommended in ARDS as it can lead to ventilator-induced lung injury. The current tidal volume of 300 mL (6 mL/kg) is appropriate for this 50 kg patient.</li><li>\u2022 Option A. Increase tidal volume to 400 mL:</li><li>\u2022 Option B. Increase FiO2 to 100%: Increasing FiO2 to 100% can temporarily improve oxygenation, but prolonged use can lead to oxygen toxicity. The goal is to reduce FiO2 while maintaining adequate oxygenation.</li><li>\u2022 Option B. Increase FiO2 to 100%:</li><li>\u2022 Option D. Increase respiratory rate: Increasing the respiratory rate helps with carbon dioxide removal but does not directly improve oxygenation. The primary intervention should focus on enhancing oxygenation through alveolar recruitment.</li><li>\u2022 Option D. Increase respiratory rate:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Increasing Positive End-Expiratory Pressure (PEEP) helps improve oxygenation in severe ARDS by increasing alveolar recruitment, preventing alveolar collapse, and improving ventilation-perfusion matching, thereby reducing the need for high FiO2 and minimizing the risk of oxygen toxicity.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "de432f6e",
      "audio": ""
    },
    {
      "text": "A 70 kg male is admitted to the ICU with ARDS after cholangitis. His ventilator settings in the prone position are as follows: Tidal volume 300 mL, PEEP 15 cm H2O, FiO2 100%. His ABG reveals a PaO2/FiO2 ratio of 50, PaCO2 of 50 mmHg, and an arterial pH of 7.13. His SpO2 is 85%, and his plateau pressure is 35 cm H2O. What is the most appropriate next step ?",
      "options": [
        {
          "label": "A",
          "text": "Reduce tidal volume to 200 mL",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increase PEEP to 18 cm H2O",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase the duration of prone position",
          "correct": false
        },
        {
          "label": "D",
          "text": "Consider ECMO",
          "correct": true
        }
      ],
      "correct_answer": "D. Consider ECMO",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Consider ECMO</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Reduce tidal volume to 200 mL: Reducing tidal volume below the recommended 4-6 mL/kg would likely lead to inadequate ventilation and worsening hypercapnia without significantly improving oxygenation.</li><li>\u2022 Option A. Reduce tidal volume to 200 mL:</li><li>\u2022 Option B. Increase PEEP to 18 cm H2O: Increasing PEEP might marginally improve oxygenation, but with a high plateau pressure of 35 cm H2O, further increasing PEEP carries a significant risk of barotrauma and overdistention of the lungs.</li><li>\u2022 Option B. Increase PEEP to 18 cm H2O:</li><li>\u2022 Option C. Increase the duration of prone position: While prolonged prone positioning can sometimes enhance oxygenation, the patient's severe hypoxemia and hypercapnia suggest that a more advanced intervention, such as ECMO, is necessary.</li><li>\u2022 Option C. Increase the duration of prone position:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 ECMO (Extracorporeal Membrane Oxygenation) is indicated for patients with severe ARDS who have refractory hypoxemia and hypercapnia despite optimal ventilatory management, providing adequate oxygenation and CO2 removal, allowing the lungs to rest and recover.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "339bc2b3",
      "audio": ""
    },
    {
      "text": "A 58-year-old woman with a 30-pack-year smoking history presents with chronic cough and shortness of breath. Spirometry shows an FEV1/FVC ratio of 0.60. What does this finding suggest?",
      "options": [
        {
          "label": "A",
          "text": "Restrictive lung disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Obstructive lung disease",
          "correct": true
        },
        {
          "label": "C",
          "text": "Normal lung function",
          "correct": false
        },
        {
          "label": "D",
          "text": "Interstitial lung disease",
          "correct": false
        }
      ],
      "correct_answer": "B. Obstructive lung disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 A reduced FEV1/FVC ratio (typically < 0.70) is a hallmark of obstructive lung diseases, where airflow is limited, such as COPD and asthma.</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option A. Restrictive lung disease: Characterized by reduced lung volumes with a normal or increased FEV1/FVC ratio.</li><li>\u2022 Option A. Restrictive lung disease:</li><li>\u2022 Option C. Normal lung function: Normal PFTs would show a normal FEV1/FVC ratio.</li><li>\u2022 Option C. Normal lung function:</li><li>\u2022 Option D. Interstitial lung disease: A type of restrictive lung disease.</li><li>\u2022 Option D. Interstitial lung disease:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A reduced FEV1/FVC ratio (< 0.70) on spirometry is indicative of obstructive lung disease, commonly seen in conditions like COPD and asthma.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "435c470d",
      "audio": ""
    },
    {
      "text": "A 70-year-old man with a history of smoking and progressive dyspnea presents with a barrel chest and expiratory wheezing. Which PFT finding is LEAST likely in this patient with suspected emphysema?",
      "options": [
        {
          "label": "A",
          "text": "Normal residual volume (RV)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Decreased forced vital capacity (FVC)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Normal vital capacity (VC)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Decreased FEV1/FVC ratio",
          "correct": false
        }
      ],
      "correct_answer": "A. Normal residual volume (RV)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Emphysema, a type of COPD, is characterized by air trapping and hyperinflation, leading to increased residual volume.</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option B. Decreased forced vital capacity (FVC) : Common in emphysema due to air trapping.</li><li>\u2022 Option B.</li><li>\u2022 Decreased forced vital capacity (FVC)</li><li>\u2022 :</li><li>\u2022 Option C. Normal vital capacity (VC): While possible in early disease, VC often decreases as emphysema progresses.</li><li>\u2022 Option C. Normal vital capacity (VC):</li><li>\u2022 Option D. Decreased FEV1/FVC ratio: Hallmark of obstructive lung disease like emphysema.</li><li>\u2022 Option</li><li>\u2022 D. Decreased FEV1/FVC ratio:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In emphysema, expect increased residual volume (RV) due to air trapping, along with decreased FEV1/FVC ratio and forced vital capacity (FVC).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "37e82709",
      "audio": ""
    },
    {
      "text": "A medical student is using the following device to assess lung function in a patient with suspected asthma. Which of the following lung volumes cannot be directly measured using this device?",
      "options": [
        {
          "label": "A",
          "text": "Tidal volume (TV)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vital capacity (VC)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Functional residual capacity (FRC)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Forced expiratory volume in 1 second (FEV1)",
          "correct": false
        }
      ],
      "correct_answer": "C. Functional residual capacity (FRC)",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/picture1.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Functional residual capacity (FRC)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The given instrument is a hand held spirometer. Spirometry can measure airflow during forced maneuvers and can estimate FVC, FEV1, and peak expiratory flow rate (PEFR). Spirometry cannot measure residual volume and the associated capacities (like TLC/FRC).</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option A. Tidal volume (TV): The volume of air inhaled or exhaled during normal breathing. Can be measured in Spirometry</li><li>\u2022 Option A. Tidal volume (TV):</li><li>\u2022 Option B. Vital capacity (VC): The maximum volume of air that can be exhaled after a maximal inhalation. Can be measured in Spirometry</li><li>\u2022 Option B. Vital capacity (VC):</li><li>\u2022 Option D. Forced expiratory volume in 1 second (FEV1): The volume of air exhaled in the first second of a forced exhalation. Can be measured in Spirometry</li><li>\u2022 Option D. Forced expiratory volume in 1 second (FEV1):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Spirometry can measure FVC, FEV1, and TV, but it cannot measure RV or FRC.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3181ca6e",
      "audio": ""
    },
    {
      "text": "A patient's flow-volume (FV) loop demonstrates the following (red line in the image is the patients actual FV loop, background blue line is the predicted normal). What does this finding indicate?",
      "options": [
        {
          "label": "A",
          "text": "Normal lung function",
          "correct": false
        },
        {
          "label": "B",
          "text": "Restrictive lung disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Upper airway obstruction",
          "correct": false
        },
        {
          "label": "D",
          "text": "Obstructive lung disease",
          "correct": true
        }
      ],
      "correct_answer": "D. Obstructive lung disease",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/picture2.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Obstructive lung disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The concave shape with scooped appearance of expiratory limb and reduced PEFR on the expiratory limb are classic for obstructive lung diseases like COPD and asthma, indicating airflow limitation during exhalation. The patient also has a near normal FVC, further strengthening the diagnosis of obstruction.</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option A. Normal lung function: Normal flow-volume loops are relatively linear.</li><li>\u2022 Option A. Normal lung function:</li><li>\u2022 Option B. Restrictive lung disease: Usually shows a smaller loop with normal shape.</li><li>\u2022 Option B. Restrictive lung disease:</li><li>\u2022 Option C. Upper airway obstruction: Typically shows flattening on the inspiratory limb of the flow-volume loop.</li><li>\u2022 Option C. Upper airway obstruction:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A concave, scooped expiratory flow-volume loop with reduced PEFR is indicative of obstructive lung disease such as COPD or asthma.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "173c7cdb",
      "audio": ""
    },
    {
      "text": "A patient with wheezing and shortness of breath undergoes spirometry. A decreased maximum mid-expiratory flow rate (MMEF or FEF25-75%) is observed. Which airways are most likely affected?",
      "options": [
        {
          "label": "A",
          "text": "Trachea",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mainstem bronchi",
          "correct": false
        },
        {
          "label": "C",
          "text": "Medium-sized bronchi",
          "correct": false
        },
        {
          "label": "D",
          "text": "Small airways (bronchioles)",
          "correct": true
        }
      ],
      "correct_answer": "D. Small airways (bronchioles)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Small airways (bronchioles)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 MMEF, also known as FEF25-75%, reflects airflow in the small airways (bronchioles). A decrease in MMEF suggests obstruction in these airways, which is a common finding in conditions like asthma and COPD.</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option A. Trachea: Obstruction here would cause stridor, a high-pitched sound on inspiration.</li><li>\u2022 Option</li><li>\u2022 A. Trachea:</li><li>\u2022 Option B. Mainstem bronchi: Obstruction here would cause more severe symptoms and a different flow-volume loop pattern.</li><li>\u2022 Option</li><li>\u2022 B. Mainstem bronchi:</li><li>\u2022 Option C. Medium-sized bronchi: While potentially affected, these airways are not the primary site of obstruction reflected by a decreased MMEF</li><li>\u2022 Option</li><li>\u2022 C. Medium-sized bronchi:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A decreased MMEF (FEF25-75%) indicates obstruction in the small airways (bronchioles), which is common in asthma and COPD.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2021fd58",
      "audio": ""
    },
    {
      "text": "A 70-year-old man with a history of heavy smoking presents with a new onset of stridor and progressive dyspnea. His flow-volume loop is shown. What is the most likely cause?",
      "options": [
        {
          "label": "A",
          "text": "Asthma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Main bronchus obstruction",
          "correct": true
        },
        {
          "label": "C",
          "text": "Large airway tumor",
          "correct": false
        },
        {
          "label": "D",
          "text": "COPD",
          "correct": false
        }
      ],
      "correct_answer": "B. Main bronchus obstruction",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/picture3.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Main bronchus obstruction</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 This patient has a unilateral mainstem bronchus obstruction. The flow-volume loop shows both an end-inspiratory and end-expiratory tail and is most commonly known as a biphasic flow-volume curve. This finding has also been described as \u201ctwo compartments.\u201d</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option A. Asthma: Typically shows a concave expiratory limb without biphasic flattening.</li><li>\u2022 Option A. Asthma:</li><li>\u2022 Option C. Large airway tumor: While it can cause fixed obstruction with flattening of both limbs, a biphasic pattern is more indicative of a main bronchus obstruction.</li><li>\u2022 Option C. Large airway tumor:</li><li>\u2022 Option D. COPD: Shows a concave expiratory limb and does not typically cause a biphasic pattern in the flow-volume loop.</li><li>\u2022 Option D. COPD:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A biphasic flow-volume loop indicates a main bronchus obstruction, often presenting with both end-inspiratory and end-expiratory tailing.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "de4e2798",
      "audio": ""
    },
    {
      "text": "A patient is in ICU and you are noticing the flow-volume loop as shown. What is the most likely explanation for this finding?",
      "options": [
        {
          "label": "A",
          "text": "Spontaneous breathing",
          "correct": false
        },
        {
          "label": "B",
          "text": "Positive pressure ventilation",
          "correct": true
        },
        {
          "label": "C",
          "text": "Airway obstruction",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lung collapse",
          "correct": false
        }
      ],
      "correct_answer": "B. Positive pressure ventilation",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/picture4.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Positive pressure ventilation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 In this FV loop expiration precedes inspiration and this is opposite to normal spontaneous respiration. This is due to positive pressure ventilation, where air is forced into the lungs.</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option A. Spontaneous breathing : Would show a normal pattern with inspiration preceding expiration.</li><li>\u2022 Option A. Spontaneous breathing</li><li>\u2022 Option C. Airway obstruction : Would cause a concave shape on the expiratory limb.</li><li>\u2022 Option C. Airway obstruction</li><li>\u2022 Option D. Lung collapse : Would result in a smaller loop with decreased flows.</li><li>\u2022 Option D. Lung collapse</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A flow-volume loop where expiration precedes inspiration indicates positive pressure ventilation, commonly seen in patients receiving mechanical ventilation in the ICU.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "26597f6a",
      "audio": ""
    },
    {
      "text": "A 65-year-old woman with a history of rheumatoid arthritis presents with progressive shortness of breath. Pulmonary function tests reveal a decreased diffusing capacity of the lung for carbon monoxide (DLCO). Which of the following conditions is the most likely cause of her decreased DLCO?",
      "options": [
        {
          "label": "A",
          "text": "Asthma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Congestive heart failure",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pulmonary hemorrhage",
          "correct": false
        },
        {
          "label": "D",
          "text": "Interstitial lung disease",
          "correct": true
        }
      ],
      "correct_answer": "D. Interstitial lung disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Interstitial lung disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Interstitial lung disease, a known complication of rheumatoid arthritis, leads to thickening and fibrosis of the alveolar-capillary membrane, reducing gas diffusion and causing a decrease in DLCO.</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option A. Asthma: While asthma can cause a reduced DLCO due to air trapping, it is not the most likely cause in this clinical scenario.</li><li>\u2022 Option A. Asthma:</li><li>\u2022 Option B. Congestive heart failure : Can cause a reduced DLCO due to pulmonary edema, but the patient's history of rheumatoid arthritis makes ILD more likely.</li><li>\u2022 Option B. Congestive heart failure</li><li>\u2022 Option C. Pulmonary hemorrhage : Can cause a transient increase in DLCO due to the presence of blood in the alveoli.</li><li>\u2022 Option C. Pulmonary hemorrhage</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In a patient with rheumatoid arthritis and progressive shortness of breath, a decreased DLCO is most likely due to interstitial lung disease, a common pulmonary complication associated with rheumatoid arthritis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d8d55a17",
      "audio": ""
    },
    {
      "text": "A 28-year-old woman with systemic lupus erythematosus (SLE) presents with sudden onset of hemoptysis and shortness of breath. Her DLCO is 163%. What underlying pathology is most likely responsible for this finding?",
      "options": [
        {
          "label": "A",
          "text": "Pneumonia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Interstitial lung disease (ILD)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Alveolar hemorrhage",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pleural effusion",
          "correct": false
        }
      ],
      "correct_answer": "C. Alveolar hemorrhage",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Alveolar hemorrhage</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 In patients with systemic lupus erythematosus (SLE) presenting with hemoptysis and an increased DLCO, alveolar hemorrhage is the most likely cause. The presence of blood in the alveoli increases the binding capacity for carbon monoxide, thereby increasing DLCO.</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option A. Pneumonia : Typically associated with normal or decreased DLCO due to inflammation and consolidation, not an increase.</li><li>\u2022 Option A. Pneumonia</li><li>\u2022 Option B. Interstitial lung disease (ILD) : Usually associated with a decreased DLCO due to fibrosis and thickening of the alveolar-capillary membrane.</li><li>\u2022 Option B. Interstitial lung disease (ILD)</li><li>\u2022 Option D. Pleural effusion : Does not typically affect DLCO in the same manner; it might decrease lung volumes but not directly increase DLCO.</li><li>\u2022 Option D. Pleural effusion</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Increased DLCO in a patient with SLE and sudden hemoptysis suggested alveolar hemorrhage, where the presence of blood in the alveoli elevates carbon monoxide binding capacity.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6851a093",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman with a history of systemic sclerosis presents with progressive dyspnea. Which of the following pulmonary function test results would be most consistent with her underlying condition?",
      "options": [
        {
          "label": "A",
          "text": "Increased DLCO",
          "correct": false
        },
        {
          "label": "B",
          "text": "Normal DLCO",
          "correct": false
        },
        {
          "label": "C",
          "text": "Decreased DLCO",
          "correct": true
        },
        {
          "label": "D",
          "text": "Increased FEV1/FVC ratio",
          "correct": false
        }
      ],
      "correct_answer": "C. Decreased DLCO",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Systemic sclerosis can cause interstitial lung disease (ILD), a condition that decreases the diffusing capacity of the lung for carbon monoxide (DLCO) due to fibrosis and thickening of the alveolar-capillary membrane.</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option A. Increased DLCO: Seen in conditions like asthma, pulmonary hemorrhage, or polycythemia.</li><li>\u2022 Option A. Increased DLCO:</li><li>\u2022 Option B. Normal DLCO: Unlikely in ILD, which typically causes a reduced DLCO.</li><li>\u2022 Option B. Normal DLCO:</li><li>\u2022 Option D. Increased FEV1/FVC ratio: Not characteristic of ILD, which is a restrictive pattern.</li><li>\u2022 Option D. Increased FEV1/FVC ratio:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Systemic sclerosis can lead to interstitial lung disease (ILD), characterized by a decreased DLCO due to fibrosis and thickening of the alveolar-capillary membrane.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bd6fce03",
      "audio": ""
    },
    {
      "text": "A 74-year-old former naval ship worker with a 40-pack-year smoking history presents with progressive dyspnea, dry cough, bilateral end-inspiratory crackles, and no clubbing. PFT is given below. Total lung capacity 67% of predicted Residual volume 72% of predicted FVC 65% of predicted FEVI 75% of predicted FEV I/FVC ratio 89% (Normal) DLCO 52% of predicted Chest X-ray reveals bilateral lower zone predominant lesions. Which diagnosis is most likely?",
      "options": [
        {
          "label": "A",
          "text": "Emphysema",
          "correct": false
        },
        {
          "label": "B",
          "text": "Asbestosis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pneumonia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bronchogenic carcinoma",
          "correct": false
        }
      ],
      "correct_answer": "B. Asbestosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Asbestosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The history of asbestos exposure (naval ship worker), progressive dyspnea, dry cough, restrictive PFT pattern, and bilateral lower zone opacities are consistent with asbestosis.</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option A. Emphysema: Typically causes obstructive pattern on PFTs, upper lobe predominant changes, and may present with wheezing.</li><li>\u2022 Option A. Emphysema:</li><li>\u2022 Option C. Pneumonia: Usually acute onset with fever and consolidation on imaging.</li><li>\u2022 Option C. Pneumonia:</li><li>\u2022 Option D. Bronchogenic carcinoma: Often associated with a history of smoking but usually presents as a mass or nodule on imaging.</li><li>\u2022 Option D. Bronchogenic carcinoma:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Asbestosis is characterized by a history of asbestos exposure, restrictive PFT pattern, progressive dyspnea, and bilateral lower zone opacities on imaging.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c89c7ddf",
      "audio": ""
    },
    {
      "text": "65-year-old man undergoes pulmonary function testing (PFT) as part of a routine medical health check (MHC). He has no pulmonary issues and is a lifelong non-smoker. The PFT results are shown below. Which of the following findings is most likely consistent with the observed data?",
      "options": [
        {
          "label": "A",
          "text": "Obstructive lung disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Restrictive lung disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Normal lung function",
          "correct": true
        },
        {
          "label": "D",
          "text": "Combined obstructive and restrictive lung disease",
          "correct": false
        }
      ],
      "correct_answer": "C. Normal lung function",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-194313.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Normal lung function</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The PFT results show normal FVC (102% predicted), FEV1 (95% predicted), FEV1/FVC ratio (73%) and DLCO (84% of predicted) No significant change post-bronchodilator indicates no reversible obstruction.</li><li>\u2022 The PFT results show normal FVC (102% predicted), FEV1 (95% predicted), FEV1/FVC ratio (73%) and DLCO (84% of predicted)</li><li>\u2022 No significant change post-bronchodilator indicates no reversible obstruction.</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option A. Obstructive lung disease : Typically has an FEV1/FVC ratio < 70%.</li><li>\u2022 Option A. Obstructive lung disease</li><li>\u2022 Option B. Restrictive lung disease : Typically shows a reduced TLC.</li><li>\u2022 Option B. Restrictive lung disease</li><li>\u2022 Option D. Combined obstructive and restrictive lung disease : Would show both a reduced FEV1/FVC ratio and reduced TLC.</li><li>\u2022 Option D. Combined obstructive and restrictive lung disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Normal PFT results include an FEV1/FVC ratio around 75-80%, no significant change post-bronchodilator, and normal predicted values for FVC, FEV1, and DLCO.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "17de7da1",
      "audio": ""
    },
    {
      "text": "A 41-year-old smoker presents with shortness of breath (SOB). His pulmonary function test (PFT) results are shown below. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Asthma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronic obstructive pulmonary disease (COPD)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Restrictive lung disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pulmonary embolism",
          "correct": false
        }
      ],
      "correct_answer": "B. Chronic obstructive pulmonary disease (COPD)",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-113621.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Chronic obstructive pulmonary disease (COPD)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The PFT results indicate severe obstruction: FEV1 is markedly reduced (19% predicted). FEV1/FVC ratio is significantly decreased (54%), consistent with obstructive lung disease. RV is increased (257% predicted), indicating air trapping. TLC is within normal limits (108% predicted), ruling out restrictive lung disease. DLCO is severely reduced (3% predicted), consistent with emphysema, a common cause of COPD.</li><li>\u2022 The PFT results indicate severe obstruction: FEV1 is markedly reduced (19% predicted). FEV1/FVC ratio is significantly decreased (54%), consistent with obstructive lung disease. RV is increased (257% predicted), indicating air trapping. TLC is within normal limits (108% predicted), ruling out restrictive lung disease. DLCO is severely reduced (3% predicted), consistent with emphysema, a common cause of COPD.</li><li>\u2022 FEV1 is markedly reduced (19% predicted). FEV1/FVC ratio is significantly decreased (54%), consistent with obstructive lung disease. RV is increased (257% predicted), indicating air trapping. TLC is within normal limits (108% predicted), ruling out restrictive lung disease. DLCO is severely reduced (3% predicted), consistent with emphysema, a common cause of COPD.</li><li>\u2022 FEV1 is markedly reduced (19% predicted).</li><li>\u2022 FEV1/FVC ratio is significantly decreased (54%), consistent with obstructive lung disease.</li><li>\u2022 RV is increased (257% predicted), indicating air trapping.</li><li>\u2022 TLC is within normal limits (108% predicted), ruling out restrictive lung disease.</li><li>\u2022 DLCO is severely reduced (3% predicted), consistent with emphysema, a common cause of COPD.</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option A. Asthma : Typically shows reversible airflow obstruction with significant improvement post-bronchodilator, which is not seen here (FEV1 change of -10%).</li><li>\u2022 Option A. Asthma</li><li>\u2022 Option C. Restrictive lung disease : Typically shows a reduced TLC, which is not present in these results.</li><li>\u2022 Option C. Restrictive lung disease</li><li>\u2022 Option D. Pulmonary embolism : Generally does not present with such a pronounced obstructive pattern and reduced DLCO.</li><li>\u2022 Option D. Pulmonary embolism</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 COPD is characterized by reduced FEV1 and FEV1/FVC ratio, increased RV indicating air trapping, and a reduced DLCO, particularly in cases of emphysema.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b9fa0ecb",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman presents for evaluation of shortness of breath on exertion for 2 months. She is a non-smoker and has no prior history of asthma or other pulmonary problems. She works as a receptionist in a hotel and has two cats and three parakeets at home. Her pulmonary function test (PFT) results are shown below. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Chronic obstructive pulmonary disease (COPD)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Myasthenia gravis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypersensitivity pneumonitis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pulmonary embolism",
          "correct": false
        }
      ],
      "correct_answer": "C. Hypersensitivity pneumonitis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-113701.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Hypersensitivity pneumonitis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The PFT results indicate a restrictive pattern: FEV1 is significantly reduced (43% predicted). FVC is significantly reduced (40% predicted) suggesting a restrictive pattern. FEV1/FVC ratio is increased (91%), consistent with a restrictive pattern. Total Lung Capacity (TLC) is reduced (44% predicted), confirming a restrictive pattern. DLCO is severely reduced (16% predicted), which is suggestive of intrinsic restriction (ILD) The patient's exposure to birds (parakeets) is a common cause of hypersensitivity pneumonitis, leading to lung inflammation and fibrosis (ILD)</li><li>\u2022 The PFT results indicate a restrictive pattern: FEV1 is significantly reduced (43% predicted). FVC is significantly reduced (40% predicted) suggesting a restrictive pattern. FEV1/FVC ratio is increased (91%), consistent with a restrictive pattern. Total Lung Capacity (TLC) is reduced (44% predicted), confirming a restrictive pattern. DLCO is severely reduced (16% predicted), which is suggestive of intrinsic restriction (ILD)</li><li>\u2022 FEV1 is significantly reduced (43% predicted). FVC is significantly reduced (40% predicted) suggesting a restrictive pattern. FEV1/FVC ratio is increased (91%), consistent with a restrictive pattern. Total Lung Capacity (TLC) is reduced (44% predicted), confirming a restrictive pattern. DLCO is severely reduced (16% predicted), which is suggestive of intrinsic restriction (ILD)</li><li>\u2022 FEV1 is significantly reduced (43% predicted).</li><li>\u2022 FVC is significantly reduced (40% predicted) suggesting a restrictive pattern.</li><li>\u2022 FEV1/FVC ratio is increased (91%), consistent with a restrictive pattern.</li><li>\u2022 Total Lung Capacity (TLC) is reduced (44% predicted), confirming a restrictive pattern.</li><li>\u2022 DLCO is severely reduced (16% predicted), which is suggestive of intrinsic restriction (ILD)</li><li>\u2022 The patient's exposure to birds (parakeets) is a common cause of hypersensitivity pneumonitis, leading to lung inflammation and fibrosis (ILD)</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option A. Chronic obstructive pulmonary disease (COPD) : Typically shows a reduced FEV1/FVC ratio and increased TLC due to air trapping, not a restrictive pattern.</li><li>\u2022 Option A. Chronic obstructive pulmonary disease (COPD)</li><li>\u2022 Option B. Myasthenia gravis : Can cause a restrictive pattern but typically presents with muscle weakness rather than severe reductions in lung volumes and DLCO.</li><li>\u2022 Option B. Myasthenia gravis</li><li>\u2022 Option D. Pulmonary embolism : Generally does not present with a restrictive pattern on PFT and primarily affects DLCO if significant, but not the overall lung volumes.</li><li>\u2022 Option D. Pulmonary embolism</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hypersensitivity pneumonitis is characterized by a restrictive pattern on PFTs, decreased TLC, and significantly reduced DLCO. Bird exposure, particularly to parakeets, is a common cause.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8f415b86",
      "audio": ""
    },
    {
      "text": "A 36-year-old woman presents with worsening shortness of breath on exertion and exercise limitation. She is a lifelong non-smoker and has no significant past medical history. Her pulmonary function test (PFT) results are shown below. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Chronic obstructive pulmonary disease (COPD)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Myasthenia gravis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Interstitial lung disease (ILD)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pulmonary embolism",
          "correct": false
        }
      ],
      "correct_answer": "B. Myasthenia gravis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/26/screenshot-2024-06-26-102120.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Myasthenia gravis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The PFT results indicate a restrictive pattern: FEV1 is significantly reduced (30% predicted). FEV1/FVC ratio is normal (99%) FVC is significantly reduced (26% predicted) suggesting a restrictive pattern. Total Lung Capacity (TLC) is reduced (53% predicted), confirming a restrictive pattern. RV/TLC ratio is increased (65%), which can be seen in conditions that affect muscle strength. DLCO is relatively normal (84% predicted), which typically occurs in extrinsic restriction.</li><li>\u2022 The PFT results indicate a restrictive pattern: FEV1 is significantly reduced (30% predicted). FEV1/FVC ratio is normal (99%) FVC is significantly reduced (26% predicted) suggesting a restrictive pattern. Total Lung Capacity (TLC) is reduced (53% predicted), confirming a restrictive pattern. RV/TLC ratio is increased (65%), which can be seen in conditions that affect muscle strength. DLCO is relatively normal (84% predicted), which typically occurs in extrinsic restriction.</li><li>\u2022 FEV1 is significantly reduced (30% predicted). FEV1/FVC ratio is normal (99%) FVC is significantly reduced (26% predicted) suggesting a restrictive pattern. Total Lung Capacity (TLC) is reduced (53% predicted), confirming a restrictive pattern. RV/TLC ratio is increased (65%), which can be seen in conditions that affect muscle strength. DLCO is relatively normal (84% predicted), which typically occurs in extrinsic restriction.</li><li>\u2022 FEV1 is significantly reduced (30% predicted).</li><li>\u2022 FEV1/FVC ratio is normal (99%)</li><li>\u2022 FVC is significantly reduced (26% predicted) suggesting a restrictive pattern.</li><li>\u2022 Total Lung Capacity (TLC) is reduced (53% predicted), confirming a restrictive pattern.</li><li>\u2022 RV/TLC ratio is increased (65%), which can be seen in conditions that affect muscle strength.</li><li>\u2022 DLCO is relatively normal (84% predicted), which typically occurs in extrinsic restriction.</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option A. Chronic obstructive pulmonary disease (COPD) : Typically shows a reduced FEV1/FVC ratio and increased TLC due to air trapping, not a restrictive pattern.</li><li>\u2022 Option A. Chronic obstructive pulmonary disease (COPD)</li><li>\u2022 Option C. Interstitial lung disease (ILD) : Causes intrinsic restriction hence presents with significant diffusion impairment, often with very low DLCO values.</li><li>\u2022 Option C. Interstitial lung disease (ILD)</li><li>\u2022 Option D. Pulmonary embolism : Generally does not present with a restrictive pattern on PFT and primarily affects DLCO if significant enough, not the overall lung volumes.</li><li>\u2022 Option D. Pulmonary embolism</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Myasthenia gravis can present with a restrictive pattern on PFTs characterized by reduced FEV1 and FVC with a normal FEV1/FVC ratio, reduced TLC, and an increased RV/TLC ratio.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "99c24d04",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman presents with a history of deep vein thrombosis (DVT) six months ago. She is concerned about her risk of recurrence. Which of the following factors is the strongest predictor of recurrent venous thromboembolism (VTE)?",
      "options": [
        {
          "label": "A",
          "text": "Factor V Leiden mutation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oral contraceptive use",
          "correct": false
        },
        {
          "label": "C",
          "text": "Active malignancy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Prior history of DVT",
          "correct": true
        }
      ],
      "correct_answer": "D. Prior history of DVT",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Prior history of DVT</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Factor V Leiden mutation: While a significant risk factor for VTE, it is not the strongest predictor of recurrence compared to a prior VTE event.</li><li>\u2022 Option A. Factor V Leiden mutation:</li><li>\u2022 Option B. Oral contraceptive use: This is a transient risk factor that decreases after discontinuation.</li><li>\u2022 Option B. Oral contraceptive use:</li><li>\u2022 Option C. Active malignancy: Increases VTE risk but is less predictive of recurrence than a prior VTE.</li><li>\u2022 Option C. Active malignancy:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A prior history of venous thromboembolism (VTE) is the strongest predictor of recurrent events.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ae027bde",
      "audio": ""
    },
    {
      "text": "A 30-year-old man with a recent left leg fracture presents with sudden severe pain, swelling, and bluish discoloration as shown in the picture. Doppler ultrasound confirms non compressible femoral, popliteal, and saphenous veins. Which of the following statements is TRUE regarding this condition?",
      "options": [
        {
          "label": "A",
          "text": "It is a benign condition with low risk of complications",
          "correct": false
        },
        {
          "label": "B",
          "text": "It is a surgical emergency requiring immediate intervention",
          "correct": true
        },
        {
          "label": "C",
          "text": "It is typically managed with anticoagulation alone",
          "correct": false
        },
        {
          "label": "D",
          "text": "It is associated with a low risk of pulmonary embolism.",
          "correct": false
        }
      ],
      "correct_answer": "B. It is a surgical emergency requiring immediate intervention",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/picture4.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) It is a surgical emergency requiring immediate intervention.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. It is a benign condition with low risk of complications: It is a serious condition with high risk of limb loss.</li><li>\u2022 Option A.</li><li>\u2022 It is a benign condition with low risk of complications:</li><li>\u2022 Option C. It is typically managed with anticoagulation alone: Anticoagulation alone is insufficient; surgical intervention is necessary.</li><li>\u2022 Option C.</li><li>\u2022 It is typically managed with anticoagulation alone:</li><li>\u2022 Option D. It is associated with a low risk of pulmonary embolism: It carries a high risk of pulmonary embolism.</li><li>\u2022 Option D.</li><li>\u2022 It is associated with a low risk of pulmonary embolism:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Phlegmasia cerulea dolens is a surgical emergency requiring immediate intervention to prevent limb ischemia and gangrene.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "38894b98",
      "audio": ""
    },
    {
      "text": "A patient with suspected acute pulmonary embolism (PE) undergoes transthoracic echocardiography (TTE). 2D Echo shows akinesia of the right ventricle (RV) mid-free wall with preserved contraction of the RV apex. What is this characteristic finding called?",
      "options": [
        {
          "label": "A",
          "text": "McConnell's sign",
          "correct": true
        },
        {
          "label": "B",
          "text": "D sign",
          "correct": false
        },
        {
          "label": "C",
          "text": "60/60 sign",
          "correct": false
        },
        {
          "label": "D",
          "text": "RV strain pattern",
          "correct": false
        }
      ],
      "correct_answer": "A. McConnell's sign",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. D sign: Indicates RV dilation in PE.</li><li>\u2022 Option B. D sign:</li><li>\u2022 Option C. 60/60 sign: Refers to specific Doppler findings in pulmonary hypertension.</li><li>\u2022 Option C. 60/60 sign:</li><li>\u2022 Option D. RV strain pattern: A more general term for RV dysfunction, not specific to PE.</li><li>\u2022 Option D. RV strain pattern:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 McConnell's sign is a specific echocardiographic finding in acute pulmonary embolism, indicating regional right ventricular dysfunction.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "76bcbc5c",
      "audio": ""
    },
    {
      "text": "A 40-year-old woman on chronic steroid therapy presents with sudden-onset shortness of breath and syncope. CT pulmonary angiography (CTPA) confirms a large saddle Pulmonary Embolism (PE). She is normotensive, but echocardiogram shows moderate right ventricular (RV) dysfunction and elevated brain natriuretic peptide (BNP). Which of the following classifies her Pulmonary Embolism?",
      "options": [
        {
          "label": "A",
          "text": "Massive PE",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sub-massive PE",
          "correct": true
        },
        {
          "label": "C",
          "text": "Low risk PE",
          "correct": false
        },
        {
          "label": "D",
          "text": "Unclassified",
          "correct": false
        }
      ],
      "correct_answer": "B. Sub-massive PE",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Sub-massive PE</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Massive PE: Characterized by sustained hypotension (systolic BP < 90 mmHg for at least 15 minutes), shock, or requiring inotropic support. This is not applicable here as the patient is normotensive.</li><li>\u2022 Option A. Massive PE:</li><li>\u2022 Option C. Low Risk PE: Patients are normotensive and do not have evidence of RV dysfunction or myocardial injury. This is incorrect because the patient has RV dysfunction and elevated BNP.</li><li>\u2022 Option C. Low Risk PE:</li><li>\u2022 Option D . Unclassified: Not a standard clinical classification for PE. PE cases are typically classified as massive, submassive, or low risk based on hemodynamic stability and RV function.</li><li>\u2022 Option D</li><li>\u2022 Unclassified:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Submassive PE is characterized by normotension with evidence of right ventricular dysfunction or myocardial injury.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "932697b2",
      "audio": ""
    },
    {
      "text": "A 65-year-old man with a history of recent surgery presents with swelling and pain in his right calf. Which of the following conditions would NOT be associated with an elevated D-dimer level?",
      "options": [
        {
          "label": "A",
          "text": "Deep vein thrombosis (DVT)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pulmonary embolism (PE)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sepsis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Iron-deficiency anemia",
          "correct": true
        }
      ],
      "correct_answer": "D. Iron-deficiency anemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Iron-deficiency anemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. DVT: DVT leads to clot formation and breakdown, resulting in elevated D-dimer levels.</li><li>\u2022 Option A. DVT:</li><li>\u2022 Option B. PE: PE is often preceded by DVT, leading to elevated D-dimer levels.</li><li>\u2022 Option B. PE:</li><li>\u2022 Option C. Sepsis: Sepsis can cause systemic inflammation and activation of coagulation, leading to elevated D-dimer levels.</li><li>\u2022 Option C. Sepsis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Iron-deficiency anemia does not typically lead to elevated D-dimer levels, unlike conditions that activate the coagulation system or fibrinolysis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c899dd2b",
      "audio": ""
    },
    {
      "text": "A 34-year-old patient with allergic bronchopulmonary aspergillosis (ABPA) on chronic steroids presents to the ER with swelling and pain in the left lower limb and sudden onset breathlessness. On arrival, the patient is hemodynamically stable but the shock index is >1. Compression ultrasound showed a left lower limb DVT. Which of the following tests would be the most definitive to confirm the probable diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "CT Pulmonary angiogram",
          "correct": true
        },
        {
          "label": "B",
          "text": "ECG",
          "correct": false
        },
        {
          "label": "C",
          "text": "Echocardiogram",
          "correct": false
        },
        {
          "label": "D",
          "text": "MRI of infont of thorax",
          "correct": false
        }
      ],
      "correct_answer": "A. CT Pulmonary angiogram",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) CT Pulmonary angiogram (CTPA)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. ECG: Might show nonspecific signs like sinus tachycardia or right heart strain but cannot definitively diagnose PE.</li><li>\u2022 Option B. ECG:</li><li>\u2022 Option C. Echocardiogram: Can detect right ventricular dysfunction, a common finding in PE, but not always diagnostic, especially in patients with pre-existing cardiac conditions.</li><li>\u2022 Option C. Echocardiogram:</li><li>\u2022 Option D. MRI of infont of thorax : Less readily available and not as sensitive or specific as CTPA for diagnosing PE.</li><li>\u2022 Option D. MRI</li><li>\u2022 of infont of thorax</li><li>\u2022 :</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 CT Pulmonary Angiogram (CTPA) is the gold standard for diagnosing pulmonary embolism, providing detailed visualization of the pulmonary vasculature to detect emboli.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "642c2b6d",
      "audio": ""
    },
    {
      "text": "A 60-year-old male with prostate cancer presents with worsening breathlessness, chest pain, and syncope. He is tachycardic and CTPA confirms pulmonary embolism (PE). Cardiac troponins and BNP levels are normal, but echocardiogram shows reduced RV function. Which of the following is the most appropriate in-hospital treatment for this patient?",
      "options": [
        {
          "label": "A",
          "text": "LMWH (Low Molecular Weight Heparin)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Warfarin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bivalirudin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Alteplase",
          "correct": false
        }
      ],
      "correct_answer": "A. LMWH (Low Molecular Weight Heparin)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) LMWH (Low Molecular Weight Heparin)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Warfarin: Requires close INR monitoring, has a delayed onset of action and has numerous drug interactions. Hence, not appropriate for in-hospital management.</li><li>\u2022 Option B. Warfarin:</li><li>\u2022 Option C. Bivalirudin: A direct thrombin inhibitor typically used primarily in patients with heparin-induced thrombocytopenia (HIT).</li><li>\u2022 Option C. Bivalirudin:</li><li>\u2022 Option D. Alteplase: A thrombolytic agent reserved for high-risk PE with hemodynamic instability.</li><li>\u2022 Option D. Alteplase:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In cancer patients with intermediate-low risk pulmonary embolism (PE), Low Molecular Weight Heparin (LMWH) is preferred due to its efficacy and lower bleeding risk.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7c025629",
      "audio": ""
    },
    {
      "text": "A 50-year-old gentleman with a family history of colorectal cancer presents with pleuritic chest pain, breathlessness and syncope. On examination he has a swollen right leg. His ECG is shown. Which of the following statements regarding the condition is NOT true?",
      "options": [
        {
          "label": "A",
          "text": "Sinus tachycardia is the most common finding in PE",
          "correct": false
        },
        {
          "label": "B",
          "text": "S1Q3T3 is pathognomonic of Pulmonary Embolism",
          "correct": true
        },
        {
          "label": "C",
          "text": "T-wave inversion in the anterior leads can be a sign of right heart strain",
          "correct": false
        },
        {
          "label": "D",
          "text": "The ECG findings in this patient are suggestive of Pulmonary embolism",
          "correct": false
        }
      ],
      "correct_answer": "B. S1Q3T3 is pathognomonic of Pulmonary Embolism",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-101539.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) S1Q3T3 is pathognomonic of Pulmonary Embolism</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Sinus tachycardia is the most common ECG finding in PE: True.</li><li>\u2022 Option A. Sinus tachycardia is the most common ECG finding in PE:</li><li>\u2022 Option C. T-wave inversions in the anterior leads can be a sign of right heart strain: True.</li><li>\u2022 Option C. T-wave inversions in the anterior leads can be a sign of right heart strain:</li><li>\u2022 Option D. The ECG findings in this patient are suggestive of PE: Patient has the classic S1Q3T3 pattern along with T inversions in anterior leads and RBBB. ECG also shows a borderline right axis deviation</li><li>\u2022 Option D. The ECG findings in this patient are suggestive of PE:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The S1Q3T3 pattern is highly suggestive of pulmonary embolism (PE) but is not pathognomonic, as it can occur in other conditions causing acute right heart strain.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e080f9e7",
      "audio": ""
    },
    {
      "text": "A patient with massive pulmonary embolism and shock undergoes thrombolysis with alteplase, but their blood pressure remains low despite aggressive fluid resuscitation, and oxygen saturation does not improve. What is the next most appropriate step in management?",
      "options": [
        {
          "label": "A",
          "text": "Repeat thrombolysis with a higher dose of alteplase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Administer anticoagulation with heparin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Proceed with surgical embolectomy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Continue supportive care and monitor",
          "correct": false
        }
      ],
      "correct_answer": "C. Proceed with surgical embolectomy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Proceed with surgical embolectomy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Repeat thrombolysis with a higher dose of alteplase : Not recommended due to increased bleeding risk.</li><li>\u2022 Option A.</li><li>\u2022 Repeat thrombolysis with a higher dose of alteplase</li><li>\u2022 :</li><li>\u2022 Option B. Administer anticoagulation with heparin : Indicated after successful thrombolysis or embolectomy.</li><li>\u2022 Option B.</li><li>\u2022 Administer anticoagulation with heparin</li><li>\u2022 :</li><li>\u2022 Option D. Continue supportive care and monitor: Not sufficient in a patient with persistent shock and hypoxemia.</li><li>\u2022 Option D.</li><li>\u2022 Continue supportive care and monitor:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In cases of massive PE with hemodynamic instability where thrombolysis fails, surgical or catheter-directed embolectomy is the next step to remove the clot and restore blood flow.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c2910b3c",
      "audio": ""
    },
    {
      "text": "A 50-year-old woman with no significant past medical history presents with pleuritic chest pain and shortness of breath after a long flight. Her heart rate is 110 beats per minute. Which of the following would NOT increase her Wells probability score for pulmonary embolism (PE)?",
      "options": [
        {
          "label": "A",
          "text": "SBP \u2264 90 mm Hg",
          "correct": true
        },
        {
          "label": "B",
          "text": "Recent immobilization",
          "correct": false
        },
        {
          "label": "C",
          "text": "History of DVT or PE",
          "correct": false
        },
        {
          "label": "D",
          "text": "Heart rate > 100 beats/minute",
          "correct": false
        }
      ],
      "correct_answer": "A. SBP \u2264 90 mm Hg",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) SBP \u2264 90 mm Hg</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Recent immobilization: Increased risk of DVT and PE.</li><li>\u2022 Option B. Recent immobilization:</li><li>\u2022 Option C. History of DVT or PE: Increases the likelihood of recurrent events.</li><li>\u2022 Option C. History of DVT or PE:</li><li>\u2022 Option D. Heart rate > 100 beats/minute: A sign of tachycardia, which can be seen in PE.</li><li>\u2022 Option D. Heart rate > 100 beats/minute:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Hemoptysis, while a possible symptom of PE, is not a criterion in the modified Wells score for PE.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "27dbf624",
      "audio": ""
    },
    {
      "text": "A patient presented with sudden onset chest pain and syncope. ECG showed sinus tachycardia. CTPA confirmed Pulmonary embolism. Chest radiograph given below. Identify the sign found on CXR?",
      "options": [
        {
          "label": "A",
          "text": "Hamptoms Hump",
          "correct": false
        },
        {
          "label": "B",
          "text": "Palla sign",
          "correct": true
        },
        {
          "label": "C",
          "text": "Westermark sig",
          "correct": false
        },
        {
          "label": "D",
          "text": "Split pleura sign",
          "correct": false
        }
      ],
      "correct_answer": "B. Palla sign",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/whatsapp-image-2024-06-20-at-103358-am.jpeg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/24/whatsapp-image-2024-06-24-at-55611-pm.jpeg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/picture3.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Palla sign</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hamptons hump: refers to wedge shaped opacity due to pulmonary infarct.</li><li>\u2022 Option A. Hamptons hump:</li><li>\u2022 Option C. Westermark sign: Refers to focal oligemia due to cutoff of blood supply</li><li>\u2022 Option C.</li><li>\u2022 Westermark sign:</li><li>\u2022 Option D. Split pleura sign : refers to thickening and separation of pleura with enhancement occurring in empyema.</li><li>\u2022 Option D.</li><li>\u2022 Split pleura sign</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Enlargement of right descending pulmonary artery is termed Palla sign.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "53477e24",
      "audio": ""
    },
    {
      "text": "A 45-year-old man presents with acute pulmonary embolism (PE). He is currently on anticoagulation therapy but has developed a major gastrointestinal bleed. Which of the following is the best next step?",
      "options": [
        {
          "label": "A",
          "text": "Increase the dose of anticoagulants",
          "correct": false
        },
        {
          "label": "B",
          "text": "Place an inferior vena cava (IVC) filter",
          "correct": true
        },
        {
          "label": "C",
          "text": "Switch to a different anticoagulant",
          "correct": false
        },
        {
          "label": "D",
          "text": "Perform an embolectomy",
          "correct": false
        }
      ],
      "correct_answer": "B. Place an inferior vena cava (IVC) filter",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Place an inferior vena cava (IVC) filter</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Increase the dose of anticoagulants : This would exacerbate the bleeding.</li><li>\u2022 Option A. Increase the dose of anticoagulants</li><li>\u2022 Option C. Switch to a different anticoagulant : This is not advisable in the context of active major bleeding.</li><li>\u2022 Option C. Switch to a different anticoagulant</li><li>\u2022 Option D. Perform an embolectomy : This is an invasive procedure not typically indicated as a primary step when an IVC filter can effectively prevent further emboli.</li><li>\u2022 Option D. Perform an embolectomy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 An IVC filter is recommended for patients with PE who cannot continue anticoagulation therapy due to major bleeding.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "34a25612",
      "audio": ""
    },
    {
      "text": "A 40-year-old female presents with redness, swelling, and tenderness along a superficial vein in her upper arm following an IV catheter placement. There is no fever or signs of systemic infection. What is the initial treatment?",
      "options": [
        {
          "label": "A",
          "text": "Oral antibiotics",
          "correct": false
        },
        {
          "label": "B",
          "text": "Warm compresses and NSAIDs",
          "correct": true
        },
        {
          "label": "C",
          "text": "Heparin therapy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Surgical removal of the affected vein",
          "correct": false
        }
      ],
      "correct_answer": "B. Warm compresses and NSAIDs",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Warm compresses and NSAIDs</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Oral antibiotics : Not necessary unless there are signs of infection.</li><li>\u2022 Option A. Oral antibiotics</li><li>\u2022 Option C. Heparin therapy : Anticoagulation is not needed unless there is extension into deep veins.</li><li>\u2022 Option C. Heparin therapy</li><li>\u2022 Option D. Surgical removal of the affected vein : Surgery is not indicated for initial treatment.</li><li>\u2022 Option D. Surgical removal of the affected vein</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The initial treatment for catheter-associated superficial thrombophlebitis includes conservative measures like warm compresses and NSAIDs.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d0076f66",
      "audio": ""
    },
    {
      "text": "Thrombosis in which of the following is least likely to cause pulmonary embolism?",
      "options": [
        {
          "label": "A",
          "text": "Superficial femoral vein",
          "correct": false
        },
        {
          "label": "B",
          "text": "Great saphenous vein",
          "correct": true
        },
        {
          "label": "C",
          "text": "Common femoral vein",
          "correct": false
        },
        {
          "label": "D",
          "text": "Popliteal vein",
          "correct": false
        }
      ],
      "correct_answer": "B. Great saphenous vein",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Great saphenous vein</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Superficial femoral vein: Although termed superficial, SFV is part of deep venous system</li><li>\u2022 Option A.</li><li>\u2022 Superficial femoral vein:</li><li>\u2022 Option C . Common femoral vein and D. Popliteal vein: are veins of the deep venous system and thrombus propagation can cause pulmonary embolism.</li><li>\u2022 Option C</li><li>\u2022 . Common femoral vein</li><li>\u2022 and</li><li>\u2022 D.</li><li>\u2022 Popliteal vein:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Thrombosis in great saphenous vein is least likely to cause pulmonary embolism.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "935723a4",
      "audio": ""
    },
    {
      "text": "A 60-year-old male with chronic kidney disease (CKD) stage 4 presents to the emergency department with acute onset shortness of breath and pleuritic chest pain. His D-dimer test is elevated, and clinical examination raises suspicion for pulmonary embolism (PE). What is the preferred diagnostic test in this scenario?",
      "options": [
        {
          "label": "A",
          "text": "CT pulmonary angiography (CTPA)",
          "correct": false
        },
        {
          "label": "B",
          "text": "V/Q scan",
          "correct": true
        },
        {
          "label": "C",
          "text": "D-dimer assay",
          "correct": false
        },
        {
          "label": "D",
          "text": "Echocardiography",
          "correct": false
        }
      ],
      "correct_answer": "B. V/Q scan",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) V/Q scan</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. CT pulmonary angiography (CTPA) : Although CTPA is the gold standard for PE diagnosis, it requires iodinated contrast, which can cause contrast-induced nephropathy in patients with CKD.</li><li>\u2022 Option A. CT pulmonary angiography (CTPA)</li><li>\u2022 Option C. D-dimer assay : While useful as an initial screening test, a positive D-dimer is not definitive for diagnosing PE and must be followed by imaging studies.</li><li>\u2022 Option C. D-dimer assay</li><li>\u2022 Option D. Echocardiography : This can identify right heart strain, a secondary effect of PE, but is not sufficient for primary diagnosis of PE and does not provide direct visualization of pulmonary emboli.</li><li>\u2022 Option D. Echocardiography</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In patients with advanced chronic kidney disease, a V/Q scan is preferred for diagnosing PE.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "30c27170",
      "audio": ""
    },
    {
      "text": "A 62-year-old woman with a history of deep vein thrombosis (DVT) treated one year ago presents with complaints of persistent leg swelling, pain, and hyperpigmentation around her ankles. What is the recommended initial management for her condition?",
      "options": [
        {
          "label": "A",
          "text": "Long-term anticoagulation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Compression therapy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Surgical vein stripping",
          "correct": false
        },
        {
          "label": "D",
          "text": "Systemic corticosteroids",
          "correct": false
        }
      ],
      "correct_answer": "B. Compression therapy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Compression therapy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Long-term anticoagulation : Prevents new clots but does not treat the chronic symptoms of PTS.</li><li>\u2022 Option A. Long-term anticoagulation</li><li>\u2022 Option C. Surgical vein stripping : Not typically indicated for PTS; it's more for varicose veins without significant post-thrombotic changes.</li><li>\u2022 Option C. Surgical vein stripping</li><li>\u2022 Option D. Systemic corticosteroids : Not a treatment for PTS and do not address the underlying venous insufficiency.</li><li>\u2022 Option D. Systemic corticosteroids</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Compression therapy is the mainstay of treatment for post-thrombotic syndrome (PTS).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c3557760",
      "audio": ""
    },
    {
      "text": "A 45-year-old banker with a history of DVT presents with progressive dyspnea, chest tightness, and syncope. PFTs are normal, but DLCO is reduced. ECHO shows elevated Right Ventricular Systolic Pressure (RVSP). What is the next BEST step?",
      "options": [
        {
          "label": "A",
          "text": "MRI angiogram of the thorax",
          "correct": false
        },
        {
          "label": "B",
          "text": "CT pulmonary angiogram (CTPA)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Coronary angiography",
          "correct": false
        },
        {
          "label": "D",
          "text": "Start prostacyclin therapy",
          "correct": false
        }
      ],
      "correct_answer": "B. CT pulmonary angiogram (CTPA)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. MRI angiogram of the thorax: While useful for some vascular imaging, not as sensitive or readily available as CTPA for CTEPH.</li><li>\u2022 Option A. MRI angiogram of the thorax:</li><li>\u2022 Option C. Coronary angiography: This assesses coronary arteries, not pulmonary circulation.</li><li>\u2022 Option C. Coronary angiography:</li><li>\u2022 Option D. Start prostacyclin therapy: This is a treatment option for PAH, but not the initial step in diagnosis.</li><li>\u2022 Option D. Start prostacyclin therapy:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective :</li><li>\u2022 CTPA is the primary imaging modality for diagnosing chronic thromboembolic pulmonary hypertension (CTEPH).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fc82b61f",
      "audio": ""
    },
    {
      "text": "A 55-year-old woman with a history of pulmonary embolism (PE) has undergone pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension (CTEPH) but continues to experience exertional dyspnea and fatigue. Which of the following is an approved medication for treatment of CTEPH?",
      "options": [
        {
          "label": "A",
          "text": "Riociguat",
          "correct": true
        },
        {
          "label": "B",
          "text": "Sildenafil",
          "correct": false
        },
        {
          "label": "C",
          "text": "Macitentan",
          "correct": false
        },
        {
          "label": "D",
          "text": "Epoprostenol",
          "correct": false
        }
      ],
      "correct_answer": "A. Riociguat",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Riociguat</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option B. Sildenafil: Primarily used in pulmonary arterial hypertension (PAH), not CTEPH.</li><li>\u2022 Option B. Sildenafil:</li><li>\u2022 Option C. Macitentan: An endothelin receptor antagonist, not specifically indicated for CTEPH.</li><li>\u2022 Option C. Macitentan:</li><li>\u2022 Option D. Espoprostenol: Espoprostenol is a PGI2 analog used in PAAH but not approved for CTEPH.</li><li>\u2022 Option D. Espoprostenol:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Riociguat is an approved medication for the treatment of persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) after pulmonary endarterectomy.</li><li>\u27a4 Riociguat is an approved medication for the treatment of persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) after pulmonary endarterectomy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a9827ef1",
      "audio": ""
    },
    {
      "text": "A 60-year-old woman with idiopathic pulmonary arterial hypertension (PAH) is being evaluated for disease progression. Which hemodynamic parameter is the LEAST reliable predictor of survival in PAH patients?",
      "options": [
        {
          "label": "A",
          "text": "Brain Natriuretic Peptide (BNP) levels",
          "correct": false
        },
        {
          "label": "B",
          "text": "WHO functional class",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mean pulmonary artery pressure (mPAP)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cardiac index (CI)",
          "correct": false
        }
      ],
      "correct_answer": "C. Mean pulmonary artery pressure (mPAP)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Mean pulmonary artery pressure (mPAP)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Brain Natriuretic Peptide (BNP) levels : Elevated BNP levels correlate with right ventricular dysfunction and are a strong predictor of morbidity and mortality in PAH patients.</li><li>\u2022 Option A. Brain Natriuretic Peptide (BNP) levels</li><li>\u2022 Option B. WHO functional class : The functional classification of patients based on symptoms and exercise capacity is a well-established predictor of survival in PAH.</li><li>\u2022 Option B. WHO functional class</li><li>\u2022 Option D. Cardiac index (CI) : A measure of cardiac output relative to body size, CI is a critical parameter in assessing the severity and prognosis of PAH. A lower CI is associated with worse outcomes.</li><li>\u2022 Option D. Cardiac index (CI)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Mean pulmonary artery pressure (mPAP) is not the most reliable predictor of survival in PAH compared to parameters such as cardiac index (CI), WHO functional class, and BNP levels.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "75b26f77",
      "audio": ""
    },
    {
      "text": "A 48-year-old man with systemic sclerosis undergoes right heart catheterization. What is the threshold value of mean pulmonary arterial pressure (mPAP) that confirms the diagnosis of pulmonary hypertension (PH)?",
      "options": [
        {
          "label": "A",
          "text": ">15 mmHg",
          "correct": false
        },
        {
          "label": "B",
          "text": ">20 mmHg",
          "correct": true
        },
        {
          "label": "C",
          "text": ">25 mmHg",
          "correct": false
        },
        {
          "label": "D",
          "text": ">30 mmHg",
          "correct": false
        }
      ],
      "correct_answer": "B. >20 mmHg",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) >20 mmHg</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. >15 mmHg: Current cut off is > 20 mm Hg for diagnosing PH</li><li>\u2022 Option A. >15 mmHg:</li><li>\u2022 Option C. >25 mmHg: Old recommendation, not followed now.</li><li>\u2022 Option C. >25 mmHg:</li><li>\u2022 Option D. >30 mmHg: False</li><li>\u2022 Option D. >30 mmHg:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Pulmonary hypertension is defined as mPAP > 20 mmHg at rest</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ddf2a76d",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman with a family history of early-onset pulmonary hypertension presents with exertional dyspnea. Genetic testing is being considered. Which gene is most commonly associated with hereditary pulmonary arterial hypertension?",
      "options": [
        {
          "label": "A",
          "text": "BRCA1",
          "correct": false
        },
        {
          "label": "B",
          "text": "CFTR",
          "correct": false
        },
        {
          "label": "C",
          "text": "BMPR2",
          "correct": true
        },
        {
          "label": "D",
          "text": "KCNH2",
          "correct": false
        }
      ],
      "correct_answer": "C. BMPR2",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) BMPR2</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. BRCA1: Associated with breast and ovarian cancer susceptibility.</li><li>\u2022 Option A. BRCA1:</li><li>\u2022 Option B. CFTR: Associated with cystic fibrosis.</li><li>\u2022 Option B. CFTR:</li><li>\u2022 Option D. KCNH2: Associated with long QT syndrome.</li><li>\u2022 Option D. KCNH2:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Mutations in the BMPR2 gene are the most frequent cause of hereditary pulmonary arterial hypertension (PAH), leading to dysregulation of pulmonary vascular growth and remodeling.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1f01e2de",
      "audio": ""
    },
    {
      "text": "A 52-year-old woman presents with progressive dyspnea. Initial CXR, CT, and PFT are normal. However, echocardiography reveals an elevated RVSP of 55 mmHg. Right heart catheterization reveals normal PCWP and mPAP of 35 mmHg. What is the most likely cause of her dyspnea?",
      "options": [
        {
          "label": "A",
          "text": "Familial Pulmonary artery hypertension (FPAH)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronic thromboembolic pulmonary hypertension (CTEPH)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Idiopathic pulmonary arterial hypertension (IPAH)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Associated Pulmonary artery hypertension (APAH)",
          "correct": false
        }
      ],
      "correct_answer": "C. Idiopathic pulmonary arterial hypertension (IPAH)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)\u00a0Idiopathic pulmonary arterial hypertension (IPAH)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Familial Pulmonary artery hypertension (FPAH): While this is a possible cause, there is no indication of a family history provided in the case, making it less likely compared to IPAH.</li><li>\u2022 Option A. Familial Pulmonary artery hypertension (FPAH):</li><li>\u2022 Option B. Chronic thromboembolic pulmonary hypertension (CTEPH): Typically, patients have a history of thromboembolic events, and CT may show chronic thromboembolic disease. The normal CT in this case makes CTEPH less likely.</li><li>\u2022 Option B. Chronic thromboembolic pulmonary hypertension (CTEPH):</li><li>\u2022 Option D. Associated Pulmonary artery hypertension (APAH): This refers to PAH associated with other conditions (e.g., connective tissue disease, HIV, portal hypertension). There is no mention of such associated conditions in the patient's history, making IPAH more likely.</li><li>\u2022 Option D. Associated Pulmonary artery hypertension (APAH):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Idiopathic pulmonary arterial hypertension (IPAH) is diagnosed in the absence of known familial, associated, or secondary causes of PAH, and is characterized by elevated RVSP, normal PCWP, and elevated mPAP (\u2265 25 mmHg).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2dd899e6",
      "audio": ""
    },
    {
      "text": "A 60-year-old smoker with progressive breathlessness for one year presents with hyperinflated lungs on chest X-ray and moderate airflow obstruction on PFTs. Echocardiogram reveals an RVSP of 60 mmHg. According to the WHO classification, which group of pulmonary hypertension (PH) does this patient most likely belong to?",
      "options": [
        {
          "label": "A",
          "text": "Group 1",
          "correct": false
        },
        {
          "label": "B",
          "text": "Group 2",
          "correct": false
        },
        {
          "label": "C",
          "text": "Group 3",
          "correct": true
        },
        {
          "label": "D",
          "text": "Group 4",
          "correct": false
        }
      ],
      "correct_answer": "C. Group 3",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Group 3</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Group 1: PAH - Typically occurs in younger individuals without significant lung disease.</li><li>\u2022 Option A. Group 1: PAH -</li><li>\u2022 Option B. Group 2: Would be caused by left heart disease, not supported by the clinical picture.</li><li>\u2022 Option B. Group 2:</li><li>\u2022 Option D. Group 4: CTEPH - While possible in smokers, the absence of a prior PE history makes this less likely.</li><li>\u2022 Option D. Group 4: CTEPH -</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The patient's history of smoking, hyperinflated lungs on X-ray, and obstructive PFTs point towards an underlying lung disease (COPD), which is a common cause of Group 3 PH (PH due to Lung Diseases and/or Hypoxemia).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "60dde790",
      "audio": ""
    },
    {
      "text": "A patient undergoes right heart catheterization (RHC) for evaluation of pulmonary hypertension. The results show: mPAP: 50 mmHg PCWP: 40 mmHg PVR: 2 Wood units What is the likely type of pulmonary hypertension this patient is suffering from?",
      "options": [
        {
          "label": "A",
          "text": "Pre-capillary pulmonary hypertension",
          "correct": false
        },
        {
          "label": "B",
          "text": "Post-capillary pulmonary hypertension",
          "correct": true
        },
        {
          "label": "C",
          "text": "Combined post- and pre-capillary pulmonary hypertension",
          "correct": false
        },
        {
          "label": "D",
          "text": "Idiopathic pulmonary arterial hypertension (IPAH)",
          "correct": false
        }
      ],
      "correct_answer": "B. Post-capillary pulmonary hypertension",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Post-capillary pulmonary hypertension</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A . Pre-capillary pulmonary hypertension : Would show elevated PVR.</li><li>\u2022 Option A</li><li>\u2022 . Pre-capillary pulmonary hypertension</li><li>\u2022 :</li><li>\u2022 Option C. Combined post- and pre-capillary pulmonary hypertension: Would show elevated mPAP, PCWP, and PVR.</li><li>\u2022 Option C.</li><li>\u2022 Combined post- and pre-capillary pulmonary hypertension:</li><li>\u2022 Option D. Idiopathic pulmonary arterial hypertension (IPAH): A type of pre-capillary PH, would have elevated PVR.</li><li>\u2022 Option D.</li><li>\u2022 Idiopathic pulmonary arterial hypertension (IPAH):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The elevated mPAP and PCWP (which reflects left atrial pressure) with normal PVR are characteristic of post-capillary pulmonary hypertension, often caused by left heart disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "02e7ba10",
      "audio": ""
    },
    {
      "text": "A 36-year-old woman with Pulmonary arterial hypertension (PAH) undergoes a vasoreactivity test during right heart catheterization. The test is positive, showing a significant decrease in mPAP with vasodilators. Which medication would be the most appropriate initial treatment for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Nifedipine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Ambrisentan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Epoprostenol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tadalafil",
          "correct": false
        }
      ],
      "correct_answer": "A. Nifedipine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Nifedipine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option B. Ambrisentan: Endothelin receptor antagonist, used in non-vasoreactive PAH.</li><li>\u2022 Option B. Ambrisentan:</li><li>\u2022 Option C. Epoprostenol: Prostacyclin analog, used in severe PAH.</li><li>\u2022 Option C. Epoprostenol:</li><li>\u2022 Option D. Tadalafil: PDE5 inhibitor, used in non-vasoreactive PAH.</li><li>\u2022 Option D. Tadalafil:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Positive vasoreactivity testing suggests that the patient's pulmonary vasculature is responsive to vasodilators. High-dose calcium channel blockers (CCBs) like nifedipine are the first-line therapy for vasoreactive PAH.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5cbd791e",
      "audio": ""
    },
    {
      "text": "A patient with pulmonary arterial hypertension (PAH) is being considered for a novel therapy that targets the activin signaling pathway to reduce pulmonary vascular remodeling. Which medication is an activin receptor fusion protein that has been shown to improve cardiopulmonary function in PAH?",
      "options": [
        {
          "label": "A",
          "text": "Sotatercept",
          "correct": true
        },
        {
          "label": "B",
          "text": "Luspatercept",
          "correct": false
        },
        {
          "label": "C",
          "text": "Selexipag",
          "correct": false
        },
        {
          "label": "D",
          "text": "Macitentan",
          "correct": false
        }
      ],
      "correct_answer": "A. Sotatercept",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Sotatercept</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option B. Luspatercept: Activin receptor type IIB fusion protein that binds and inhibits members of the TGF-\u03b2 superfamily. This reduces SMAD signalling and increases erythroid maturation. Used to treat anemia in MDS and thalassemia.</li><li>\u2022 Option B. Luspatercept:</li><li>\u2022 Option C. Selexipag: Prostacyclin receptor agonist used in PAH.</li><li>\u2022 Option C. Selexipag:</li><li>\u2022 Option D. Macitentan: Endothelin receptor antagonist used in PAH.</li><li>\u2022 Option D. Macitentan:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Sotatercept is an activin receptor type IIA fusion protein that binds and inhibits members of the TGF-\u03b2 superfamily, including activins, leading to improved hemodynamics and exercise capacity in PAH.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cbd691cc",
      "audio": ""
    },
    {
      "text": "A 55-year-old female presents with progressive dyspnea and exercise intolerance. She has a history of recurrent pulmonary embolisms. Right heart catheterization confirms pulmonary hypertension, and imaging studies show organized thrombi within the pulmonary arteries. Which of the following is considered the best treatment option for her condition?",
      "options": [
        {
          "label": "A",
          "text": "Long-term anticoagulation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pulmonary endarterectomy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Balloon pulmonary angioplasty",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lung transplantation",
          "correct": false
        }
      ],
      "correct_answer": "B. Pulmonary endarterectomy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Pulmonary endarterectomy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Long-term anticoagulation : Essential for preventing new clots but does not address the existing organized thrombi causing CTEPH.</li><li>\u2022 Option A. Long-term anticoagulation</li><li>\u2022 Option C. Balloon pulmonary angioplasty : An option for patients who are not candidates for surgery or have residual disease post-endarterectomy, but not considered the first-line treatment.</li><li>\u2022 Option C. Balloon pulmonary angioplasty</li><li>\u2022 Option D. Lung transplantation : Considered for patients with advanced disease who are not candidates for other treatments, but pulmonary endarterectomy is preferred if feasible.</li><li>\u2022 Option D. Lung transplantation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Pulmonary endarterectomy is the best treatment for chronic thromboembolic pulmonary hypertension (CTEPH) as it removes organized thrombi from the pulmonary arteries, improving hemodynamics and symptoms.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1ebf58a7",
      "audio": ""
    },
    {
      "text": "A 50-year-old male presents to the OPD with exertional dyspnea, fatigue, syncope, and peripheral edema. On examination, JVP is raised and a loud P2 is noted. ECHO shows right atrial and right ventricular enlargement with a mean pulmonary artery pressure of 30 mmHg. Which of the following statements is false regarding the condition?",
      "options": [
        {
          "label": "A",
          "text": "Diuretics are given to reduce peripheral edema",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oxygen supplementation is given if PO2 is reduced",
          "correct": false
        },
        {
          "label": "C",
          "text": "For patients with persistent right heart failure, lung transplantation may be considered",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pulmonary arterial hypertension is more common in males",
          "correct": true
        }
      ],
      "correct_answer": "D. Pulmonary arterial hypertension is more common in males",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Pulmonary arterial hypertension is more common in males</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Diuretics are given to reduce peripheral edema : True. Diuretics are commonly used to manage symptoms of right heart failure, including peripheral edema.</li><li>\u2022 Option A. Diuretics are given to reduce peripheral edema</li><li>\u2022 Option B. Oxygen supplementation is given if PO2 is reduced : True. Oxygen therapy is used to maintain adequate oxygenation and prevent hypoxemia in PAH patients.</li><li>\u2022 Option B. Oxygen supplementation is given if PO2 is reduced</li><li>\u2022 Option C. For patients with persistent right heart failure, lung transplantation may be considered : True. Lung transplantation is a treatment option for patients with advanced PAH and right heart failure that is refractory to medical therapy.</li><li>\u2022 Option C. For patients with persistent right heart failure, lung transplantation may be considered</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Idiopathic Pulmonary arterial hypertension (IPAH) is more common in females than in males, with a female-to-male ratio of approximately 3:1.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "341f7e1f",
      "audio": ""
    },
    {
      "text": "A 50-year-old male presents with chronic progressive breathlessness. On examination, his JVP is elevated, there is a loud 2nd heart sound, and bilateral pedal edema. Right heart catheterization reveals pulmonary hypertension. Pre-capillary pulmonary hypertension is defined as:",
      "options": [
        {
          "label": "A",
          "text": "mPAP >20 mm Hg, PCWP > 15 mm Hg",
          "correct": false
        },
        {
          "label": "B",
          "text": "mPAP >25 mm Hg, PCWP > 15 mm Hg",
          "correct": false
        },
        {
          "label": "C",
          "text": "mPAP >20 mm Hg, PCWP < 15 mm Hg",
          "correct": true
        },
        {
          "label": "D",
          "text": "mPAP >25 mm Hg, PCWP < 15 mm Hg",
          "correct": false
        }
      ],
      "correct_answer": "C. mPAP >20 mm Hg, PCWP < 15 mm Hg",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) mPAP >20 mm Hg, PCWP < 15 mm Hg</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. mPAP >20 mm Hg, PCWP > 15 mm Hg : This describes post-capillary pulmonary hypertension, indicating elevated pressures due to left heart disease.</li><li>\u2022 Option A. mPAP >20 mm Hg, PCWP > 15 mm Hg</li><li>\u2022 Option B. mPAP >25 mm Hg, PCWP > 15 mm Hg : This was the previous threshold for post-capillary pulmonary hypertension but has been updated to mPAP >20 mm Hg.</li><li>\u2022 Option B. mPAP >25 mm Hg, PCWP > 15 mm Hg</li><li>\u2022 Option D. mPAP >25 mm Hg, PCWP < 15 mm Hg : This was the previous threshold for pre-capillary pulmonary hypertension but has been updated to mPAP >20 mm Hg.</li><li>\u2022 Option D. mPAP >25 mm Hg, PCWP < 15 mm Hg</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Pre-capillary pulmonary hypertension is defined by a mean pulmonary artery pressure (mPAP) greater than 20 mm Hg and a pulmonary capillary wedge pressure (PCWP) less than 15 mm Hg.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b096e3ea",
      "audio": ""
    },
    {
      "text": "A 45-year-old male from an endemic region presents with signs of pulmonary hypertension (PH). He has a history of hepatosplenic disease and portal hypertension. Which of the following is the most likely cause of his pulmonary hypertension?",
      "options": [
        {
          "label": "A",
          "text": "Chronic obstructive pulmonary disease (COPD)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Idiopathic pulmonary arterial hypertension (IPAH)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Schistosomiasis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Left heart disease",
          "correct": false
        }
      ],
      "correct_answer": "C. Schistosomiasis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Schistosomiasis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Chronic obstructive pulmonary disease (COPD) : Typically associated with a history of smoking and different clinical features.</li><li>\u2022 Option A. Chronic obstructive pulmonary disease (COPD)</li><li>\u2022 Option B. Idiopathic pulmonary arterial hypertension (IPAH) : A diagnosis of exclusion when other causes of PH are ruled out.</li><li>\u2022 Option B. Idiopathic pulmonary arterial hypertension (IPAH)</li><li>\u2022 Option D. Left heart disease : Causes post-capillary pulmonary hypertension, typically with elevated PCWP, which is not the scenario here.</li><li>\u2022 Option D. Left heart disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Pre-capillary pulmonary hypertension is defined by a mean pulmonary artery pressure (mPAP) greater than 20 mm Hg and a pulmonary capillary wedge pressure (PCWP) less than 15 mm Hg.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9a1d2623",
      "audio": ""
    },
    {
      "text": "The Gold's criteria for very severe COPD is: (NEET PG 2018)",
      "options": [
        {
          "label": "A",
          "text": "FEV1/FVC <0.7 and FEV1 < 30%",
          "correct": true
        },
        {
          "label": "B",
          "text": "FEV1/FVC <0.7 and FEV1 <70%",
          "correct": false
        },
        {
          "label": "C",
          "text": "FEV1/FVC<0.7 and FEV1< 50%",
          "correct": false
        },
        {
          "label": "D",
          "text": "Both A and C",
          "correct": false
        }
      ],
      "correct_answer": "A. FEV1/FVC <0.7 and FEV1 < 30%",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-164040.jpg"
      ],
      "explanation": "<p><strong>Ans. A) FEV1/FVC <0.7 and FEV1 < 30%</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Note:</li><li>\u27a4 Note:</li><li>\u27a4 Currently Class C+D have been combined and called Class E Classification of types have been updated.</li><li>\u27a4 Currently Class C+D have been combined and called Class E</li><li>\u27a4 Classification of types have been updated.</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference: GOLD 2023 guidelines</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3e0334ab",
      "audio": ""
    },
    {
      "text": "A 48-year-old man with a history of asthma presents to the clinic with worsening wheezing, cough, and shortness of breath. Which of the following is the LEAST likely trigger for his current exacerbation?",
      "options": [
        {
          "label": "A",
          "text": "Exposure to cat dander",
          "correct": false
        },
        {
          "label": "B",
          "text": "Recent URI with rhinovirus",
          "correct": false
        },
        {
          "label": "C",
          "text": "Using beta-blocker for hypertension",
          "correct": false
        },
        {
          "label": "D",
          "text": "Consuming large amounts of alcohol",
          "correct": true
        }
      ],
      "correct_answer": "D. Consuming large amounts of alcohol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Options A. Exposure to cat dander: Animal dander is a common allergen and a well-known trigger for asthma exacerbations.</li><li>\u2022 Options A. Exposure to cat dander:</li><li>\u2022 Options B. Recent URI with rhinovirus: Viral respiratory infections are among the most common triggers of asthma exacerbations.</li><li>\u2022 Options B. Recent URI with rhinovirus:</li><li>\u2022 Options C. Using a beta-blocker for hypertension: Beta-blockers can worsen asthma symptoms due to their bronchoconstrictive effects by blocking beta-2 receptors in the airways.</li><li>\u2022 Options C. Using a beta-blocker for hypertension:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Alcohol consumption is not a direct trigger for bronchoconstriction and airway inflammation in asthma.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f67517dc",
      "audio": ""
    },
    {
      "text": "A 5-year-old boy with a family history of asthma and allergies presents with recurrent wheezing, coughing, and shortness of breath. Genetic testing is being considered to assess his risk of developing persistent asthma. Which of the following genes is MOST consistently associated with asthma susceptibility?",
      "options": [
        {
          "label": "A",
          "text": "CFTR",
          "correct": false
        },
        {
          "label": "B",
          "text": "BRCA1",
          "correct": false
        },
        {
          "label": "C",
          "text": "ORMDL3",
          "correct": true
        },
        {
          "label": "D",
          "text": "KCNH2",
          "correct": false
        }
      ],
      "correct_answer": "C. ORMDL3",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) ORMDL3</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Options A. CFTR: Associated with cystic fibrosis.</li><li>\u2022 Options A. CFTR:</li><li>\u2022 Options B. BRCA1: Associated with breast and ovarian cancer.</li><li>\u2022 Options B. BRCA1:</li><li>\u2022 Options D. KCNH2: Associated with long QT syndrome.</li><li>\u2022 Options D. KCNH2:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 ORMDL3 is the most consistently associated gene with asthma susceptibility.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2d43eb50",
      "audio": ""
    },
    {
      "text": "A 36-year-old woman experiences recurrent episodes of wheezing and nasal congestion after taking aspirin for a headache. Which of the following is most likely associated with her condition?",
      "options": [
        {
          "label": "A",
          "text": "Raised serum IgE levels",
          "correct": false
        },
        {
          "label": "B",
          "text": "Positive skin test for inhaled allergens",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nasal polyps",
          "correct": true
        },
        {
          "label": "D",
          "text": "A type of extrinsic asthma",
          "correct": false
        }
      ],
      "correct_answer": "C. Nasal polyps",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Nasal polyps</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Raised serum IgE levels: Associated with allergic asthma, not AERD.</li><li>\u2022 Option A. Raised serum IgE levels:</li><li>\u2022 Option B. Positive skin test for inhaled allergens: Also associated with allergic asthma.</li><li>\u2022 Option B. Positive skin test for inhaled allergens:</li><li>\u2022 Option D. A type of extrinsic asthma: AERD is a type of intrinsic (non-allergic) asthma.</li><li>\u2022 Option D. A type of extrinsic asthma:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Nasal polyps are characteristic of aspirin-exacerbated respiratory disease (AERD) in patients with asthma and aspirin sensitivity.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b926f2ab",
      "audio": ""
    },
    {
      "text": "A patient experiences recurrent episodes of wheezing, cough, and shortness of breath. Which test is most reliable in confirming the diagnosis of bronchial asthma?",
      "options": [
        {
          "label": "A",
          "text": "Chest X-ray",
          "correct": false
        },
        {
          "label": "B",
          "text": "Skin prick test",
          "correct": false
        },
        {
          "label": "C",
          "text": "FEV1 measurement",
          "correct": false
        },
        {
          "label": "D",
          "text": "Demonstration of reversible obstruction on PFT",
          "correct": true
        }
      ],
      "correct_answer": "D. Demonstration of reversible obstruction on PFT",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Demonstration of reversible obstruction on PFT</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Chest X-ray: Typically normal in asthma.</li><li>\u2022 Option A. Chest X-ray:</li><li>\u2022 Option B. Skin prick test: Identifies allergic triggers, but not diagnostic of asthma.</li><li>\u2022 Option B. Skin prick test:</li><li>\u2022 Option C. FEV1 measurement: May show obstruction, but reversibility is key for diagnosis.</li><li>\u2022 Option C. FEV1 measurement:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Demonstration of reversible obstruction on PFTs is the most reliable test for confirming the diagnosis of bronchial asthma.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c12d72c9",
      "audio": ""
    },
    {
      "text": "After administering a short-acting beta-agonist (SABA) inhaler like salbutamol for suspected asthma, how long should you wait before repeating spirometry to assess for reversibility?",
      "options": [
        {
          "label": "A",
          "text": "5 minutes",
          "correct": false
        },
        {
          "label": "B",
          "text": "15 minutes",
          "correct": true
        },
        {
          "label": "C",
          "text": "30 minutes",
          "correct": false
        },
        {
          "label": "D",
          "text": "60 minutes",
          "correct": false
        }
      ],
      "correct_answer": "B. 15 minutes",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) 15 minutes</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. 5 minutes: Too soon; the full effect of the bronchodilator may not yet be evident.</li><li>\u2022 Option A.</li><li>\u2022 5 minutes:</li><li>\u2022 Option C. 30 minutes and, D. 60 minutes : Waiting longer may lead to the bronchodilator effect wearing off, giving a false negative result.</li><li>\u2022 Option C.</li><li>\u2022 30 minutes and,</li><li>\u2022 D.</li><li>\u2022 60 minutes</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Wait 15 minutes after administering a SABA inhaler like salbutamol before repeating spirometry to assess for reversibility.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "afafbff7",
      "audio": ""
    },
    {
      "text": "A 68-year-old man with stable COPD and resting oxygen saturation of 88% on room air is started on long-term oxygen therapy (LTOT). Which of the following is NOT a known benefit of LTOT in COPD?",
      "options": [
        {
          "label": "A",
          "text": "Improved survival",
          "correct": false
        },
        {
          "label": "B",
          "text": "Reduced pulmonary vascular resistance",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased hematocrit",
          "correct": true
        },
        {
          "label": "D",
          "text": "Improved V/Q mismatch",
          "correct": false
        }
      ],
      "correct_answer": "C. Increased hematocrit",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Increased hematocrit</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Long-term oxygen therapy (LTOT) in COPD patients with chronic hypoxemia (resting SpO2 \u2264 88%) has several established benefits:</li><li>\u2022 Improved survival: LTOT has been shown to increase survival in patients with severe resting hypoxemia (PaO2 \u2264 55 mmHg). Reduced pulmonary vascular resistance: LTOT helps reduce pulmonary hypertension by improving oxygenation and decreasing hypoxic vasoconstriction. Improved V/Q mismatch: By increasing alveolar oxygen tension, LTOT can help correct the ventilation-perfusion mismatch often seen in COPD. Decreased hematocrit (polycythemia): Chronic hypoxemia can trigger an increase in red blood cell production (polycythemia). LTOT can reverse this effect</li><li>\u2022 Improved survival: LTOT has been shown to increase survival in patients with severe resting hypoxemia (PaO2 \u2264 55 mmHg).</li><li>\u2022 Improved survival:</li><li>\u2022 Reduced pulmonary vascular resistance: LTOT helps reduce pulmonary hypertension by improving oxygenation and decreasing hypoxic vasoconstriction.</li><li>\u2022 Reduced pulmonary vascular resistance:</li><li>\u2022 Improved V/Q mismatch: By increasing alveolar oxygen tension, LTOT can help correct the ventilation-perfusion mismatch often seen in COPD.</li><li>\u2022 Improved V/Q mismatch:</li><li>\u2022 Decreased hematocrit (polycythemia): Chronic hypoxemia can trigger an increase in red blood cell production (polycythemia). LTOT can reverse this effect</li><li>\u2022 Decreased hematocrit (polycythemia):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Long-term oxygen therapy (LTOT) in COPD improves survival, reduces pulmonary vascular resistance, and improves V/Q mismatch, but it does not increase hematocrit.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "35028351",
      "audio": ""
    },
    {
      "text": "A 72-year-old man with severe emphysema secondary to alpha-1 antitrypsin deficiency is being evaluated for long-term oxygen therapy (LTOT). Which of the following scenarios would NOT meet the criteria for LTOT in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Resting PaO2 of 54 mmHg and evidence of cor pulmonale",
          "correct": false
        },
        {
          "label": "B",
          "text": "Resting SpO2 of 88% on room air and a history of two COPD exacerbations in the past year",
          "correct": false
        },
        {
          "label": "C",
          "text": "Resting PaO2 of 58 mmHg and a hematocrit of 55%",
          "correct": false
        },
        {
          "label": "D",
          "text": "Resting SpO2 of 89% and a normal 6-minute walk distance",
          "correct": true
        }
      ],
      "correct_answer": "D. Resting SpO2 of 89% and a normal 6-minute walk distance",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Resting PaO2 of 54 mmHg and evidence of cor pulmonale: Meets the criteria for LTOT.</li><li>\u2022 Option A. Resting PaO2 of 54 mmHg and evidence of cor pulmonale:</li><li>\u2022 Option B. Resting SpO2 of 88% and a history of two COPD exacerbations: Meets the criteria due to low SpO2.</li><li>\u2022 Option B. Resting SpO2 of 88% and a history of two COPD exacerbations:</li><li>\u2022 Option C. Resting PaO2 of 58 mmHg and a hematocrit of 55%: Meets the criteria due to low PaO2 and high hematocrit</li><li>\u2022 Option C. Resting PaO2 of 58 mmHg and a hematocrit of 55%:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Resting SpO2 of 89% and a normal 6-minute walk distance do not meet the criteria for long-term oxygen therapy (LTOT) in COPD.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "00a8e2f3",
      "audio": ""
    },
    {
      "text": "A 68-year-old man with severe COPD and chronic bronchitis presents with a history of frequent exacerbations despite optimal bronchodilator therapy. He has a 50-pack-year smoking history and continues to smoke 1 pack per day. Which of the following medications is most likely to reduce the frequency of his exacerbations?",
      "options": [
        {
          "label": "A",
          "text": "Tiotropium",
          "correct": false
        },
        {
          "label": "B",
          "text": "Salmeterol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Roflumilast",
          "correct": true
        },
        {
          "label": "D",
          "text": "Prednisolone",
          "correct": false
        }
      ],
      "correct_answer": "C. Roflumilast",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Tiotropium: While a LAMA improves lung function and symptoms, it doesn't have the same impact on exacerbation frequency as roflumilast.</li><li>\u2022 Option A. Tiotropium:</li><li>\u2022 Option B. Salmeterol: LABAs improve lung function but don't specifically target exacerbations like roflumilast.</li><li>\u2022 Option B. Salmeterol:</li><li>\u2022 Option D. Prednisolone: Oral steroids are used for acute exacerbations, not long-term prevention.</li><li>\u2022 Option D. Prednisolone:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Roflumilast (PDE4 inhibitor) is indicated for severe COPD with chronic bronchitis and frequent exacerbations, reducing inflammation and mucus production.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bada230a",
      "audio": ""
    },
    {
      "text": "A 60-year-old smoker with a history of COPD presents to the clinic with a COPD Assessment Test (CAT) score of 15 and two hospitalizations for COPD exacerbations in the past year. Which GOLD category does he belong to based on the 2023 GOLD guidelines?",
      "options": [
        {
          "label": "A",
          "text": "GOLD A",
          "correct": false
        },
        {
          "label": "B",
          "text": "GOLD B",
          "correct": false
        },
        {
          "label": "C",
          "text": "GOLD C",
          "correct": false
        },
        {
          "label": "D",
          "text": "GOLD E",
          "correct": true
        }
      ],
      "correct_answer": "D. GOLD E",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/picture41.jpg"
      ],
      "explanation": "<p><strong>Ans. D) GOLD E</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. GOLD A: Low risk, low symptoms</li><li>\u2022 Option A. GOLD A:</li><li>\u2022 Option B. GOLD B: Low risk, high symptoms</li><li>\u2022 Option B. GOLD B:</li><li>\u2022 Option C. GOLD C: No longer used in the 2023 guidelines</li><li>\u2022 Option C. GOLD C:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Patients with a high symptom burden (CAT score \u226510) or a history of exacerbations belong to GOLD category E according to the 2023 GOLD guidelines.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fb7b9e7d",
      "audio": ""
    },
    {
      "text": "A 68-year-old man with a long history of smoking and progressive dyspnea presents with a barrel chest and expiratory wheezing. Which of the following pulmonary function test (PFT) findings is NOT typically seen in emphysema?",
      "options": [
        {
          "label": "A",
          "text": "Increased total lung capacity (TLC)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Decreased FEV1/FVC ratio",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased diffusing capacity of the lung for carbon monoxide (DLCO)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Decreased vital capacity (VC)",
          "correct": false
        }
      ],
      "correct_answer": "C. Increased diffusing capacity of the lung for carbon monoxide (DLCO)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Increased diffusing capacity of the lung for carbon monoxide (DLCO)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Increased total lung capacity (TLC) : Common in emphysema due to air trapping and hyperinflation.</li><li>\u2022 Option A.</li><li>\u2022 Increased total lung capacity (TLC)</li><li>\u2022 :</li><li>\u2022 Option B. Decreased FEV1/FVC ratio: Hallmark of obstructive lung disease like emphysema.</li><li>\u2022 Option B. Decreased FEV1/FVC ratio:</li><li>\u2022 Option D. Decreased vital capacity (VC): Often seen in emphysema due to severe air trapping - also called as \u2018pseudo-restriction\u2019</li><li>\u2022 Option D. Decreased vital capacity (VC):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Increased DLCO is not typically seen in emphysema, as this condition reduces gas exchange surface area, leading to decreased DLCO.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c540bc68",
      "audio": ""
    },
    {
      "text": "A 65-year-old patient with severe COPD undergoes spirometry after bronchodilator administration. His FEV1 is 28% of the predicted value. Which GOLD stage does he belong to?",
      "options": [
        {
          "label": "A",
          "text": "GOLD 1 (Mild)",
          "correct": false
        },
        {
          "label": "B",
          "text": "GOLD 2 (Moderate)",
          "correct": false
        },
        {
          "label": "C",
          "text": "GOLD 3 (Severe)",
          "correct": false
        },
        {
          "label": "D",
          "text": "GOLD 4 (Very Severe)",
          "correct": true
        }
      ],
      "correct_answer": "D. GOLD 4 (Very Severe)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) GOLD 4 (Very Severe)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. GOLD 1 (Mild) : FEV1 \u2265 80% predicted</li><li>\u2022 Option A. GOLD 1</li><li>\u2022 (Mild)</li><li>\u2022 :</li><li>\u2022 Option B. GOLD 2 ( Moderate) : 50% \u2264 FEV1 < 80% predicted</li><li>\u2022 Option B. GOLD 2 (</li><li>\u2022 Moderate)</li><li>\u2022 :</li><li>\u2022 Option C. GOLD 3 (Severe) : 30% \u2264 FEV1 < 50% predicted</li><li>\u2022 Option C. GOLD 3</li><li>\u2022 (Severe)</li><li>\u2022 :</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Very severe COPD (GOLD 4) is defined by a post-bronchodilator FEV1 less than 30% of the predicted value.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b95563c9",
      "audio": ""
    },
    {
      "text": "A 62-year-old woman with COPD reports that she becomes short of breath when walking at her own pace on level ground, and sometimes has to stop for breath. Based on the modified Medical Research Council (mMRC) dyspnea scale, what is her dyspnea grade?",
      "options": [
        {
          "label": "A",
          "text": "mMRC 0",
          "correct": false
        },
        {
          "label": "B",
          "text": "mMRC 1",
          "correct": false
        },
        {
          "label": "C",
          "text": "mMRC 2",
          "correct": true
        },
        {
          "label": "D",
          "text": "mMRC 3",
          "correct": false
        }
      ],
      "correct_answer": "C. mMRC 2",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) mMRC 2</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. mMRC 0: No breathlessness except with strenuous exercise.</li><li>\u2022 Option A. mMRC 0:</li><li>\u2022 Option B. mMRC 1: Breathlessness when hurrying or walking up a slight hill.</li><li>\u2022 Option B. mMRC 1:</li><li>\u2022 Option D. mMRC 3: Walks slower than others of same age due to breathlessness or stops for breath at own pace.</li><li>\u2022 Option D. mMRC 3:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The patient's description matches the mMRC grade 2 criterion: \"Short of breath when hurrying on the level or walking up a slight hill.\"</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "94830675",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a component of the BODE index, a prognostic tool in COPD that incorporates the mMRC dyspnea scale?",
      "options": [
        {
          "label": "A",
          "text": "Body mass index (BMI)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Airflow obstruction (FEV1)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dyspnea (mMRC grade)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Exacerbation frequency",
          "correct": true
        }
      ],
      "correct_answer": "D. Exacerbation frequency",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Exacerbation frequency</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. BMI: Lower BMI is associated with worse prognosis in COPD.</li><li>\u2022 Option A. BMI:</li><li>\u2022 Option B. Airflow obstruction (FEV1): Lower FEV1 indicates worse lung function and prognosis.</li><li>\u2022 Option B. Airflow obstruction (FEV1):</li><li>\u2022 Option C. Dyspnea (mMRC grade): Higer mMRC grade indicates more severe dyspnea and worse prognosis.</li><li>\u2022 Option C. Dyspnea (mMRC grade):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Exacerbation frequency, while important, is not included in the BODE index, which incorporates BMI, FEV1, mMRC dyspnea grade, and 6-minute walk distance.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d7c9131a",
      "audio": ""
    },
    {
      "text": "A 55-year-old man with a 20-pack-year smoking history presents with progressive shortness of breath and chronic cough. Spirometry reveals an FEV1 of 62% predicted and an FEV1/FVC ratio of 39%. After administration of a bronchodilator (BD), the FEV1 improves to 75% predicted, and the FEV1/FVC ratio improves to 73%. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Asthma",
          "correct": true
        },
        {
          "label": "B",
          "text": "COPD (Chronic Obstructive Pulmonary Disease)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Allergic Bronchopulmonary Aspergillosis (ABPA)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pulmonary Langerhans Cell Histiocytosis",
          "correct": false
        }
      ],
      "correct_answer": "A. Asthma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Asthma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. COPD (Chronic Obstructive Pulmonary Disease) : Although COPD can also cause airflow obstruction, it is typically less reversible with bronchodilators.</li><li>\u2022 Option B. COPD</li><li>\u2022 (Chronic Obstructive Pulmonary Disease)</li><li>\u2022 :</li><li>\u2022 Option C. Allergic Bronchopulmonary Aspergillosis (ABPA) : While ABPA can cause asthma-like symptoms, it is usually associated with elevated IgE levels and positive Aspergillus serology.</li><li>\u2022 Option C.</li><li>\u2022 Allergic Bronchopulmonary Aspergillosis (ABPA)</li><li>\u2022 :</li><li>\u2022 Option D. Pulmonary Langerhans Cell Histiocytosis: Primarily seen in smokers and associated with cystic lung lesions on imaging.</li><li>\u2022 Option D. Pulmonary Langerhans Cell Histiocytosis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Post-bronchodilator FEV1/FVC > 70% rules out COPD and establishes the diagnosis of asthma, with significant improvement in FEV1 indicating reversibility.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e02b6f1b",
      "audio": ""
    },
    {
      "text": "A 60-year-old smoker with a long-standing history of dyspnea and a scanty cough experiences relief with bronchodilator therapy. Pulmonary function tests reveal an FEV1/FVC 54% and FEV1 50% predicted. Post Bronchodilator neb his FEV1/FVC improved to 65% and FEV1 improved to 57%. Which of the following is NOT a typical feature of this patient's likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Irreversible airflow limitation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Decreased residual volume (RV)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Affects small airways",
          "correct": false
        },
        {
          "label": "D",
          "text": "Can occur due to protease-antiprotease imbalance",
          "correct": false
        }
      ],
      "correct_answer": "B. Decreased residual volume (RV)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Decreased residual volume (RV)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Irreversible airflow limitation: This is the hallmark of COPD.</li><li>\u2022 Option A. Irreversible airflow limitation:</li><li>\u2022 Option C. Affects small airways: Small airway inflammation and narrowing contribute to COPD.</li><li>\u2022 Option C. Affects small airways:</li><li>\u2022 Option D. Can occurs due to protease-antiprotease imbalance: This imbalance contributes to the destruction of lung tissue in emphysema, which is a major cause of COPD</li><li>\u2022 Option D. Can occurs due to protease-antiprotease imbalance:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 COPD is characterized by air trapping, leading to an increased residual volume (RV), not decreased.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d5d68c49",
      "audio": ""
    },
    {
      "text": "A patient with alpha-1 antitrypsin deficiency is found to have emphysema predominantly affecting the lower lobes of the lungs. Which type of emphysema is this most consistent with?",
      "options": [
        {
          "label": "A",
          "text": "Centrilobular emphysema",
          "correct": false
        },
        {
          "label": "B",
          "text": "Paraseptal emphysema",
          "correct": false
        },
        {
          "label": "C",
          "text": "Panacinar emphysema",
          "correct": true
        },
        {
          "label": "D",
          "text": "Bullous emphysema",
          "correct": false
        }
      ],
      "correct_answer": "C. Panacinar emphysema",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Panacinar emphysema</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Centrilobular emphysema: Predominantly affects the respiratory bronchioles and is more common in smokers.</li><li>\u2022 Option A. Centrilobular emphysema:</li><li>\u2022 Option B. Paraseptal emphysema: Occurs adjacent to pleural surfaces and interlobular septa.</li><li>\u2022 Option B. Paraseptal emphysema:</li><li>\u2022 Option D. Bullous emphysema: Refers to large bullae formation, not a distinct type.</li><li>\u2022 Option D. Bullous emphysema:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Panacinar emphysema involves uniform destruction of the acinus and is typically seen in the lower lobes of patients with alpha-1 antitrypsin deficiency.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1c46176e",
      "audio": ""
    },
    {
      "text": "A 65-year-old man with moderate to severe COPD is being considered for treatment with inhaled corticosteroids (ICS). Which of the following statements is TRUE regarding the use of ICS in COPD?",
      "options": [
        {
          "label": "A",
          "text": "ICS reduce mortality in COPD",
          "correct": false
        },
        {
          "label": "B",
          "text": "ICS reduce the frequency of COPD exacerbations.",
          "correct": true
        },
        {
          "label": "C",
          "text": "ICS reduce the rate of decline of FEV1 in COPD",
          "correct": false
        },
        {
          "label": "D",
          "text": "ICS reduce the incidence of pneumonia in COPD.",
          "correct": false
        }
      ],
      "correct_answer": "B. ICS reduce the frequency of COPD exacerbations.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) ICS reduce the frequency of COPD exacerbations.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. ICS reduce mortality in COPD : Not true. But recently, triple combinations (LABA + LAMA + ICS) in selected patients (Group E) has shown to reduce mortality.</li><li>\u2022 Option A.</li><li>\u2022 ICS reduce mortality in COPD</li><li>\u2022 :</li><li>\u2022 Option C. ICS reduce the rate of decline of FEV1 in COPD : Not true.</li><li>\u2022 Option C.</li><li>\u2022 ICS reduce the rate of decline of FEV1 in COPD</li><li>\u2022 :</li><li>\u2022 Option D. ICS reduce the incidence of pneumonia in COPD : Actually, ICS may slightly increase the risk of pneumonia.</li><li>\u2022 Option D.</li><li>\u2022 ICS reduce the incidence of pneumonia in COPD</li><li>\u2022 :</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Inhaled corticosteroids (ICS) reduce the frequency of COPD exacerbations.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ec9b2133",
      "audio": ""
    },
    {
      "text": "A 69-year-old smoker with COPD has had three hospitalizations for exacerbations in the past year. He is already on LABA(long acting beta 2 agonist), LAMA long acting muscarinic antagonist) and ICS (inhaled corticosteroids). Which of the following treatments is most likely to decrease the frequency of his exacerbations?",
      "options": [
        {
          "label": "A",
          "text": "Daily azithromycin 500mg",
          "correct": true
        },
        {
          "label": "B",
          "text": "Continuous oxygen at 2 L/min",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nocturnal BiPAP (bilevel positive airway pressure)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Inhaled corticosteroids",
          "correct": false
        }
      ],
      "correct_answer": "A. Daily azithromycin 500mg",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Daily azithromycin 500mg</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Continuous oxygen at 2 L/min: While oxygen therapy is crucial for patients with chronic hypoxemia, it doesn't directly reduce the frequency of exacerbations.</li><li>\u2022 Option B. Continuous oxygen at 2 L/min:</li><li>\u2022 Option C. Nocturnal BiPAP (bilevel positive airway pressure) : This is indicated for COPD patients with hypercapnic respiratory failure or nocturnal desaturation, not as a primary prevention for exacerbations.</li><li>\u2022 Option C.</li><li>\u2022 Nocturnal BiPAP (bilevel positive airway pressure)</li><li>\u2022 :</li><li>\u2022 Option D. Inhaled corticosteroids: The patient is already on ICS, and further increasing the dose is unlikely to provide additional benefit in preventing exacerbations.</li><li>\u2022 Option D. Inhaled corticosteroids:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Daily azithromycin 500mg can significantly reduce the frequency of exacerbations in severe COPD patients already on LABA, LAMA, and ICS therapy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "41f9f722",
      "audio": ""
    },
    {
      "text": "A 68-year-old man with an acute exacerbation of COPD presents with respiratory distress, tachypnea, and altered mental status. Which of the following would be an absolute contraindication to initiating non-invasive ventilation (NIV)?",
      "options": [
        {
          "label": "A",
          "text": "Hypoxemia (PaO2 < 60 mmHg on room air)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypercapnia (PaCO2 > 50 mmHg)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Respiratory acidosis (pH < 7.35)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Inability to protect airway",
          "correct": true
        }
      ],
      "correct_answer": "D. Inability to protect airway",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Inability to protect airway</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hypoxemia (PaO2 < 60 mmHg on room air): NIV can be used to improve oxygenation in COPD exacerbations.</li><li>\u2022 Option A. Hypoxemia (PaO2 < 60 mmHg on room air):</li><li>\u2022 Option B. Hypercapnia (PaCO2 > 50 mmHg): NIV can improve ventilation and reduce CO2 levels.</li><li>\u2022 Option B.</li><li>\u2022 Hypercapnia (PaCO2 > 50 mmHg):</li><li>\u2022 Option C. Respiratory acidosis (pH < 7.35): NIV can help correct acidosis caused by hypercapnia.</li><li>\u2022 Option C.</li><li>\u2022 Respiratory acidosis (pH < 7.35):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Inability to protect the airway is an absolute contraindication to initiating non-invasive ventilation (NIV) in patients with acute exacerbation of COPD.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "10ab7608",
      "audio": ""
    },
    {
      "text": "A 30-year-old occasional smoker presents with a chronic cough and dyspnea on exertion. Physical examination is unremarkable, and chest X-ray is normal. Spirometry reveals an FEV1 of 60% predicted and an FEV1/FVC ratio of 80%. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Asthma",
          "correct": false
        },
        {
          "label": "B",
          "text": "COPD (Chronic Obstructive Pulmonary Disease)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Preserved Ratio Impaired Spirometry (PRISm)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Normal lung function",
          "correct": false
        }
      ],
      "correct_answer": "C. Preserved Ratio Impaired Spirometry (PRISm)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Preserved Ratio Impaired Spirometry (PRISm)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Asthma: Usually shows a reduced FEV1/FVC ratio with reversibility.</li><li>\u2022 Option A. Asthma:</li><li>\u2022 Option B. COPD (Chronic Obstructive Pulmonary Disease) : Requires an FEV1/FVC < 0.70.</li><li>\u2022 Option B.</li><li>\u2022 COPD (Chronic Obstructive Pulmonary Disease)</li><li>\u2022 :</li><li>\u2022 Option D. Normal lung function: Not possible with reduced FEV1.</li><li>\u2022 Option D. Normal lung function:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 PRISm (Preserved Ratio Impaired Spirometry) is characterized by a reduced FEV1 with a normal FEV1/FVC ratio, often seen as a potential precursor to COPD.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "23275bd9",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman with a history of asthma presents with worsening wheezing, cough, and shortness of breath. There is no associated angioedema or urticaria. Her vital signs are stable, and her oxygen saturation is 94% on room air. Would intramuscular epinephrine be indicated in this scenario?",
      "options": [
        {
          "label": "A",
          "text": "Yes, epinephrine is indicated for all asthma exacerbations.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Yes, but only if she fails to respond to inhaled bronchodilators.",
          "correct": false
        },
        {
          "label": "C",
          "text": "No, epinephrine is only indicated for asthma associated with anaphylaxis or angioedema.",
          "correct": true
        },
        {
          "label": "D",
          "text": "No, epinephrine should only be used in patients with severe asthma exacerbations requiring hospitalization.",
          "correct": false
        }
      ],
      "correct_answer": "C. No, epinephrine is only indicated for asthma associated with anaphylaxis or angioedema.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Yes, epinephrine is indicated for all asthma exacerbations: Incorrect. Epinephrine is a potent drug reserved for life-threatening situations like anaphylaxis.</li><li>\u2022 Option A. Yes, epinephrine is indicated for all asthma exacerbations:</li><li>\u2022 Option B. Yes, but only if she fails to respond to inhaled bronchodilators: Incorrect. While epinephrine may be used in refractory cases, it's not the initial therapy for most asthma exacerbations.</li><li>\u2022 Option B. Yes, but only if she fails to respond to inhaled bronchodilators:</li><li>\u2022 Option D. No, epinephrine should only be used in patients with severe asthma exacerbations requiring hospitalization: Incorrect. While epinephrine is often used in severe cases, it's indicated for any asthma exacerbation with anaphylaxis or angioedema, regardless of severity.</li><li>\u2022 Option D. No, epinephrine should only be used in patients with severe asthma exacerbations requiring hospitalization:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Intramuscular epinephrine is only indicated for asthma exacerbations associated with anaphylaxis or angioedema.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f5e6c5ae",
      "audio": ""
    },
    {
      "text": "A 28-year-old woman with mild persistent asthma is well-controlled on a low-dose inhaled corticosteroid (ICS) as maintenance therapy. She experiences occasional wheezing and shortness of breath, especially after exercise. According to current asthma guidelines, which of the following is the preferred reliever medication for her symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Short-acting beta-agonist (SABA) alone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Short-acting muscarinic antagonist (SAMA) alone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Low-dose ICS + SABA combination",
          "correct": false
        },
        {
          "label": "D",
          "text": "Low-dose ICS + LABA (long-acting beta-agonist) combination",
          "correct": true
        }
      ],
      "correct_answer": "D. Low-dose ICS + LABA (long-acting beta-agonist) combination",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Low-dose ICS + LABA (long-acting beta-agonist) combination</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Short-acting beta-agonist (SABA) alone: Although SABAs provide quick relief, they don't address underlying inflammation.</li><li>\u2022 Option A.</li><li>\u2022 Short-acting beta-agonist (SABA) alone:</li><li>\u2022 Option B. Short-acting muscarinic antagonist (SAMA) alone: Less effective than SABAs in most cases.</li><li>\u2022 Option B.</li><li>\u2022 Short-acting muscarinic antagonist (SAMA) alone:</li><li>\u2022 Option C. Low-dose ICS + SABA combination : Not preferred as the LABA component is short-acting and doesn't provide sustained bronchodilation.</li><li>\u2022 Option C.</li><li>\u2022 Low-dose ICS + SABA combination</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The preferred reliever medication for mild persistent asthma is a combination inhaler containing both low-dose ICS and a LABA.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1a301582",
      "audio": ""
    },
    {
      "text": "A 20-year-old man with severe asthma remains symptomatic despite high-dose inhaled corticosteroids (ICS), long-acting muscarinic antagonists (LAMA), and long-acting beta-agonists (LABA). He is also on oral steroids and montelukast. Further evaluation reveals elevated IgE levels and FeNO (fractional exhaled nitric oxide) of 55 ppb. Which therapy is most likely to be effective for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Inhaled short-acting beta-agonists (SABA) as needed",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bronchial thermoplasty",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti-IgE therapy (e.g., omalizumab)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Oral corticosteroids at higher doses",
          "correct": false
        }
      ],
      "correct_answer": "C. Anti-IgE therapy (e.g., omalizumab)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Anti-IgE therapy (e.g., omalizumab)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Inhaled short-acting beta-agonists (SABA) as needed: Used for quick relief, not long-term control.</li><li>\u2022 Option A.</li><li>\u2022 Inhaled short-acting beta-agonists (SABA) as needed:</li><li>\u2022 Option B. Bronchial thermoplasty: Considered for severe refractory asthma but not the first-line option in this case.</li><li>\u2022 Option B. Bronchial thermoplasty:</li><li>\u2022 Option D. Oral corticosteroids at higher doses: Already on high doses, increasing further may lead to adverse effects.</li><li>\u2022 Option</li><li>\u2022 D. Oral corticosteroids at higher doses:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Anti-IgE therapy (e.g., omalizumab) is indicated for severe allergic asthma not controlled with standard therapy, especially in the presence of elevated IgE and FeNO levels.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d75d971c",
      "audio": ""
    },
    {
      "text": "A 10-year-old boy with a history of mild persistent asthma is brought to the ER with an acute exacerbation. His symptoms include wheezing, shortness of breath, and cough. He is using accessory muscles to breathe, and his peak flow is 50% of his personal best. Which of the following is NOT recommended as part of his initial management?",
      "options": [
        {
          "label": "A",
          "text": "Oxygen therapy to maintain SpO2 \u2265 94%",
          "correct": false
        },
        {
          "label": "B",
          "text": "Repeated doses of nebulized salbutamol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Oral prednisolone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Inhaled Formeterol",
          "correct": true
        }
      ],
      "correct_answer": "D. Inhaled Formeterol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Inhaled Formeterol</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Oxygen therapy to maintain SpO2 \u2265 94%: Essential to correct hypoxemia.</li><li>\u2022 Option A. Oxygen therapy to maintain SpO2 \u2265 94%:</li><li>\u2022 Option B. Repeated doses of nebulized salbutamol: Mainstay of acute bronchodilator therapy.</li><li>\u2022 Option B. Repeated doses of nebulized salbutamol:</li><li>\u2022 Option C. Oral prednisolone: Oral corticosteroids reduce airway inflammation and are important in exacerbation management.</li><li>\u2022 Option C. Oral prednisolone:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 LABAs like formoterol are not used in the acute management of asthma exacerbations due to their delayed onset of action.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bdea24d5",
      "audio": ""
    },
    {
      "text": "All of the following are complications of CPAP therapy in OSA except:",
      "options": [
        {
          "label": "A",
          "text": "Nasal congestion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Difficulty inhaling",
          "correct": true
        },
        {
          "label": "C",
          "text": "Claustrophobia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Aerophagia",
          "correct": false
        }
      ],
      "correct_answer": "B. Difficulty inhaling",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Nasal congestion: Common due to the air pressure and can be mitigated with humidification or steroid/saline nasal sprays.</li><li>\u2022 Option A. Nasal congestion:</li><li>\u2022 Option C. Claustrophobia: A common issue due to the mask, which can make some patients feel confined. Can mitigate by changing mask interface (e.g., nasal prongs)</li><li>\u2022 Option C. Claustrophobia:</li><li>\u2022 Option D. Aerophagia: Swallowing air, which can lead to bloating and discomfort, is a known side effect of CPAP therapy. Can mitigate to some extent by administering antacids</li><li>\u2022 Option D. Aerophagia:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Difficulty inhaling is not a typical complication of CPAP therapy; common issues include nasal congestion, claustrophobia, and aerophagia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8996155b",
      "audio": ""
    },
    {
      "text": "A 65-year-old man with a history of severe COPD presents to the emergency department with an acute exacerbation. He is tachypneic, using accessory muscles of respiration, and his oxygen saturation is 88% on room air. Arterial blood gas analysis shows a pH of 7.28 and PaCO2 of 65 mmHg. Which of the following is the most appropriate next step in management?",
      "options": [
        {
          "label": "A",
          "text": "Initiate noninvasive positive pressure ventilation (NIPPV)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Start intravenous (IV) methylprednisolone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Administer a nebulized bronchodilator",
          "correct": false
        },
        {
          "label": "D",
          "text": "Proceed with endotracheal intubation (ETT) and mechanical ventilation",
          "correct": false
        }
      ],
      "correct_answer": "A. Initiate noninvasive positive pressure ventilation (NIPPV)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Initiate noninvasive positive pressure ventilation (NIPPV)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Start IV methylprednisolone: Corticosteroids are indicated in COPD exacerbations, but NIPPV should be prioritized in patients with respiratory failure.</li><li>\u2022 Option B. Start IV methylprednisolone:</li><li>\u2022 Option C. Administer a nebulized bronchodilator: Bronchodilators are important for symptom relief, but they won't address the primary issue of hypercapnia and acidosis.</li><li>\u2022 Option C. Administer a nebulized bronchodilator:</li><li>\u2022 Option D. Proceed with endotracheal intubation (ETT) and mechanical ventilation: While intubation may be necessary if NIPPV fails or the patient deteriorates, it is not the first-line treatment due to its associated risks and complications.</li><li>\u2022 Option D. Proceed with endotracheal intubation (ETT) and mechanical ventilation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Initiate noninvasive positive pressure ventilation (NIPPV) for patients with acute COPD exacerbation and respiratory failure to improve ventilation and avoid invasive mechanical ventilation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e93fea23",
      "audio": ""
    },
    {
      "text": "A young patient with asthma is given a device to monitor his asthma. What is the device?",
      "options": [
        {
          "label": "A",
          "text": "Peak flow meter",
          "correct": true
        },
        {
          "label": "B",
          "text": "Spirometer",
          "correct": false
        },
        {
          "label": "C",
          "text": "Body plethysmograph",
          "correct": false
        },
        {
          "label": "D",
          "text": "Incentive spirometer",
          "correct": false
        }
      ],
      "correct_answer": "A. Peak flow meter",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/picture5.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/picture6.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/picture7.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/picture8.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Peak flow meter</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Spirometer: Measures lung volumes and flow rates during forced exhalation and inhalation.</li><li>\u2022 Option B. Spirometer:</li><li>\u2022 Option C. Body plethysmograph: Measures total lung capacity and airway resistance.</li><li>\u2022 Option C. Body plethysmograph:</li><li>\u2022 Option D. Incentive spirometer: Helps improve lung function by encouraging deep breaths.</li><li>\u2022 Option D. Incentive spirometer:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The dveice shown in the image is a peak flow meter used by asthmatics to measure how fast they can forcefully exhale, providing a quick assessment of airway obstruction.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "236a69b1",
      "audio": ""
    },
    {
      "text": "A 62-year-old patient with known bronchiectasis is hospitalized with acute worsening of cough, sputum production, and fever. Which antibiotic regimen is most appropriate for this exacerbation?",
      "options": [
        {
          "label": "A",
          "text": "Amoxicillin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Azithromycin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Piperacillin-tazobactam",
          "correct": true
        },
        {
          "label": "D",
          "text": "Doxycycline",
          "correct": false
        }
      ],
      "correct_answer": "C. Piperacillin-tazobactam",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Piperacillin-tazobactam</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Amoxicillin: Not effective against Pseudomonas .</li><li>\u2022 Option A. Amoxicillin:</li><li>\u2022 Option B. Azithromycin: May be used in chronic management but not first-line for acute exacerbations with Pseudomonas.</li><li>\u2022 Option B. Azithromycin:</li><li>\u2022 Option D. Doxycycline: Not effective against Pseudomonas.</li><li>\u2022 Option D. Doxycycline:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Piperacillin-tazobactam is the preferred antibiotic for acute exacerbations of bronchiectasis due to its broad-spectrum activity against Pseudomonas aeruginosa and other gram-negative organisms.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "eb691ea2",
      "audio": ""
    },
    {
      "text": "A 65-year-old man with chronic cough and sputum production undergoes bronchoscopy, which reveals dilated airways and nodular lesions. Bronchial washings culture positive for Mycobacterium avium complex (MAC). Which type of bronchiectasis is most likely associated?",
      "options": [
        {
          "label": "A",
          "text": "Cylindrical bronchiectasis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Varicose bronchiectasis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cystic bronchiectasis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Traction bronchiectasis",
          "correct": false
        }
      ],
      "correct_answer": "B. Varicose bronchiectasis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Varicose bronchiectasis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Cylindrical bronchiectasis: This type of bronchiectasis is characterized by uniformly dilated airways, typically seen in post-infectious bronchiectasis or bronchiectasis associated with bronchial obstruction.</li><li>\u2022 Option A. Cylindrical bronchiectasis:</li><li>\u2022 Option C. Cystic bronchiectasis: This is the most severe form of bronchiectasis, with large, balloon-like dilations of the airways. While it can be seen in NTM infections, it's less common than varicose bronchiectasis.</li><li>\u2022 Option C. Cystic bronchiectasis:</li><li>\u2022 Option D. Traction bronchiectasis: This type is caused by fibrosis pulling on the airways, often seen in conditions like tuberculosis or sarcoidosis. It presents with irregular dilations and distortions of the airways but is less common in NTM infections.</li><li>\u2022 Option D. Traction bronchiectasis:</li><li>\u2022 Key Point: Varicose bronchiectasis is the most common type seen in NTM infections, particularly Mycobacterium avium complex (MAC). The irregular dilations and constrictions of the airways resemble varicose veins.</li><li>\u2022 Key Point:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Varicose bronchiectasis, with irregular airway dilation and constriction, is commonly seen in NTM infections like Mycobacterium avium complex (MAC).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1da0cd42",
      "audio": ""
    },
    {
      "text": "A 66-year-old man presented after coughing up copious amounts of blood-tinged sputum at his nursing home Physical examination shows digital clubbing and cyanosis of the lips. Coarse crackles are heard throughout the lung fields and his SpO2 is 95%. A chest X-ray reveals increased translucency and tram-track opacities in the right lower lung field. What is the likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Bronchiectasis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Chronic bronchitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Aspiration pneumonia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Emphysema",
          "correct": false
        }
      ],
      "correct_answer": "A. Bronchiectasis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Bronchiectasis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Chronic bronchitis: Typically seen in patients with a history of smoking and characterized by a chronic, productive cough. However, copious amounts of blood-tinged sputum and signs of chronic hypoxia (e.g., digital clubbing, lip cyanosis) are less typical.</li><li>\u2022 Option B.</li><li>\u2022 Chronic bronchitis:</li><li>\u2022 Option C. Aspiration pneumonia: Common in patients with a history of stroke, which may result in dysphagia. Patients with aspiration pneumonia may present with dyspnea, cough, and hypoxemia, but would not typically show the tram-track opacities seen in this case.</li><li>\u2022 Option C.</li><li>\u2022 Aspiration pneumonia:</li><li>\u2022 Option D. Emphysema: Usually presents with a history of a chronic cough that is characteristically worse in the mornings, production of small amounts of sputum, and dyspnea. Chest X-rays typically show hyperinflation rather than tram-track opacities.</li><li>\u2022 Option D.</li><li>\u2022 Emphysema:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Bronchiectasis presents with chronic cough, copious sputum, hemoptysis, coarse crackles, and tram-track opacities on X-ray, along with digital clubbing and cyanosis due to chronic hypoxia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8512d86d",
      "audio": ""
    },
    {
      "text": "A 4-year-old girl presents with productive cough, high fever, poor weight gain, and frequent respiratory infections. Exam reveals crackles in the left lower lung. Chest X-ray shows dilated bronchi and infiltrates. Sputum culture: pink rods on Gram stain, non-lactose fermenting, oxidase positive. She is at increased risk for which condition?",
      "options": [
        {
          "label": "A",
          "text": "Cirrhosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypothyroidism",
          "correct": false
        },
        {
          "label": "C",
          "text": "Panacinar emphysema",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pancreatitis",
          "correct": true
        }
      ],
      "correct_answer": "D. Pancreatitis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Pancreatitis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Cirrhosis: Although CF can lead to liver disease, pancreatitis is a more immediate and common complication.</li><li>\u2022 Option A. Cirrhosis:</li><li>\u2022 Option B. Hypothyroidism: Not typically associated with CF.</li><li>\u2022 Option B. Hypothyroidism:</li><li>\u2022 Option C. Panacinar emphysema: More commonly related to alpha-1 antitrypsin deficiency, not CF.</li><li>\u2022 Option C. Panacinar emphysema:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Cystic fibrosis, characterized by chronic respiratory infections and bronchiectasis, increases the risk of pancreatitis due to thick mucus secretions affecting the pancreas.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "59b7e646",
      "audio": ""
    },
    {
      "text": "A 47-year-old man complains of cough, shortness of breath, and daily copious sputum production. He has a history of frequent lung infections. His SpO2 is 95%. Diffuse crackles and wheezing are heard on auscultation throughout the lung fields. A CT scan is shown. The patient is at greatest risk for which of the following complications?",
      "options": [
        {
          "label": "A",
          "text": "Hemoptysis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Rhizopus infections",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pneumothorax",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lung cancer",
          "correct": false
        }
      ],
      "correct_answer": "A. Hemoptysis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/picture9.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Hemoptysis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Rhizopus infections: Causes Mucormycosis. Uncommon in bronchiectasis. More common in patients with DKA or COVID19</li><li>\u2022 Option B. Rhizopus infections:</li><li>\u2022 Option C. Pneumothorax: While possible, it is less common in bronchiectasis. More common in Emphysema</li><li>\u2022 Option C. Pneumothorax:</li><li>\u2022 Option D. Lung cancer: Bronchiectasis is not a risk factor for lung cancer</li><li>\u2022 Option D. Lung cancer:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Bronchiectasis, characterized by chronic productive cough and recurrent lung infections, significantly increases the risk of hemoptysis due to damage and dilation of the bronchial arteries.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9b884851",
      "audio": ""
    },
    {
      "text": "A 25-year-old man with a history of upper respiratory tract infections presents with four other respiratory infections this year and frequent bouts of otitis media. He was diagnosed with bronchiectasis as a child. Which structure is most likely defective in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Cells with multilobular nuclei and enzyme-filled granules",
          "correct": false
        },
        {
          "label": "B",
          "text": "Collagen \u03b1-chains in triplets",
          "correct": false
        },
        {
          "label": "C",
          "text": "Heavy and light protein chains linked by disulfide bonds",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tubular arrangements of linked heavy chains that slide against one another",
          "correct": true
        }
      ],
      "correct_answer": "D. Tubular arrangements of linked heavy chains that slide against one another",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Tubular arrangements of linked heavy chains that slide against one another</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Cells with multilobular nuclei and enzyme-filled granules: Refers to neutrophils, not related to this condition.</li><li>\u2022 Option A. Cells with multilobular nuclei and enzyme-filled granules:</li><li>\u2022 Option B. Collagen \u03b1-chains in triplets: Related to collagen structure, not relevant here.</li><li>\u2022 Option B. Collagen \u03b1-chains in triplets:</li><li>\u2022 Option C. Heavy and light protein chains linked by disulfide bonds: Refers to immunoglobulins, not relevant here.</li><li>\u2022 Option C. Heavy and light protein chains linked by disulfide bonds:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The patient's symptoms suggest primary ciliary dyskinesia (Kartagener syndrome), where the defect is in the cilia's dynein arms, which are tubular arrangements of linked heavy chains that slide against one another to facilitate movement.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f1a8e73e",
      "audio": ""
    },
    {
      "text": "A 5-year-old child with cystic fibrosis presents with a persistent cough and frequent respiratory infections over the past year. Sputum cultures have consistently grown a specific pathogen. Given the patient's age and clinical history, which pathogen is most likely responsible for these early respiratory infections?",
      "options": [
        {
          "label": "A",
          "text": "Pseudomonas aeruginosa",
          "correct": false
        },
        {
          "label": "B",
          "text": "Staphylococcus aureus",
          "correct": true
        },
        {
          "label": "C",
          "text": "Haemophilus influenzae",
          "correct": false
        },
        {
          "label": "D",
          "text": "Streptococcus pneumoniae",
          "correct": false
        }
      ],
      "correct_answer": "B. Staphylococcus aureus",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Staphylococcus aureus</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Pseudomonas aeruginosa: This pathogen typically becomes more prevalent in the respiratory tracts of cystic fibrosis patients as they get older and is associated with chronic lung infections and a more rapid decline in lung function.</li><li>\u2022 Option A. Pseudomonas aeruginosa:</li><li>\u2022 Option C. Haemophilus influenzae: This bacterium can cause respiratory infections but is less common and less significant than Staphylococcus aureus in the early stages of cystic fibrosis.</li><li>\u2022 Option C. Haemophilus influenzae:</li><li>\u2022 Option D. Streptococcus pneumoniae: Although it can cause respiratory infections, it is not the primary pathogen in early cystic fibrosis respiratory infections.</li><li>\u2022 Option D. Streptococcus pneumoniae:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Staphylococcus aureus is the primary pathogen responsible for early respiratory infections in young children with cystic fibrosis, frequently causing persistent and recurrent infections.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f6a4215d",
      "audio": ""
    },
    {
      "text": "A 16-year-old patient with cystic fibrosis, who has been colonized with Burkholderia cepacia complex (BCC), is scheduled for a lung transplant evaluation. What is a major concern related to BCC colonization in this context?",
      "options": [
        {
          "label": "A",
          "text": "Increased risk of liver dysfunction post-transplant",
          "correct": false
        },
        {
          "label": "B",
          "text": "Reduced success rates of lung transplantation",
          "correct": true
        },
        {
          "label": "C",
          "text": "Higher likelihood of developing diabetes post-transplant",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increased risk of gastrointestinal complications",
          "correct": false
        }
      ],
      "correct_answer": "B. Reduced success rates of lung transplantation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Reduced success rates of lung transplantation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Increased risk of liver dysfunction post-transplant: This is not specifically related to BCC colonization.</li><li>\u2022 Option A. Increased risk of liver dysfunction post-transplant:</li><li>\u2022 Option C. Higher likelihood of developing diabetes post-transplant: Diabetes can occur post-transplant but is not specifically linked to BCC.</li><li>\u2022 Option C. Higher likelihood of developing diabetes post-transplant:</li><li>\u2022 Option D. Increased risk of gastrointestinal complications: Gastrointestinal issues are common in cystic fibrosis but not specifically related to BCC colonization.</li><li>\u2022 Option D. Increased risk of gastrointestinal complications:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Burkholderia cepacia complex (BCC) colonization in cystic fibrosis patients is a significant concern due to the reduced success rates and increased risk of severe infections post-lung transplantation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fdab46b5",
      "audio": ""
    },
    {
      "text": "A 55-year-old patient with a history of non-CF bronchiectasis presents for a routine follow-up. The patient has experienced a noticeable decline in lung function over the past few years. What is the typical annual decline in FEV1 for patients with non-CF bronchiectasis?",
      "options": [
        {
          "label": "A",
          "text": "10-15 mL per year",
          "correct": false
        },
        {
          "label": "B",
          "text": "20-30 mL per year",
          "correct": false
        },
        {
          "label": "C",
          "text": "50-55 mL per year",
          "correct": true
        },
        {
          "label": "D",
          "text": "70-80 mL per year",
          "correct": false
        }
      ],
      "correct_answer": "C. 50-55 mL per year",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) 50-55 mL per year</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A . 10-15 mL per year: This rate is too low and more typical of normal aging in healthy individuals.</li><li>\u2022 Option A</li><li>\u2022 10-15 mL per year:</li><li>\u2022 Option B. 20-30 mL per year: This is the decline seen in healthy controls, not in bronchiectasis patients.</li><li>\u2022 Option B. 20-30 mL per year:</li><li>\u2022 Option D. 70-80 mL per year: This rate is higher than what is typically observed in non-CF bronchiectasis.</li><li>\u2022 Option D. 70-80 mL per year:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Patients with non-CF bronchiectasis typically experience an annual decline in FEV1 of about 50-55 mL, highlighting the progressive nature of the disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "93b0f906",
      "audio": ""
    },
    {
      "text": "A male patient with cystic fibrosis is found to be infertile despite having normal spermatogenesis. What is the most likely cause of this infertility?",
      "options": [
        {
          "label": "A",
          "text": "Obstruction of the epididymis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Complete involution of the vas deferens",
          "correct": true
        },
        {
          "label": "C",
          "text": "Defective spermatogenesis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hormonal imbalances",
          "correct": false
        }
      ],
      "correct_answer": "B. Complete involution of the vas deferens",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Complete involution of the vas deferens</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Obstruction of the epididymis: Not the primary cause.</li><li>\u2022 Option A. Obstruction of the epididymis:</li><li>\u2022 Option C. Defective spermatogenesis: Spermatogenesis is typically normal in CF.</li><li>\u2022 Option C. Defective spermatogenesis:</li><li>\u2022 Option D. Hormonal imbalances: Infertility in CF is primarily due to anatomical defects.</li><li>\u2022 Option D. Hormonal imbalances:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 In cystic fibrosis, nearly 99% of males are infertile due to the complete involution of the vas deferens, despite having normal spermatogenesis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b229de18",
      "audio": ""
    },
    {
      "text": "A 35-year-old with cystic fibrosis presents with right lower quadrant abdominal pain, nausea, vomiting, and obstipation. Abdominal X-ray reveals a mass in the ileocecal region with dilated bowel loops. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Appendicitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Crohn's disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Distal intestinal obstruction syndrome (DIOS)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Intussusception",
          "correct": false
        }
      ],
      "correct_answer": "C. Distal intestinal obstruction syndrome (DIOS)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Distal Intestinal Obstruction Syndrome (DIOS)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Appendicitis: While appendicitis can present with similar symptoms, the presence of a mass in the ileocecal region and the patient's history of cystic fibrosis make DIOS a more likely diagnosis</li><li>\u2022 Option A. Appendicitis:</li><li>\u2022 Option B. Crohn's disease: Crohn's disease is an inflammatory bowel disease that can cause abdominal pain and bowel obstruction. However, it is less common in cystic fibrosis patients and typically presents with a different clinical picture and radiological findings</li><li>\u2022 Option B. Crohn's disease:</li><li>\u2022 Option D. Intussusception: Intussusception is the telescoping of one segment of the intestine into another. While it can cause bowel obstruction, it is more common in children and usually presents with a sausage-shaped mass on palpation, which is not seen in this case.</li><li>\u2022 Option D. Intussusception:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Distal Intestinal Obstruction Syndrome (DIOS) is a common complication in cystic fibrosis, characterized by the buildup of thick, sticky stools in the distal ileum and cecum, leading to abdominal pain, nausea, vomiting, and obstipation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c27d341a",
      "audio": ""
    },
    {
      "text": "A 28-year-old female patient with cystic fibrosis is found to have the most common mutation seen in these patients. What is the primary defect caused by this mutation?",
      "options": [
        {
          "label": "A",
          "text": "Impaired synthesis of the CFTR protein",
          "correct": false
        },
        {
          "label": "B",
          "text": "Defective chloride channel function at the cell surface",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased degradation of the CFTR protein in the endoplasmic reticulum",
          "correct": true
        },
        {
          "label": "D",
          "text": "Abnormal post-translational modification of the CFTR protein",
          "correct": false
        }
      ],
      "correct_answer": "C. Increased degradation of the CFTR protein in the endoplasmic reticulum",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Increased degradation of the CFTR protein in the endoplasmic reticulum</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Impaired synthesis of the CFTR protein: The delta F508 mutation affects protein folding, not synthesis.</li><li>\u2022 Option A. Impaired synthesis of the CFTR protein:</li><li>\u2022 Option B. Defective chloride channel function at the cell surface : This is a consequence, but the primary issue is the degradation before reaching the cell surface.</li><li>\u2022 Option B. Defective chloride channel function at the cell surface</li><li>\u2022 Option D. Abnormal post-translational modification of the CFTR protein : This is not the main issue with the delta F508 mutation</li><li>\u2022 Option D. Abnormal post-translational modification of the CFTR protein</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The most common mutation in cystic fibrosis, delta F508, leads to increased degradation of the CFTR protein in the endoplasmic reticulum, preventing it from reaching the cell surface and causing impaired chloride and water transport.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5fe43de9",
      "audio": ""
    },
    {
      "text": "A 24-year-old patient with cystic fibrosis has a homozygous F508del mutation in the CFTR gene. What is the most appropriate treatment regimen?",
      "options": [
        {
          "label": "A",
          "text": "Ivacaftor monotherapy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lumacaftor/Ivacaftor combination",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tezacaftor/Ivacaftor combination",
          "correct": false
        },
        {
          "label": "D",
          "text": "Elexacaftor/Tezacaftor/Ivacaftor combination",
          "correct": true
        }
      ],
      "correct_answer": "D. Elexacaftor/Tezacaftor/Ivacaftor combination",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Elexacaftor/Tezacaftor/Ivacaftor combination</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Ivacaftor monotherapy: Effective for certain gating mutations but not sufficient for the F508del mutation.</li><li>\u2022 Option A. Ivacaftor monotherapy:</li><li>\u2022 Option B. Lumacaftor/Ivacaftor combination: Provides benefit for F508del mutation but is less effective than the triple therapy.</li><li>\u2022 Option B. Lumacaftor/Ivacaftor combination:</li><li>\u2022 Option C. Tezacaftor/Ivacaftor combination: An improvement over Lumacaftor/Ivacaftor but still not as effective as the triple therapy for the F508del mutation</li><li>\u2022 Option C. Tezacaftor/Ivacaftor combination:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The Elexacaftor/Tezacaftor/Ivacaftor combination (Trikafta) is the most advanced and effective treatment for patients with the F508del mutation in the CFTR gene.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "32cae779",
      "audio": ""
    },
    {
      "text": "A 22-year-old cystic fibrosis patient is found to have a CFTR mutation that results in defective protein processing and impaired channel function. Which type of CFTR defect is most effectively treated with a combination of potentiators and correctors?",
      "options": [
        {
          "label": "A",
          "text": "Class I mutation leading to no CFTR protein production",
          "correct": false
        },
        {
          "label": "B",
          "text": "Class II mutation causing defective protein processing",
          "correct": true
        },
        {
          "label": "C",
          "text": "Class III mutation resulting in defective channel regulation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Class IV mutation causing decreased conductance",
          "correct": false
        }
      ],
      "correct_answer": "B. Class II mutation causing defective protein processing",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Class II mutation causing defective protein processing</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Class I mutation leading to no CFTR protein production: These mutations produce little to no CFTR protein, making correctors and potentiators ineffective.</li><li>\u2022 Option A. Class I mutation leading to no CFTR protein production:</li><li>\u2022 Option C. Class III mutation resulting in defective channel regulation : Typically treated effectively with potentiators alone, as the CFTR protein is present but dysfunctional.</li><li>\u2022 Option C. Class III mutation resulting in defective channel regulation</li><li>\u2022 Option D. Class IV mutation causing decreased conductance: Potentiators may help, but the primary defect involves reduced channel function rather than misprocessing.</li><li>\u2022 Option D. Class IV mutation causing decreased conductance:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Class II CFTR mutations causing defective protein processing are most effectively treated with a combination of correctors and potentiators.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "babca9e8",
      "audio": ""
    },
    {
      "text": "A 40-year-old man presents with massive hemoptysis and is desaturating. Which of the following is incorrect according to AAFP guidelines?",
      "options": [
        {
          "label": "A",
          "text": "Avoid Endotracheal intubation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Selective intubation of the bleeding lung to remove blood clots",
          "correct": true
        },
        {
          "label": "C",
          "text": "Insert a single-lumen endotracheal tube",
          "correct": false
        },
        {
          "label": "D",
          "text": "Position the patient with the bleeding side down",
          "correct": false
        }
      ],
      "correct_answer": "B. Selective intubation of the bleeding lung to remove blood clots",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Selective intubation of the bleeding lung to remove blood clots</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Avoid Endotracheal intubation: Recommended unless absolutely necessary, to use the cough reflex for blood removal.</li><li>\u2022 Option A. Avoid Endotracheal intubation:</li><li>\u2022 Option C. Insert a single-lumen endotracheal tube: Incorrect as it does not allow for selective ventilation and protection of the nonbleeding lung.</li><li>\u2022 Option C. Insert a single-lumen endotracheal tube:</li><li>\u2022 Option D. Position the patient with the bleeding side down : Correct as it uses gravitational advantage to prevent blood from entering the nonbleeding lung.</li><li>\u2022 Option D. Position the patient with the bleeding side down</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 According to AAFP guidelines, selective intubation should be performed on the nonbleeding lung, not the bleeding lung, to protect the nonbleeding lung from contamination and ensure effective ventilation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bccdff32",
      "audio": ""
    },
    {
      "text": "A 55-year-old lady presents with non-massive hemoptysis. What is the most common cause?",
      "options": [
        {
          "label": "A",
          "text": "Tuberculosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Viral bronchitis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Lung cancer",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pulmonary embolism",
          "correct": false
        }
      ],
      "correct_answer": "B. Viral bronchitis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Viral bronchitis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Tuberculosis: It is one of the most common causes in developing countries like India.</li><li>\u2022 Option A. Tuberculosis:</li><li>\u2022 Option C. Lung cancer: A significant cause but not the most common.</li><li>\u2022 Option C. Lung cancer:</li><li>\u2022 Option D. Pulmonary embolism: Can cause hemoptysis, but it is not the most common cause of non-massive hemoptysis.</li><li>\u2022 Option D. Pulmonary embolism:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Viral bronchitis is the most common cause of non-massive hemoptysis, typically resulting from inflammation and irritation of the airways.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c91ff5fa",
      "audio": ""
    },
    {
      "text": "A 65-year-old male presents with massive hemoptysis. What is the procedure of choice for controlling the bleeding?",
      "options": [
        {
          "label": "A",
          "text": "Bronchoscopy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bronchial artery embolization",
          "correct": true
        },
        {
          "label": "C",
          "text": "Surgical resection",
          "correct": false
        },
        {
          "label": "D",
          "text": "Intravenous antibiotic therapy",
          "correct": false
        }
      ],
      "correct_answer": "B. Bronchial artery embolization",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Bronchial artery embolization</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Bronchoscopy: Useful for diagnosis and initial management but not primarily for controlling severe bleeding.</li><li>\u2022 Option A. Bronchoscopy:</li><li>\u2022 Option C. Surgical resection: Considered when embolization fails or is not feasible, but it is more invasive.</li><li>\u2022 Option C. Surgical resection:</li><li>\u2022 Option D. Intravenous antibiotic therapy: Used to treat underlying infections but not effective for immediate control of severe bleeding.</li><li>\u2022 Option D. Intravenous antibiotic therapy:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Bronchial artery embolization is the procedure of choice for controlling bleeding in life-threatening cases of massive hemoptysis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f29b90b1",
      "audio": ""
    },
    {
      "text": "All of the following are complications of obstructive sleep apnea (OSA) except:",
      "options": [
        {
          "label": "A",
          "text": "Hypertension",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stroke",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pulmonary fibrosis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cardiovascular disease",
          "correct": false
        }
      ],
      "correct_answer": "C. Pulmonary fibrosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Pulmonary fibrosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Options A. Hypertension: Common in OSA due to repeated hypoxic episodes and increased sympathetic activity.</li><li>\u2022 Options A. Hypertension:</li><li>\u2022 Option B. Stroke: Increased risk due to the association of OSA with hypertension and other cardiovascular risk factors.</li><li>\u2022 Option B. Stroke:</li><li>\u2022 Option D. Cardiovascular disease: Strongly linked with OSA, including conditions such as heart failure and arrhythmias.</li><li>\u2022 Option D. Cardiovascular disease:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pulmonary fibrosis is not a typical complication of obstructive sleep apnea (OSA); common complications include hypertension, stroke, and cardiovascular disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4a47f1ec",
      "audio": ""
    },
    {
      "text": "A 70-year-old man presents with dyspnea and pleuritic chest pain. A chest X-ray reveals a pleural effusion. Diagnostic thoracentesis is performed, and pleural fluid analysis shows the following: pleural fluid protein/serum protein ratio of 0.7. How would this pleural effusion be classified?",
      "options": [
        {
          "label": "A",
          "text": "Transudative",
          "correct": false
        },
        {
          "label": "B",
          "text": "Exudative",
          "correct": true
        },
        {
          "label": "C",
          "text": "Malignant",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hemorrhagic",
          "correct": false
        }
      ],
      "correct_answer": "B. Exudative",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Exudative</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Transudative : Transudative effusions do not meet Light's criteria for exudative effusions and are typically due to systemic factors such as heart failure or cirrhosis.</li><li>\u2022 Option A. Transudative</li><li>\u2022 Option C. Malignant : While malignancy can cause exudative effusions, this classification is based on Light's criteria, not etiology.</li><li>\u2022 Option C. Malignant</li><li>\u2022 Option D. Hemorrhagic : Refers to the presence of blood in the pleural fluid, which is a descriptive term rather than a classification based on Light's criteria.</li><li>\u2022 Option D. Hemorrhagic</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A pleural effusion is classified as exudative if one or more of Light's criteria are met, such as a pleural fluid protein/serum protein ratio > 0.5. In this case, the pleural fluid protein/serum protein ratio is 0.7, classifying it as exudative.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4e350f6e",
      "audio": ""
    },
    {
      "text": "A 70-year-old man presents with dyspnea and pleuritic chest pain. Thoracentesis reveals loculated pleural fluid, pH of 7.15, glucose of 2.8 mmol/L (50 mg/dL), and gross pus in the pleural space. Which of the following is not an indication for chest drain placement?",
      "options": [
        {
          "label": "A",
          "text": "Loculated pleural fluid",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pleural fluid pH < 7.2",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pleural fluid glucose < 60 mg/dL",
          "correct": true
        },
        {
          "label": "D",
          "text": "Presence of gross pus in the pleural space",
          "correct": false
        }
      ],
      "correct_answer": "C. Pleural fluid glucose < 60 mg/dL",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Pleural fluid glucose <60 mg/dL)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Loculated pleural fluid : Indicates complicated effusion that often requires drainage</li><li>\u2022 Option A. Loculated pleural fluid</li><li>\u2022 Option B. Pleural fluid pH <7.2 : Suggests a more severe infection or inflammation needing drainage</li><li>\u2022 Option B. Pleural fluid pH <7.2</li><li>\u2022 Option D. Presence of gross pus in the pleural space: Clearly indicates empyema, which requires drainage.</li><li>\u2022 Option D. Presence of gross pus in the pleural space:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 While low pleural fluid glucose (<3.3 mmol/L or <60 mg/dL) suggests a complicated effusion, it is not an absolute indication for chest drain placement. However, loculated pleural fluid, pleural fluid pH <7.2, and the presence of gross pus in the pleural space are definite indications for chest drain placement to prevent or treat empyema or complicated parapneumonic effusions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7a0f0b8f",
      "audio": ""
    },
    {
      "text": "A 65-year-old patient with loculated pleural effusion has been treated with antibiotics and tube thoracostomy. Despite treatment, the patient continues to have fever, leukocytosis, and anorexia. Which of the following treatments should be considered next to improve clinical outcomes ?",
      "options": [
        {
          "label": "A",
          "text": "Intrapleural fibrinolytic agents alone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNase)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Repeat thoracostomy",
          "correct": false
        },
        {
          "label": "D",
          "text": "High-dose corticosteroids",
          "correct": false
        }
      ],
      "correct_answer": "B. Intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNase)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNase)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Intrapleural fibrinolytic agents alone : Controlled trials have not shown improvement in drainage with fibrinolytic agents alone.</li><li>\u2022 Option A. Intrapleural fibrinolytic agents alone</li><li>\u2022 Option C. Repeat thoracostomy : Not typically the next step when combination therapy of tPA and DNase can be more effective.</li><li>\u2022 Option C. Repeat thoracostomy</li><li>\u2022 Option D. High-dose corticosteroids : Not indicated for improving drainage or treating persistent symptoms in pleural effusion</li><li>\u2022 Option D. High-dose corticosteroids</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNase) should be considered when fever, leukocytosis, or anorexia persist despite antibiotics and tube thoracostomy, as this combination has been shown to improve clinical outcomes, including increased drainage, decreased length of stay, and decreased surgical referral.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "08e0928c",
      "audio": ""
    },
    {
      "text": "A 45-year-old male with a history of alcoholism presents with acute onset of left-sided chest pain and shortness of breath. Chest X-ray reveals a left-sided pleural effusion and pneumothorax. Thoracentesis yields turbid, red-brown fluid with a pH of 5.5. Which of the following is the most likely diagnosis ?",
      "options": [
        {
          "label": "A",
          "text": "Uncomplicated parapneumonic effusion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Malignancy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Esophageal rupture",
          "correct": true
        },
        {
          "label": "D",
          "text": "Tuberculosis",
          "correct": false
        }
      ],
      "correct_answer": "C. Esophageal rupture",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Esophageal rupture</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Uncomplicated parapneumonic effusions typically have clear to turbid fluid with a near normal pH</li><li>\u2022 Option A. Uncomplicated parapneumonic effusions</li><li>\u2022 Option B. Malignant effusions are rarely associated with pneumothorax or a low pH</li><li>\u2022 Option B. Malignant</li><li>\u2022 Option D. Tuberculosis effusions are usually serous to serosanguineous  and have a near normal pH</li><li>\u2022 Option D. Tuberculosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The combination of pleural effusion, pneumothorax, red-brown fluid, and low pH strongly suggests esophageal rupture.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7ec1d128",
      "audio": ""
    },
    {
      "text": "A 70-year-old male presents with sudden onset of pleuritic chest pain and dyspnea. On examination he had an irregularly irregular pulse. X ray showed a wedge shaped opacity with effusion in the left lung. Which of the following is the most likely cause of the effusion ?",
      "options": [
        {
          "label": "A",
          "text": "Pulmonary infarction",
          "correct": true
        },
        {
          "label": "B",
          "text": "Esophageal rupture",
          "correct": false
        },
        {
          "label": "C",
          "text": "Malignancy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Parapneumonic effusion",
          "correct": false
        }
      ],
      "correct_answer": "A. Pulmonary infarction",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Pulmonary infarction</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Esophageal rupture: This would present with severe chest pain, often radiating to the back, and may be associated with subcutaneous emphysema or mediastinal air.</li><li>\u2022 Option B. Esophageal rupture:</li><li>\u2022 Option C. Malignancy: While malignancy can cause pleural effusions, they are typically more indolent in onset and not associated with the acute presentation or wedge-shaped opacity seen in this case.</li><li>\u2022 Option C. Malignancy:</li><li>\u2022 Option D. Parapneumonic effusion: This is an effusion associated with pneumonia and would likely present with fever, cough, and a more diffuse consolidation on chest X-ray.</li><li>\u2022 Option D. Parapneumonic effusion:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The combination of sudden-onset pleuritic chest pain, dyspnea, irregularly irregular pulse (suggesting atrial fibrillation), and a wedge-shaped opacity on chest X-ray is highly suggestive of pulmonary embolism with subsequent pulmonary infarction, which can cause pleural effusion.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "24ffa70f",
      "audio": ""
    },
    {
      "text": "A 40-year-old male with a history of lymphoma presents with dyspnea and a large pleural effusion. Pleural fluid analysis reveals a milky white appearance and an elevated triglyceride level. Which of the following is the most likely diagnosis ?",
      "options": [
        {
          "label": "A",
          "text": "Empyema",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chylothorax",
          "correct": true
        },
        {
          "label": "C",
          "text": "Hemothorax",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pseudochylous effusion",
          "correct": false
        }
      ],
      "correct_answer": "B. Chylothorax",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Chylothorax</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Empyema presents with purulent fluid and a low glucose level.</li><li>\u2022 Option A. Empyema</li><li>\u2022 Option C. Hemothorax presents with bloody fluid.</li><li>\u2022 Option C. Hemothorax</li><li>\u2022 Option D. Pseudochylothorax has a milky white appearance but normal triglyceride levels</li><li>\u2022 Option D. Pseudochylothorax</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A milky white appearance and elevated triglyceride level in pleural fluid are characteristic of chylothorax, which results from the disruption of the thoracic duct.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "65108fcb",
      "audio": ""
    },
    {
      "text": "A 55-year-old male presents with a gradual onset of dyspnea and a non-productive cough. Ultrasound confirms the presence of pleural effusion. Which of the following minimum fluid pocket depths on ultrasound would be considered adequate for a safe diagnostic thoracentesis?",
      "options": [
        {
          "label": "A",
          "text": "5 mm",
          "correct": false
        },
        {
          "label": "B",
          "text": "10 mm",
          "correct": true
        },
        {
          "label": "C",
          "text": "15 mm",
          "correct": false
        },
        {
          "label": "D",
          "text": "20 mm",
          "correct": false
        }
      ],
      "correct_answer": "B. 10 mm",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) 10 mm</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. 5 mm: This is too shallow and increases the risk of puncturing the lung.</li><li>\u2022 Option A. 5 mm:</li><li>\u2022 Option C. 15 mm and D. 20 mm: While these depths are safe, they are not the minimum required. A 10 mm pocket is sufficient for a diagnostic thoracentesis.</li><li>\u2022 Option C. 15 mm and D. 20 mm:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A minimum pleural fluid pocket depth of 10 mm on ultrasound is considered adequate for a safe diagnostic thoracentesis, providing sufficient space to insert the needle and aspirate fluid without risking lung injury.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6b65d8bd",
      "audio": ""
    },
    {
      "text": "A 24-year-old tall, thin male presents with acute-onset left-sided chest pain and shortness of breath. He reports a 10-pack-year smoking history. Chest X-ray reveals a small apical pneumothorax. Which of the following statements is most accurate regarding his condition?",
      "options": [
        {
          "label": "A",
          "text": "This is most likely a secondary spontaneous pneumothorax due to underlying lung disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "The presence of apical blebs is highly suggestive of Marfan syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Smoking is an important risk factor",
          "correct": true
        },
        {
          "label": "D",
          "text": "Recurrence of pneumothorax is unlikely in this patient population.",
          "correct": false
        }
      ],
      "correct_answer": "C. Smoking is an important risk factor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) smoking is an important risk factor</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. This is most likely a secondary spontaneous pneumothorax due to underlying lung disease : This is likely a primary, not secondary, spontaneous pneumothorax given the absence of underlying lung disease.</li><li>\u2022 Option A.</li><li>\u2022 This is most likely a secondary spontaneous pneumothorax due to underlying lung disease</li><li>\u2022 Option B. The presence of apical blebs is highly suggestive of Marfan syndrome : Apical blebs are not specific to Marfan syndrome; they are common in Primary spontaneous pneumothorax</li><li>\u2022 Option B.</li><li>\u2022 The presence of apical blebs is highly suggestive of Marfan syndrome</li><li>\u2022 Option D. Recurrence of pneumothorax is unlikely in this patient population : Recurrence of PSP is common, especially in smokers.</li><li>\u2022 Option D.</li><li>\u2022 Recurrence of pneumothorax is unlikely in this patient population</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Smoking is an important risk factor for primary spontaneous pneumothorax, which is often associated with the rupture of subpleural apical blebs in young, tall, thin individuals. Recurrence is common, especially in smokers.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d0a04049",
      "audio": ""
    },
    {
      "text": "A 25-year-old male with no significant past medical history presents to the emergency department with sudden onset of sharp, right-sided chest pain and shortness of breath. His JVP is normal and BP is 110/70 mm Hg. He denies any recent trauma or illness. X-ray is shown. What is the likely diagnosis ?",
      "options": [
        {
          "label": "A",
          "text": "Pneumonia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pulmonary embolism",
          "correct": false
        },
        {
          "label": "C",
          "text": "Primary spontaneous pneumothorax",
          "correct": true
        },
        {
          "label": "D",
          "text": "Tension pneumothorax",
          "correct": false
        }
      ],
      "correct_answer": "C. Primary spontaneous pneumothorax",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-160110.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Primary spontaneous pneumothorax</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Pneumonia: would typically present with consolidation or infiltrates on chest x-ray.</li><li>\u2022 Option A. Pneumonia:</li><li>\u2022 Option B. Pulmonary embolism: could present with chest pain and shortness of breath, but x-ray findings are usually normal or show subtle abnormalities.</li><li>\u2022 Option B. Pulmonary embolism:</li><li>\u2022 Option D. Tension pneumothorax: this is a life-threatening emergency where the patients would be having high JVP and hypotension and X rays usually show mediastinal shift and tracheal deviation, which are not seen in this image.</li><li>\u2022 Option D. Tension pneumothorax:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The chest X-ray shows a visible visceral pleural line with no lung markings peripheral to it, indicating a pneumothorax. Given the patient's young age, lack of underlying lung disease, and absence of trauma, the most likely diagnosis is a primary spontaneous pneumothorax, typically caused by the rupture of apical blebs in the lungs.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cfa86810",
      "audio": ""
    },
    {
      "text": "A 28-year-old male presents to the emergency department with sudden onset of shortness of breath, chest pain, and tachycardia. Upon examination, he has decreased breath sounds on the left side, jugular venous distention, and tracheal deviation to the right. The most appropriate immediate management of this patient is:",
      "options": [
        {
          "label": "A",
          "text": "Chest X-ray to confirm the diagnosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Needle decompression in the second intercostal space, midclavicular line",
          "correct": true
        },
        {
          "label": "C",
          "text": "Placement of a chest tube in the fourth intercostal space, anterior axillary line",
          "correct": false
        },
        {
          "label": "D",
          "text": "Intubation and mechanical ventilation",
          "correct": false
        }
      ],
      "correct_answer": "B. Needle decompression in the second intercostal space, midclavicular line",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Needle decompression in the second intercostal space, midclavicular line</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Chest X-ray to confirm the diagnosis: While a chest X-ray can confirm the diagnosis, it should not delay the immediate treatment of needle decompression in a suspected tension pneumothorax.</li><li>\u2022 Option A. Chest X-ray to confirm the diagnosis:</li><li>\u2022 Option C. Placement of a chest tube in the fourth intercostal space, anterior axillary line: This is the definitive treatment for pneumothorax, but needle decompression is the immediate life-saving intervention in a tension pneumothorax.</li><li>\u2022 Option C. Placement of a chest tube in the fourth intercostal space, anterior axillary line:</li><li>\u2022 Option D. Intubation and mechanical ventilation: While intubation and mechanical ventilation may be necessary later in the management, needle decompression is the priority in stabilizing the patient's condition.</li><li>\u2022 Option D. Intubation and mechanical ventilation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The immediate management of a tension pneumothorax is needle decompression in the second intercostal space, midclavicular line, to relieve the pressure in the pleural space and stabilize the patient's condition. This is a life-saving intervention that should be performed promptly based on clinical suspicion without waiting for imaging confirmation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "27783840",
      "audio": ""
    },
    {
      "text": "A 70-year-old man is diagnosed with idiopathic pulmonary fibrosis (IPF) after presenting with progressive dyspnea and a dry cough and he has a strong family history. Which gene mutation is most commonly associated with idiopathic pulmonary fibrosis?",
      "options": [
        {
          "label": "A",
          "text": "CFTR",
          "correct": false
        },
        {
          "label": "B",
          "text": "MUC5B",
          "correct": true
        },
        {
          "label": "C",
          "text": "BRCA1",
          "correct": false
        },
        {
          "label": "D",
          "text": "KRAS",
          "correct": false
        }
      ],
      "correct_answer": "B. MUC5B",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. CFTR: Associated with cystic fibrosis, not IPF.</li><li>\u2022 Option</li><li>\u2022 A. CFTR:</li><li>\u2022 Option C. BRCA1: Associated with breast and ovarian cancer, not IPF.</li><li>\u2022 Option</li><li>\u2022 C. BRCA1:</li><li>\u2022 Option D. KRAS: Commonly associated with various cancers, including lung cancer, but not specifically IPF.</li><li>\u2022 Option</li><li>\u2022 D. KRAS:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The MUC5B gene mutation is the most commonly associated genetic variant with idiopathic pulmonary fibrosis (IPF).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a0e270a8",
      "audio": ""
    },
    {
      "text": "A 68-year-old woman presents with progressive shortness of breath and a dry cough. High-resolution CT of the chest reveals honeycombing and reticular opacities. Based on epidemiological data, which of the following is the most common interstitial lung disease?",
      "options": [
        {
          "label": "A",
          "text": "Non-specific interstitial pneumonia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Desquamative interstitial pneumonia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Idiopathic pulmonary fibrosis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Respiratory bronchiolitis associated interstitial lung disease",
          "correct": false
        }
      ],
      "correct_answer": "C. Idiopathic pulmonary fibrosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Non-specific interstitial pneumonia: Less common than IPF and has different radiographic and clinical features.</li><li>\u2022 Option</li><li>\u2022 A. Non-specific interstitial pneumonia:</li><li>\u2022 Option B. Desquamative interstitial pneumonia: Also less common and typically associated with smoking.</li><li>\u2022 Option</li><li>\u2022 B. Desquamative interstitial pneumonia:</li><li>\u2022 Option D. Respiratory bronchiolitis associated interstitial lung disease: Primarily seen in smokers but less common than IPF.</li><li>\u2022 Option</li><li>\u2022 D. Respiratory bronchiolitis associated interstitial lung disease:</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The most common interstitial lung disease is idiopathic pulmonary fibrosis.</li><li>\u2022 The most common interstitial lung disease is idiopathic pulmonary fibrosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "df587835",
      "audio": ""
    },
    {
      "text": "A 65-year-old retired coal miner presents with progressive shortness of breath and chronic cough. He has a long history of working in coal mines. Which of the following conditions is least likely to be associated with his occupational history?",
      "options": [
        {
          "label": "A",
          "text": "Chronic obstructive pulmonary disease (COPD)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Interstitial lung disease (ILD)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chronic bronchitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lung cancer",
          "correct": true
        }
      ],
      "correct_answer": "D. Lung cancer",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Lung cancer</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Chronic obstructive pulmonary disease (COPD): CWP can lead to the development of COPD due to long-term exposure to coal dust.</li><li>\u2022 Option A. Chronic obstructive pulmonary disease (COPD):</li><li>\u2022 Option B. Interstitial lung disease (ILD): CWP is a form of ILD caused by coal dust inhalation.</li><li>\u2022 Option B. Interstitial lung disease (ILD):</li><li>\u2022 Option C. Chronic bronchitis: Chronic bronchitis is common in coal workers due to continuous exposure to coal dust.</li><li>\u2022 Option C. Chronic bronchitis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Coal workers' pneumoconiosis (CWP), or black lung disease, is associated with chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), and chronic bronchitis due to long-term inhalation of coal dust. However, CWP is not directly associated with an increased risk of lung cancer.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2bc97830",
      "audio": ""
    },
    {
      "text": "A 55-year-old man with a history of working in the mining industry presents with chronic cough and joint pain. Chest X-ray shows multiple, rounded nodules in the lungs. He also has a known diagnosis of rheumatoid arthritis. Which of the following diagnoses best explains his clinical presentation?",
      "options": [
        {
          "label": "A",
          "text": "Sarcoidosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tuberculosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Caplan syndrome",
          "correct": true
        },
        {
          "label": "D",
          "text": "Interstitial lung disease",
          "correct": false
        }
      ],
      "correct_answer": "C. Caplan syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Caplan syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Sarcoidosis: Characterized by bilateral hilar lymphadenopathy and non-caseating granulomas, not typically associated with rheumatoid arthritis and mining exposure.</li><li>\u2022 Option A. Sarcoidosis:</li><li>\u2022 Option B. Tuberculosis: Typically presents with cavitary lesions or consolidations, not rounded nodules, and is not associated with rheumatoid arthritis.</li><li>\u2022 Option B. Tuberculosis:</li><li>\u2022 Option D. Interstitial lung disease (ILD): Refers to a group of disorders causing fibrosis and scarring of the lung tissue, which can include conditions like idiopathic pulmonary fibrosis, but does not typically present with the specific combination of rheumatoid arthritis and mining exposure seen in Caplan syndrome.</li><li>\u2022 Option D. Interstitial lung disease (ILD):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Caplan syndrome, or rheumatoid pneumoconiosis, occurs in patients with rheumatoid arthritis who are exposed to dust such as silica or coal dust. It is characterized by multiple, rounded nodules on chest X-ray in the setting of pneumoconiosis and rheumatoid arthritis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0c1a95a8",
      "audio": ""
    },
    {
      "text": "A 48-year-old man who works in an aerospace manufacturing plant presents with progressive dyspnea, cough, and fatigue. Chest X-ray showed bilateral hilar lymphadenopathy, and a transbronchial lung biopsy revealed non-caseating granulomas. Which diagnostic test is most appropriate for confirming the diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Bronchoalveolar lavage (BAL) with CD4/CD8 ratio",
          "correct": false
        },
        {
          "label": "B",
          "text": "Beryllium lymphocyte proliferation test (BeLPT)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Serum angiotensin-converting enzyme (ACE) level",
          "correct": false
        },
        {
          "label": "D",
          "text": "HRCT of the chest",
          "correct": false
        }
      ],
      "correct_answer": "B. Beryllium lymphocyte proliferation test (BeLPT)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Beryllium lymphocyte proliferation test (BeLPT)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Bronchoalveolar lavage (BAL) with CD4/CD8 ratio : Useful in sarcoidosis but not specific for berylliosis.</li><li>\u2022 Option A. Bronchoalveolar lavage (BAL) with CD4/CD8 ratio</li><li>\u2022 Option C. Serum angiotensin-converting enzyme (ACE) level: Elevated in sarcoidosis but not specific for berylliosis.</li><li>\u2022 Option C. Serum angiotensin-converting enzyme (ACE) level:</li><li>\u2022 Option D. High-resolution CT scan of the chest: Helps in identifying interstitial lung disease but does not confirm beryllium exposure or CBD.</li><li>\u2022 Option D. High-resolution CT scan of the chest:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Beryllium lymphocyte proliferation test (BeLPT) is the most appropriate diagnostic test for confirming chronic beryllium disease (CBD) in a patient with a history of beryllium exposure and findings of non-caseating granulomas on biopsy. The BeLPT measures the proliferation of lymphocytes in response to beryllium exposure and is specific for diagnosing beryllium sensitization and chronic beryllium disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cc1c6804",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman presents with chronic cough, dyspnea, and fatigue. She keeps birds as pets, and high-resolution CT of the chest is done and shown. All are useful for diagnosis except:",
      "options": [
        {
          "label": "A",
          "text": "Bronchoalveolar lavage (BAL) with lymphocyte count",
          "correct": false
        },
        {
          "label": "B",
          "text": "Serum angiotensin-converting enzyme (ACE) level",
          "correct": true
        },
        {
          "label": "C",
          "text": "Serum antigen-specific IgG testing",
          "correct": false
        },
        {
          "label": "D",
          "text": "Non-caseating granulomas in lung biopsy",
          "correct": false
        }
      ],
      "correct_answer": "B. Serum angiotensin-converting enzyme (ACE) level",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-124749.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Serum angiotensin-converting enzyme (ACE) level</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Bronchoalveolar lavage (BAL) with lymphocyte count : An increased lymphocyte count and CD4/CD8 ration of < 1 in BAL fluid is indicative of HP and helps in the diagnosis.</li><li>\u2022 Option A. Bronchoalveolar lavage (BAL) with lymphocyte count</li><li>\u2022 Option C. Serum antigen-specific IgG testing : Identifies antibodies against specific antigens (such as bird proteins) that can cause HP, making it useful for diagnosis.</li><li>\u2022 Option C. Serum antigen-specific IgG testing</li><li>\u2022 Option D. Non-caseating granulomas in lung biopsy : The presence of non-caseating granulomas is a key histopathological feature of HP, supporting the diagnosis.</li><li>\u2022 Option D. Non-caseating granulomas in lung biopsy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Serum angiotensin-converting enzyme (ACE) level is typically elevated in sarcoidosis but is not specific for hypersensitivity pneumonitis (HP). Therefore, it is not useful for diagnosing HP.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "afd28be6",
      "audio": ""
    },
    {
      "text": "A 55-year-old agricultural worker presents with symptoms of chronic cough, dyspnea, and fatigue. He reports working with moldy hay and grain regularly. Based on the table, which pathogen is most likely responsible for his condition?",
      "options": [
        {
          "label": "A",
          "text": "Penicillium casei",
          "correct": false
        },
        {
          "label": "B",
          "text": "Coffee bean dust",
          "correct": false
        },
        {
          "label": "C",
          "text": "Saccharopolyspora rectivirgula",
          "correct": true
        },
        {
          "label": "D",
          "text": "Botrytis cinerea",
          "correct": false
        }
      ],
      "correct_answer": "C. Saccharopolyspora rectivirgula",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Saccharopolyspora rectivirgula</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Penicillium casei: Associated with Cheese washer\u2019s lung, not typically found in moldy hay or grain.</li><li>\u2022 Option A. Penicillium casei:</li><li>\u2022 Option B. Coffee bean dust : Associated with Coffee worker\u2019s lung, not relevant to this patient's agricultural exposure.</li><li>\u2022 Option B. Coffee bean dust</li><li>\u2022 Option D. Botrytis cinerea: Associated with Wine maker\u2019s lung, linked to grape exposure, not moldy hay or grain.</li><li>\u2022 Option D. Botrytis cinerea:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The patient's occupational exposure to moldy hay and grain is consistent with Farmer's lung, caused by inhaling thermophilic actinomycetes such as Saccharopolyspora rectivirgula.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "29c107c5",
      "audio": ""
    },
    {
      "text": "A 28-year-old woman with a known diagnosis of sarcoidosis presents with new-onset facial weakness and decreased tear production. She also reports episodes of dry mouth and swelling near her jawline. Which specific manifestation of sarcoidosis is most likely?",
      "options": [
        {
          "label": "A",
          "text": "Mikulicz syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Heerfordt syndrome",
          "correct": true
        },
        {
          "label": "C",
          "text": "L\u00f6fgren syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Blau syndrome",
          "correct": false
        }
      ],
      "correct_answer": "B. Heerfordt syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Heerfordt syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Mikulicz syndrome : Characterized by chronic, painless enlargement of the parotid and lacrimal glands, often associated with Sj\u00f6gren's syndrome.</li><li>\u2022 Option A. Mikulicz syndrome</li><li>\u2022 Option C. L\u00f6fgren syndrome : Characterized by bilateral hilar lymphadenopathy, erythema nodosum, and arthritis.</li><li>\u2022 Option C. L\u00f6fgren syndrome</li><li>\u2022 Option D. Blau syndrome : A genetic disorder presenting with granulomatous arthritis, uveitis, and dermatitis, seen in children, not related to Heerfordt syndrome.</li><li>\u2022 Option D. Blau syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Heerfordt syndrome, also known as uveoparotid fever, is a rare manifestation of sarcoidosis characterized by parotid gland enlargement, uveitis, fever, and facial nerve palsy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f0d3410e",
      "audio": ""
    },
    {
      "text": "A 35-year-old African American woman presents with bilateral hilar lymphadenopathy, erythema nodosum, and arthritis. She also reports occasional fever and malaise. What is the most likely clinical syndrome associated with her presentation in the context of sarcoidosis?",
      "options": [
        {
          "label": "A",
          "text": "L\u00f6fgren syndrome",
          "correct": true
        },
        {
          "label": "B",
          "text": "Heerfordt syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mikulicz syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Blau syndrome",
          "correct": false
        }
      ],
      "correct_answer": "A. L\u00f6fgren syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Heerfordt syndrome : Associated with uveoparotid fever, characterized by parotid gland enlargement, uveitis, fever, and facial nerve palsy.</li><li>\u2022 Option B. Heerfordt syndrome</li><li>\u2022 Option C. Mikulicz syndrome: Characterized by chronic, painless enlargement of the parotid and lacrimal glands, not specific to sarcoidosis.</li><li>\u2022 Option C. Mikulicz syndrome:</li><li>\u2022 Option D. Blau syndrome: A genetic disorder presenting with granulomatous arthritis, uveitis, and dermatitis, seen in children, not related to L\u00f6fgren syndrome.</li><li>\u2022 Option D. Blau syndrome:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 L\u00f6fgren syndrome is a clinical syndrome associated with sarcoidosis characterized by the triad of bilateral hilar lymphadenopathy, erythema nodosum, and arthritis, often accompanied by fever and malaise.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "39e95bec",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman presents with multiple facial lesions as shown in the image. She also reports chronic fatigue and dyspnea. Biopsy of the skin lesions shows non-caseating granulomas. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Lupus vulgaris",
          "correct": false
        },
        {
          "label": "B",
          "text": "Leprosy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lupus pernio",
          "correct": true
        },
        {
          "label": "D",
          "text": "Discoid lupus",
          "correct": false
        }
      ],
      "correct_answer": "C. Lupus pernio",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-131733.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Lupus pernio</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Lupus vulgaris: A form of cutaneous tuberculosis that presents with reddish-brown plaques, not typically associated with non-caseating granulomas.</li><li>\u2022 Option A. Lupus vulgaris:</li><li>\u2022 Option B. Leprosy: Presents with hypopigmented or reddish skin lesions with sensory loss and is diagnosed by the presence of Mycobacterium leprae in skin biopsy.</li><li>\u2022 Option B. Leprosy:</li><li>\u2022 Option D. Discoid lupus : Presents with chronic discoid lesions, erythematous plaques with scaling, and can be associated with systemic lupus erythematosus, but does not typically show non-caseating granulomas.</li><li>\u2022 Option D. Discoid lupus</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Lupus pernio is a specific form of cutaneous sarcoidosis characterized by chronic, violaceous, indurated lesions on the face, especially around the nose, cheeks, and ears, and is associated with systemic sarcoidosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e4dffb7e",
      "audio": ""
    },
    {
      "text": "A 40-year-old woman with a known diagnosis of sarcoidosis presents with new-onset vision problems and facial droop on one side. Which of the following neurological manifestations is least likely to be associated with her condition?",
      "options": [
        {
          "label": "A",
          "text": "Optic neuritis",
          "correct": false
        },
        {
          "label": "B",
          "text": "CN VII nerve palsy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Posterior hypothalamic involvement",
          "correct": true
        },
        {
          "label": "D",
          "text": "Basilar meningitis",
          "correct": false
        }
      ],
      "correct_answer": "C. Posterior hypothalamic involvement",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Posterior hypothalamic involvement</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Optic neuritis : Sarcoidosis can cause inflammation of the optic nerve, leading to vision problems.</li><li>\u2022 Option A. Optic neuritis</li><li>\u2022 Option B. 7th nerve palsy : Facial nerve palsy is a well-known manifestation of neurosarcoidosis, presenting as facial droop.</li><li>\u2022 Option B. 7th nerve palsy</li><li>\u2022 Option D. Basilar meningitis : Sarcoidosis can lead to chronic basilar meningitis, presenting with symptoms such as headache and cranial nerve deficits.</li><li>\u2022 Option D. Basilar meningitis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Sarcoidosis can involve the nervous system, leading to various neurological manifestations such as CN VII palsy, optic neuritis, and basilar meningitis. Posterior hypothalamic involvement is least likely in this context.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "36d7af93",
      "audio": ""
    },
    {
      "text": "A 40-year-old woman with biopsy-proven pulmonary sarcoidosis presents with worsening dyspnea and cough. Imaging shows progressive pulmonary involvement which is progressing despite initial management by his clinician. Which of the following is the treatment for refractory disease?",
      "options": [
        {
          "label": "A",
          "text": "Methotrexate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Infliximab",
          "correct": true
        },
        {
          "label": "C",
          "text": "Prednisone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Azathioprine",
          "correct": false
        }
      ],
      "correct_answer": "B. Infliximab",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Infliximab</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Methotrexate : Used as a second-line treatment or steroid-sparing agent, but not typically first-line for refractory disease.</li><li>\u2022 Option A. Methotrexate</li><li>\u2022 Option C. Prednisone : The first-line treatment for sarcoidosis, but the patient has refractory disease, indicating that prednisone alone is not sufficient.</li><li>\u2022 Option C. Prednisone</li><li>\u2022 Option D. Azathioprine: An immunosuppressive agent used as a second-line treatment or steroid-sparing agent, but not the first choice for refractory disease.</li><li>\u2022 Option D. Azathioprine:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Infliximab, a TNF-alpha inhibitor, is used for treating severe or refractory sarcoidosis when initial treatments such as corticosteroids (e.g., prednisone) and second-line agents (e.g., methotrexate, azathioprine) are not effective.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0156f273",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman presents with progressive dyspnea, recurrent pneumothoraces, and chylous pleural effusions. High-resolution CT of the chest shows diffuse thin-walled cysts. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Lymphangioleiomyomatosis (LAM)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Sarcoidosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Idiopathic pulmonary fibrosis (IPF)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chronic obstructive pulmonary disease (COPD)",
          "correct": false
        }
      ],
      "correct_answer": "A. Lymphangioleiomyomatosis (LAM)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Sarcoidosis: Typically presents with bilateral hilar lymphadenopathy and non-caseating granulomas, not diffuse thin-walled cysts.</li><li>\u2022 Option B. Sarcoidosis:</li><li>\u2022 Option C. Idiopathic pulmonary fibrosis (IPF): Characterized by progressive fibrosis and honeycombing on CT, not thin-walled cysts.</li><li>\u2022 Option C. Idiopathic pulmonary fibrosis (IPF):</li><li>\u2022 Option D. Chronic obstructive pulmonary disease (COPD): Characterized by airflow obstruction and emphysematous changes, not diffuse thin-walled cysts.</li><li>\u2022 Option D. Chronic obstructive pulmonary disease (COPD):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Lymphangioleiomyomatosis (LAM) is a rare lung disease affecting women of childbearing age, characterized by diffuse thin-walled cysts on high-resolution CT, recurrent pneumothoraces, and chylous pleural effusions. It involves the proliferation of abnormal smooth muscle-like cells, distinguishing it from other conditions like sarcoidosis, idiopathic pulmonary fibrosis, and chronic obstructive pulmonary disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1d0998cb",
      "audio": ""
    },
    {
      "text": "A 42-year-old man presents with progressive dyspnea and a chronic cough productive of white, frothy sputum. Chest X-ray shows bilateral alveolar infiltrates, and high-resolution CT of the chest reveals a \"crazy paving\" pattern. Bronchoalveolar lavage (BAL) yields milky fluid with periodic acid-Schiff (PAS)-positive material. Which of the following is the most likely diagnosis ?",
      "options": [
        {
          "label": "A",
          "text": "Idiopathic pulmonary fibrosis (IPF)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pulmonary alveolar proteinosis (PAP)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Sarcoidosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pneumocystis jirovecii pneumonia (PJP)",
          "correct": false
        }
      ],
      "correct_answer": "B. Pulmonary alveolar proteinosis (PAP)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Pulmonary alveolar proteinosis (PAP</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Idiopathic pulmonary fibrosis (IPF): Typically presents with progressive fibrosis and honeycombing on CT, not a \"crazy paving\" pattern.</li><li>\u2022 Option A. Idiopathic pulmonary fibrosis (IPF):</li><li>\u2022 Option C. Sarcoidosis: Characterized by bilateral hilar lymphadenopathy and non-caseating granulomas, not PAS-positive material in BAL.</li><li>\u2022 Option C. Sarcoidosis:</li><li>\u2022 Option D. Pneumocystis jirovecii pneumonia (PJP): Can present with diffuse bilateral infiltrates, but the BAL fluid would typically show Pneumocystis organisms on special staining, not PAS-positive material.</li><li>\u2022 Option D. Pneumocystis jirovecii pneumonia (PJP):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pulmonary alveolar proteinosis (PAP) is diagnosed by the accumulation of surfactant-like material in the alveoli, presenting with progressive dyspnea, a chronic cough with white frothy sputum, bilateral alveolar infiltrates on chest X-ray, and a \"crazy paving\" pattern on high-resolution CT. The presence of PAS-positive material in bronchoalveolar lavage fluid confirms the diagnosis. This condition is distinct from idiopathic pulmonary fibrosis, sarcoidosis, and Pneumocystis jirovecii pneumonia, each having unique diagnostic features and findings.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ddab3218",
      "audio": ""
    },
    {
      "text": "A 50-year-old man presents with a three-month history of non-productive cough, low-grade fever, and progressive dyspnea. Chest X-ray reveals bilateral patchy infiltrates, and high-resolution CT shows peripheral consolidation and ground-glass opacities. Lung biopsy reveals organizing pneumonia with granulation tissue within the alveolar ducts and bronchioles. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Cryptogenic organizing pneumonia (COP)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Idiopathic pulmonary fibrosis (IPF)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sarcoidosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chronic eosinophilic pneumonia (CEP)",
          "correct": false
        }
      ],
      "correct_answer": "A. Cryptogenic organizing pneumonia (COP)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Idiopathic pulmonary fibrosis (IPF): Typically presents with progressive fibrosis and honeycombing on CT, not peripheral consolidation and ground-glass opacities.</li><li>\u2022 Option B. Idiopathic pulmonary fibrosis (IPF):</li><li>\u2022 Option C. Sarcoidosis : Characterized by bilateral hilar lymphadenopathy and non-caseating granulomas, not organizing pneumonia.</li><li>\u2022 Option C. Sarcoidosis</li><li>\u2022 Option D. Chronic eosinophilic pneumonia (CEP): Characterized by peripheral infiltrates on imaging and an increased number of eosinophils in the lung and blood, not organizing pneumonia with granulation tissue.</li><li>\u2022 Option D. Chronic eosinophilic pneumonia (CEP):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cryptogenic organizing pneumonia (COP) is identified by granulation tissue within the alveolar ducts and bronchioles, presenting with a non-productive cough, low-grade fever, and progressive dyspnea. Imaging shows bilateral patchy infiltrates and peripheral consolidation with ground-glass opacities. It is differentiated from idiopathic pulmonary fibrosis, sarcoidosis, and chronic eosinophilic pneumonia, each having unique histopathological and radiological features.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c2f2b254",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman presents with a history of asthma, progressive dyspnea, and weight loss over the past few months. She also reports night sweats and cough. Chest X-ray shows peripheral infiltrates, and blood tests reveal marked eosinophilia. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Chronic eosinophilic pneumonia (CEP)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Acute eosinophilic pneumonia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypereosinophilic syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Loeffler's syndrome",
          "correct": false
        }
      ],
      "correct_answer": "A. Chronic eosinophilic pneumonia (CEP)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Acute eosinophilic pneumonia: Typically presents with acute onset of respiratory failure, diffuse pulmonary infiltrates, and eosinophilia in bronchoalveolar lavage fluid but not always in blood.</li><li>\u2022 Option B. Acute eosinophilic pneumonia:</li><li>\u2022 Option C. Hypereosinophilic syndrome : Characterized by persistent eosinophilia and multi-organ involvement, not specifically peripheral infiltrates on chest X-ray.</li><li>\u2022 Option C. Hypereosinophilic syndrome</li><li>\u2022 Option D. Loeffler's syndrome : Characterized by transient pulmonary infiltrates and blood eosinophilia, often due to parasitic infections, and usually resolves within a few weeks without leading to chronic symptoms.</li><li>\u2022 Option D. Loeffler's syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Chronic eosinophilic pneumonia (CEP) is identified by peripheral infiltrates on chest imaging and marked eosinophilia in the blood. It presents with a history of asthma, progressive dyspnea, weight loss, night sweats, and cough. This condition is distinguished from acute eosinophilic pneumonia, hypereosinophilic syndrome, and Loeffler's syndrome based on the specific clinical features, imaging findings, and chronicity of symptoms.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "58039bda",
      "audio": ""
    },
    {
      "text": "A 50-year-old man presents with cough, dyspnea, fatigue, weight loss, and splenomegaly. Blood tests reveal marked eosinophilia and elevated white blood cell count. Chest X-ray shows diffuse infiltrates. Bone marrow biopsy shows increased cellularity with eosinophil precursors and myeloid hyperplasia. What is the next step ?",
      "options": [
        {
          "label": "A",
          "text": "High-resolution computed tomography (HRCT) chest",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fluorescence in situ hybridization (FISH)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Bronchoalveolar lavage (BAL)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lung biopsy",
          "correct": false
        }
      ],
      "correct_answer": "B. Fluorescence in situ hybridization (FISH)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Fluorescence in situ hybridization (FISH)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. High-resolution computed tomography (HRCT) chest: While it provides detailed imaging of lung pathology, it does not identify specific genetic mutations needed for diagnosing MPN-HES.</li><li>\u2022 Option A. High-resolution computed tomography (HRCT) chest:</li><li>\u2022 Option C. Bronchoalveolar lavage (BAL): Useful for diagnosing infections and certain interstitial lung diseases but not for identifying genetic mutations associated with MPN-HES.</li><li>\u2022 Option C. Bronchoalveolar lavage (BAL):</li><li>\u2022 Option D. Lung biopsy: While it can provide histopathological information, it is invasive and does not identify specific genetic mutations crucial for diagnosing MPN-HES.</li><li>\u2022 Option D. Lung biopsy:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For patients with marked eosinophilia and bone marrow findings suggestive of hypereosinophilic syndrome (HES), FISH testing for specific genetic mutations is essential to confirm the diagnosis and guide treatment</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e4909d9f",
      "audio": ""
    },
    {
      "text": "A 35-year-old man presents with a chronic cough, wheezing, and night sweats. Blood tests reveal marked eosinophilia. Chest X-ray shows diffuse miliary nodules. Which of the following is the most likely diagnosis ?",
      "options": [
        {
          "label": "A",
          "text": "Chronic eosinophilic pneumonia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tuberculosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tropical pulmonary eosinophilia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Loeffler's syndrome",
          "correct": false
        }
      ],
      "correct_answer": "C. Tropical pulmonary eosinophilia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Tropical pulmonary eosinophilia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Chronic eosinophilic pneumonia: Typically presents with peripheral infiltrates on chest imaging, not miliary nodules.</li><li>\u2022 Option A. Chronic eosinophilic pneumonia:</li><li>\u2022 Option B. Tuberculosis : Miliary tuberculosis can present with diffuse miliary nodules, but it is not typically associated with marked eosinophilia.</li><li>\u2022 Option B. Tuberculosis</li><li>\u2022 Option D. Loeffler's syndrome: Characterized by transient pulmonary infiltrates and blood eosinophilia, often due to parasitic infections, but typically resolves within a few weeks and does not present with chronic symptoms or miliary nodules.</li><li>\u2022 Option D. Loeffler's syndrome:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Tropical pulmonary eosinophilia (TPE) is characterized by chronic cough, wheezing, night sweats, and marked eosinophilia. It is caused by an immunological reaction to filarial parasites and commonly presents with persistent infiltrates and diffuse miliary nodules on chest X-ray. This condition is distinguished from chronic eosinophilic pneumonia, tuberculosis, and Loeffler's syndrome based on the combination of eosinophilia, respiratory symptoms, and characteristic radiographic findings.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cd9ccc61",
      "audio": ""
    },
    {
      "text": "A 30-year-old male smoker presents with chronic cough and dyspnea. He reports unintentional weight loss and episodes of spontaneous pneumothorax. High-resolution CT of the chest shows numerous thin-walled cysts and nodules predominantly in the upper lobes. Lung biopsy reveals characteristic tennis racquet like granules on electron microscopy. What is the likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Lymphangioleiomyomatosis (LAM)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pulmonary Langerhans cell histiocytosis (PLCH)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Idiopathic pulmonary fibrosis (IPF)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sarcoidosis",
          "correct": false
        }
      ],
      "correct_answer": "B. Pulmonary Langerhans cell histiocytosis (PLCH)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Pulmonary Langerhans cell histiocytosis (PLCH)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Lymphangioleiomyomatosis (LAM): Typically affects women of childbearing age and is characterized by diffuse thin-walled cysts but not associated with Birbeck granules.</li><li>\u2022 Option A. Lymphangioleiomyomatosis (LAM):</li><li>\u2022 Option C. Idiopathic pulmonary fibrosis (IPF ): Presents with progressive fibrosis and honeycombing on imaging, not thin-walled cysts and nodules.</li><li>\u2022 Option C. Idiopathic pulmonary fibrosis (IPF</li><li>\u2022 Option D. Sarcoidosis: Characterized by bilateral hilar lymphadenopathy and non-caseating granulomas, not thin-walled cysts and Birbeck granules.</li><li>\u2022 Option D. Sarcoidosis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pulmonary Langerhans cell histiocytosis (PLCH) is a smoking-related interstitial lung disease characterized by numerous thin-walled cysts and nodules predominantly in the upper lobes and presence of Birbeck granules on electron microscopy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "246c3955",
      "audio": ""
    },
    {
      "text": "A 70-year-old non-smoker male with progressive dry cough, SOB, and NYHA Class III presents with fine bibasilar crackles and no clubbing. HRCT is shown. Which investigation is required for further evaluation?",
      "options": [
        {
          "label": "A",
          "text": "Measurement of serum precipitating antibodies",
          "correct": false
        },
        {
          "label": "B",
          "text": "Laboratory testing for connective tissue disease",
          "correct": true
        },
        {
          "label": "C",
          "text": "Transbronchial biopsy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Surgical lung biopsy",
          "correct": false
        }
      ],
      "correct_answer": "B. Laboratory testing for connective tissue disease",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-133026.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Laboratory testing for connective tissue disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Measurement of serum precipitating antibodies: Typically used to diagnose hypersensitivity pneumonitis, which is less likely given the lack of exposure history.</li><li>\u2022 Option A. Measurement of serum precipitating antibodies:</li><li>\u2022 Option C. Transbronchial biopsy: Can be helpful in certain interstitial lung diseases but may not provide sufficient tissue for a definitive diagnosis of NSIP or an underlying CTD.</li><li>\u2022 Option C. Transbronchial biopsy:</li><li>\u2022 Option D. Surgical lung biopsy : Provides more tissue for diagnosis but is more invasive. It may be considered if initial non-invasive tests do not yield a diagnosis.</li><li>\u2022 Option D. Surgical lung biopsy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Laboratory testing for connective tissue diseases is essential when HRCT shows features suggestive of Non Specific Interstitial Pneumonia (NSIP) to identify any underlying autoimmune conditions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ac989db3",
      "audio": ""
    },
    {
      "text": "A 60-year-old female is referred for chronic cough and dyspnea with exertion. Over the past year, her symptoms have steadily worsened. Pulmonary function testing shows FVC: 72%, FEV1: 80%, DLCO: 38%. HRCT of the chest is shown. Lung biopsy shows foci of scarring dispersed and surrounded by healthy lung parenchyma and fibroblasts. Which of the following is the appropriate therapy for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Pirfenidone",
          "correct": true
        },
        {
          "label": "B",
          "text": "Bosentan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acetylcysteine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Prednisolone/azathioprine",
          "correct": false
        }
      ],
      "correct_answer": "A. Pirfenidone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Bosentan: Primarily used to treat pulmonary arterial hypertension, not idiopathic pulmonary fibrosis.</li><li>\u2022 Option B. Bosentan:</li><li>\u2022 Option C. Acetylcysteine : An antioxidant used in the management of various conditions, but not first-line for IPF.</li><li>\u2022 Option C. Acetylcysteine</li><li>\u2022 Option D. Prednisolone/azathioprine: Immunosuppressive therapy that has not shown benefit and may even be harmful in patients with IPF.</li><li>\u2022 Option D. Prednisolone/azathioprine:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pirfenidone is the appropriate therapy for idiopathic pulmonary fibrosis (IPF), as it helps to slow disease progression.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f5454926",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman with suspected sarcoidosis presents with bilateral hilar lymphadenopathy, erythema nodosum, and distal renal tubular acidosis (dRTA). Which of the following statements about the disease is false?",
      "options": [
        {
          "label": "A",
          "text": "ACE is elevated in 60% of cases",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypercalcemia occurs in about 10% of patients",
          "correct": false
        },
        {
          "label": "C",
          "text": "BAL CD4/CD8 ratio > 3.5 is a characteristic finding",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lung biopsy is the gold standard for diagnosis",
          "correct": true
        }
      ],
      "correct_answer": "D. Lung biopsy is the gold standard for diagnosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. ACE is elevated in 60% of cases : Elevated angiotensin-converting enzyme (ACE) levels are seen in about 60% of patients with sarcoidosis.</li><li>\u2022 Option A. ACE is elevated in 60% of cases</li><li>\u2022 Option B. Hypercalcemia occurs in about 10% of patients : Hypercalcemia occurs in approximately 10% of patients with sarcoidosis due to increased production of vitamin D by granulomas.</li><li>\u2022 Option B. Hypercalcemia occurs in about 10% of patients</li><li>\u2022 Option C. BAL CD4/CD8 ratio > 3.5 is a characteristic finding : A high CD4/CD8 ratio in bronchoalveolar lavage (BAL) fluid is a characteristic finding in sarcoidosis.</li><li>\u2022 Option C. BAL CD4/CD8 ratio > 3.5 is a characteristic finding</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 While lung biopsy showing non-caseating granulomas is highly suggestive of sarcoidosis and can be critical in diagnosis, it is not considered the gold standard as the diagnosis often relies on a combination of clinical, radiographic, and histopathological findings. Other conditions can also present with non-caseating granulomas, necessitating clinical correlation and exclusion of other diseases for accurate diagnosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9d77912b",
      "audio": ""
    },
    {
      "text": "A 70-year-old male with a history of atrial fibrillation presents with progressive dyspnea and a dry cough over the past three months. He has been on amiodarone therapy for the past year. High-resolution CT of the chest reveals findings consistent with interstitial lung disease (ILD). All of the following medications are known to cause ILD except:",
      "options": [
        {
          "label": "A",
          "text": "Amiodarone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Methotrexate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bleomycin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cisplatin",
          "correct": true
        }
      ],
      "correct_answer": "D. Cisplatin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Amiodarone: Known to cause ILD, particularly with long-term use.</li><li>\u2022 Option</li><li>\u2022 A. Amiodarone:</li><li>\u2022 Option B. Methotrexate: Associated with ILD in patients, particularly those with rheumatoid arthritis.</li><li>\u2022 Option</li><li>\u2022 B. Methotrexate:</li><li>\u2022 Option C. Bleomycin: A chemotherapeutic agent well known for its potential to cause ILD</li><li>\u2022 Option</li><li>\u2022 C. Bleomycin:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Amiodarone, methotrexate, and bleomycin are known to cause drug-induced interstitial lung disease (ILD), while cisplatin is not typically associated with ILD; its primary toxicities are nephrotoxicity and ototoxicity.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b6768b25",
      "audio": ""
    },
    {
      "text": "A 55-year-old male with a 30-pack-year smoking history presents with progressive dyspnea and chronic cough. High-resolution CT of the chest shows diffuse interstitial changes. Which of the following interstitial lung diseases is least likely to be associated with smoking?",
      "options": [
        {
          "label": "A",
          "text": "Respiratory bronchiolitis associated ILD",
          "correct": false
        },
        {
          "label": "B",
          "text": "Desquamative Interstitial Pneumonia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Langerhans Cell Histiocytosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Usual Interstitial Pneumonia",
          "correct": true
        }
      ],
      "correct_answer": "D. Usual Interstitial Pneumonia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Respiratory bronchiolitis associated ILD: Commonly seen in smokers.</li><li>\u2022 Option</li><li>\u2022 A. Respiratory bronchiolitis associated ILD:</li><li>\u2022 Option B. Desquamative Interstitial Pneumonia: Strongly associated with smoking.</li><li>\u2022 Option</li><li>\u2022 B. Desquamative Interstitial Pneumonia:</li><li>\u2022 Option C. Langerhans Cell Histiocytosis: Typically seen in smokers and characterized by cystic lung disease.</li><li>\u2022 Option</li><li>\u2022 C. Langerhans Cell Histiocytosis:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective :</li><li>\u2022 Usual Interstitial Pneumonia is least likely to be associated with smoking.</li><li>\u2022 is least likely to be associated with smoking.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5bc32b42",
      "audio": ""
    },
    {
      "text": "A 55-year-old man with a history of working in a construction agency involved in rock tunnelling presents with acute onset of dyspnea, cough, and fatigue for the last 3 weeks. High-resolution CT shows diffuse ground-glass opacities and a crazy paving pattern. Bronchoalveolar lavage reveals large amounts of periodic acid-Schiff-positive material. Which of the following conditions is most likely ?",
      "options": [
        {
          "label": "A",
          "text": "Acute silicosis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Pulmonary alveolar proteinosis (PAP)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Idiopathic pulmonary fibrosis (IPF)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypersensitivity pneumonitis",
          "correct": false
        }
      ],
      "correct_answer": "A. Acute silicosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Acute silicosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Pulmonary alveolar proteinosis (PAP): Although PAP can present with similar imaging findings, the patient's occupational history and acute onset suggest acute silicosis.</li><li>\u2022 Option</li><li>\u2022 B. Pulmonary alveolar proteinosis (PAP):</li><li>\u2022 Option C. Idiopathic pulmonary fibrosis (IPF): Typically presents with chronic progressive dyspnea and honeycombing on imaging, not acute symptoms and crazy paving pattern.</li><li>\u2022 Option</li><li>\u2022 C. Idiopathic pulmonary fibrosis (IPF):</li><li>\u2022 Option D. Hypersensitivity pneumonitis: Related to environmental exposures, presenting with cough, dyspnea, and fatigue, but typically involves centrilobular nodules rather than crazy paving pattern</li><li>\u2022 Option</li><li>\u2022 D. Hypersensitivity pneumonitis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Acute silicosis can present with diffuse ground-glass opacities and a crazy paving pattern on high-resolution CT, and bronchoalveolar lavage may reveal large amounts of periodic acid-Schiff-positive material, reflecting occupational exposure to silica dust.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7c71ce5c",
      "audio": ""
    },
    {
      "text": "A 65-year-old man with a long history of working in construction presents with chronic cough and shortness of breath. He reports joint pain and stiffness, and a recent chest X-ray shows interstitial lung disease (ILD). Which of the following conditions is least likely to be associated with his diagnosis of silicosis?",
      "options": [
        {
          "label": "A",
          "text": "Interstitial lung disease (ILD)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronic obstructive pulmonary disease (COPD)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rheumatoid arthritis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lymphoma",
          "correct": true
        }
      ],
      "correct_answer": "D. Lymphoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Lymphoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Interstitial lung disease (ILD): Silicosis is a form of ILD caused by inhalation of silica dust.</li><li>\u2022 Option A. Interstitial lung disease (ILD):</li><li>\u2022 Option B. Chronic obstructive pulmonary disease (COPD): Long-term exposure to silica can lead to COPD.</li><li>\u2022 Option B. Chronic obstructive pulmonary disease (COPD):</li><li>\u2022 Option C. Rheumatoid arthritis: Silicosis can be associated with rheumatoid arthritis in the form of Caplan's syndrome.</li><li>\u2022 Option C. Rheumatoid arthritis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Silicosis is primarily associated with interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) due to inhalation of silica dust and can also be associated with autoimmune conditions like rheumatoid arthritis, but not with lymphoma.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "66c99c74",
      "audio": ""
    },
    {
      "text": "A 70-year-old man with a history of working in shipyards presents with chest pain and shortness of breath. Imaging reveals a pleural mass, and biopsy confirms malignant mesothelioma. Which of the following is true regarding the association of mesotheliomas with asbestos exposure?",
      "options": [
        {
          "label": "A",
          "text": "Mesotheliomas are strongly associated with smoking",
          "correct": false
        },
        {
          "label": "B",
          "text": "Short-term asbestos exposures of \u22641\u20132 years can lead to mesotheliomas",
          "correct": true
        },
        {
          "label": "C",
          "text": "Mesotheliomas are not associated with asbestos exposure",
          "correct": false
        },
        {
          "label": "D",
          "text": "Mesotheliomas develop within a few years of exposure to asbestos",
          "correct": false
        }
      ],
      "correct_answer": "B. Short-term asbestos exposures of \u22641\u20132 years can lead to mesotheliomas",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Short-term asbestos exposures of \u22641\u20132 years can lead to mesotheliomas</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Mesotheliomas are strongly associated with smoking: Mesotheliomas are not associated with smoking.</li><li>\u2022 Option A. Mesotheliomas are strongly associated with smoking:</li><li>\u2022 Option C. Mesotheliomas are not associated with asbestos exposure: Mesotheliomas are indeed associated with asbestos exposure.</li><li>\u2022 Option C. Mesotheliomas are not associated with asbestos exposure:</li><li>\u2022 Option D. Mesotheliomas develop within a few years of exposure to asbestos: Mesotheliomas can develop decades after exposure to asbestos.</li><li>\u2022 Option D. Mesotheliomas develop within a few years of exposure to asbestos:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mesotheliomas are strongly associated with asbestos exposure and can develop even after short-term exposures of \u22641\u20132 years, occurring up to 40 years in the past. They are not associated with smoking.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "45420881",
      "audio": ""
    },
    {
      "text": "A 65-year-old retired construction worker presents for a routine check-up. His chest radiograph is shown. What does it indicate?",
      "options": [
        {
          "label": "A",
          "text": "Significant pulmonary impairment",
          "correct": false
        },
        {
          "label": "B",
          "text": "Past exposure to asbestos",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pleural effusion",
          "correct": false
        },
        {
          "label": "D",
          "text": "Active tuberculosis infection",
          "correct": false
        }
      ],
      "correct_answer": "B. Past exposure to asbestos",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-124125.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Past exposure to asbestos</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Significant pulmonary impairment: Pleural plaques indicate exposure but do not imply pulmonary impairment without additional manifestations.</li><li>\u2022 Option A. Significant pulmonary impairment:</li><li>\u2022 Option C. Pleural effusion : Benign pleural effusions can occur with asbestos exposure but are not seen in this CXR</li><li>\u2022 Option C. Pleural effusion</li><li>\u2022 Option D. Active tuberculosis infection: Pleural plaques are not associated with tuberculosis (but silicosis has association)</li><li>\u2022 Option D. Active tuberculosis infection:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Chest X-ray showing bilateral calcified pleural plaques indicates past exposure to asbestos. Pleural plaques are a hallmark of asbestos exposure but do not imply significant pulmonary impairment without additional findings.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f3ec75d8",
      "audio": ""
    },
    {
      "text": "A 55-year-old woman presents with acute onset of severe dyspnea and fever. She was previously healthy but has rapidly deteriorated over the past week. Chest X-ray shows diffuse bilateral alveolar infiltrates, and HRCT of the chest reveals widespread ground-glass opacities and consolidation. Routine work up did not reveal any identifiable cause. Lung biopsy demonstrates diffuse alveolar damage with hyaline membrane formation. What is the likely diagnosis ?",
      "options": [
        {
          "label": "A",
          "text": "Acute interstitial pneumonia (AIP)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Acute respiratory distress syndrome (ARDS)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cryptogenic organizing pneumonia (COP)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Idiopathic pulmonary fibrosis (IPF)",
          "correct": false
        }
      ],
      "correct_answer": "A. Acute interstitial pneumonia (AIP)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Acute interstitial pneumonia (AIP)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Acute respiratory distress syndrome (ARDS): While ARDS also presents with diffuse alveolar damage and similar imaging findings, it is typically secondary to an identifiable cause such as sepsis, trauma, or pneumonia, whereas AIP occurs without a known trigger.</li><li>\u2022 Option B. Acute respiratory distress syndrome (ARDS):</li><li>\u2022 Option C. Cryptogenic organizing pneumonia (COP) : Usually presents with subacute symptoms and patchy lung infiltrates, not rapid onset and diffuse alveolar damage.</li><li>\u2022 Option C. Cryptogenic organizing pneumonia (COP)</li><li>\u2022 Option D. Idiopathic pulmonary fibrosis (IPF): Characterized by chronic progressive dyspnea and fibrosis with honeycombing, not acute onset or diffuse alveolar damage.</li><li>\u2022 Option D. Idiopathic pulmonary fibrosis (IPF):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Acute interstitial pneumonia (AIP) is characterized by rapid onset of severe respiratory symptoms, diffuse bilateral alveolar infiltrates, and lung biopsy showing diffuse alveolar damage with hyaline membrane formation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "13388b2e",
      "audio": ""
    }
  ]
}